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Abstract 
ALCOHOL AND MEDICATION USE IN COMMUNITY-DWELLING OLDER ADULTS: 
UNDERSTANDING THE EFFECT OF ALCOHOL AND CENTRAL NERVOUS SYSTEM-
ACTING MEDICATIONS ON THE RISK FOR FALLS 
By Maitreyee Mohanty, Ph.D. 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University. 
Advisor: Dr. Patricia Slattum, Professor and Director of Geriatric Pharmacotherapy Program  
Department of Pharmacotherapy and Outcomes Science  
Virginia Commonwealth University, 2013. 
 
Introduction: Aging, comorbid conditions, and use of medications render older adults more 
susceptible to alcohol-disease or alcohol-drug interactions that may lead to harmful outcomes. In 
this dissertation project the risk profile of alcohol and medications use among older adults was 
investigated. Considering the rise in CNS-acting medication use and the adverse effect profile 
linked to CNS-acting medications, it was also of interest to find if older adults were at risk of 
falling due to interactions between alcohol and CNS-acting medication.  
Objectives: The objectives were as follows: 1) to determine the prevalence, pattern and factors 
associated with at-risk drinking, 2) to determine the prevalence and pattern of potential 
concurrent use of CNS-acting medication and alcohol, and to identify factors associated with 
alcohol use among CNS-acting medication users, 3) to assess the effects of potential concurrent 
use of CNS-acting medications and alcohol on the risk for falls in older adults.  
Methods: The study population comprised a nationally representative sample of community-
dwelling older adults aged 65 years or older. The 2009 Medicare Current Beneficiary Survey 
(MCBS) data (n=7163) were employed to determine at-risk drinking based on the Comorbidity 
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Alcohol Risk Evaluation Tool (CARET) and to assess the effects of potential concurrent use of 
CNS-acting medication and alcohol on the risk for falls. The National Health and Nutrition 
Examination Survey (NHANES) 2005-2010 data (n=3220) were employed to determine 
potential concurrent use of alcohol and CNS-acting medications. The effect of combined use of 
alcohol and CNS-acting medications on risk of falls was assessed using logistic regression 
modeling and adjusting for confounders. Alcohol consumption was measured by the quantity-
frequency method. 
Results: In the MCBS study, 5.6% of the older adults were identified as at-risk drinkers. Adults 
aged between 65-74 years, being male, non-married, former or current smoker, and having no 
comorbid conditions were factors associated with at-risk drinking. In the NHANES study, 8.9% 
reported potential concurrent use of alcohol and CNS-acting medication. Use of at least one 
CNS-acting medication and drinking excessive alcohol, or binge drinking, was significantly 
associated with odds of falling.  
Conclusion: Hazardous alcohol use is common among older adults. A substantial proportion of 
older adults may concomitantly consume alcohol and CNS-acting medications. Odds of falling 
are greater in the presence of high alcohol intake and CNS-acting medication use. It is important 
for health care professionals to warn patients against excessive alcohol consumption. Increasing 
awareness of this issue among older adults and caregivers may help prevent falls. Contributions 
from healthcare professionals in the form of screening for potentially harmful alcohol use, 
prescription monitoring, and initiating counseling may help to reduce older adults’ risk for falls 
or other adverse effects. 
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Chapter 1 
Section 1.1 Introduction 
Alcohol use is prevalent among community-dwelling older adults and is projected to 
increase in the coming years with the aging of the baby-boomer generation. Few observational 
studies have attempted to understand the extent of alcohol use taking comorbid conditions and 
medication use into consideration. As older adults are the leading consumers of medications in 
the U.S., it is essential to understand what proportion of older adults could be at risk of 
experiencing an alcohol-medication interaction due to concurrent use of alcohol and alcohol-
interactive medications. Additionally, it is also important to investigate the impact of the 
potential concurrent use of alcohol and alcohol-interactive medications in older adults on health 
outcomes. Based on the high rates of use and risk profile of central nervous system (CNS)-acting 
medications observed in older adults, this class of medication was selected to be studied. In 
addition, CNS-acting medications share similarity with alcohol, originating from comparable 
pharmacological effect. The interaction between alcohol and CNS-acting medications potentiates 
sedation and impairment of psychomotor functions which may lead to falls, and this hypothesis 
outlines the rationale for the study.  
To provide an overview of this document, this section describes the specific aims, 
hypotheses and significance of this research endeavor. The Chapter 2 provides background 
information and elucidates the conceptual framework supporting the study. The chapter 3 
reviews of literature focusing on alcohol-medication use in older adults. Chapters 4, 6, and 5, 
details the results and discussion for each of the study objectives. Finally, the chapter 7 
summarizes the conclusions and includes suggestions for future research.    
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Section 1.2 Specific Aims 
Specific Aim 1  
I. To determine the prevalence and pattern of at-risk drinking among non-institutionalized 
older adults 
II. To identify factors associated with at-risk drinking among non-institutionalized older 
adults  
Specific Aim 2 
I. To determine the prevalence and pattern of potential concurrent use of alcohol and 
central nervous system (CNS)-acting medications among non-institutionalized older 
adults 
II. To identify factors associated with daily alcohol use among older adults taking at least 
one CNS-acting medication. 
Specific Aim 3 
I. To determine if alcohol use is associated with the risk of falling among older adults. 
II. To determine if alcohol use is associated with risk for injurious falls in older adults. 
III. To determine if alcohol use is associated with risk for recurrent falls in older adults. 
IV. To determine if varying levels of alcohol use along with CNS-acting medication use is 
associated with risk for falls among older adults.  
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Section 1.3 Hypotheses 
These hypotheses apply to Specific Aim III. Considering the likelihood that older adults 
exhibit concurrent use of alcohol and CNS-acting medication, it is of interest to understand the 
combined effect of alcohol and CNS-acting medication on the risk of falling in older adults. As 
documented by previous studies, high alcohol consumption and CNS-acting medication use have 
been separately associated with risk of falling.
1
 Pharmacologically, both alcohol and CNS-acting 
medication (included in this study) have CNS depressant effects and may cause sedation, 
dizziness, and impairment of psychomotor functions which may lead to accidental falls
2
. Thus, 
based on evidence available in the literature and pharmacological plausibility, we hypothesize 
the following. 
A. High alcohol consumption is significantly associated with higher odds of falling 
B. High alcohol consumption is significantly associated with increased odds of injurious 
fall 
C. High alcohol consumption is significantly associated with increased odds of recurrent 
falls 
D. Older drinkers taking CNS-acting medication and consuming alcohol are at greater 
odds of falling than older adults either taking CNS-acting medication only or 
consuming alcohol only 
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Section 1.4 Significance 
 The older population constitutes the fastest growing segment of the U.S. population. 
They formed 12.9% of the U.S. population in the year 2000 and by 2030 this group is projected 
to grow to be 19% of the population.
3
 The coming years will also witness the aging of the baby-
boomer generation (individuals born during 1946-1964) ushering in a sustained demand for 
healthcare services catering to the needs of older adults. This generation reportedly uses more 
illicit drugs than the preceding generation.
4,5
 Assuming that the cohort with greater lifetime rates 
of drug use will exhibit current drug use, (notwithstanding the trend of decrease in use of drugs 
of abuse with age) an increase in the number of older adults with substance abuse problems is 
expected.
5
 The large size of this cohort coupled with the higher rate of substance abuse is 
predicted to result in an unprecedented number of older adults requiring substance abuse 
treatment in the future.  
 According to the projections, the nonmedical use of psychotherapeutic drugs will rise 
from 1.2% (911,000) in 2001 to 2.4% (approximately 2.7 million) in 2020.
5
 The increase in 
prescription drug abuse may result in a rise in emergency department visits and greater 
healthcare costs. Another study predicted that older adults requiring treatment for substance 
abuse problem will increase from approximately 1.7 million in 2000-2001 to approximately 4.4 
million in 2020.
4
 
 The use of CNS-acting medications including opioid analgesics, antidepressants, and 
sedatives-hypnotics by older adults is reportedly rising.  A longitudinal study of community-
dwelling older adults found that 13.9% (n=2737) of participants used at least one CNS-active 
medication and the prevalence increased to 17.1% (n=1907) over 5 years.
6
 In 2011, emergency 
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department visits involving drugs and alcohol consumed together by older adults was reported to 
be 9,190 visits out of total of 606,653 visits.
7
 The projected increase in the use of psychoactive 
substances may translate into greater need for specialized treatment as well as preventive 
measures catering to substance abuse patients. Historically, preventive measures have focused on 
young adults. There is a dearth of research on how to address and manage drug abuse problems 
in the older generation. In addition, since most of the predictions are based on the assumption 
that lifetime users will continue to use illicit drugs, alcohol, and psychotropic drugs it is 
important to verify these assumptions. Observational studies conducted among a nationally 
representation sample of older adults assessing alcohol use, factors and adverse outcomes 
associated with alcohol use, are needed.  
 Understanding the impact of the concurrent use of alcohol and CNS-acting medications 
on the risk of falling in older adults will be helpful in planning preventive measures to lower the 
incidence of falls in high risk older adults. In situations where CNS-acting medications cannot be 
discontinued patient at risk for falls due to their concurrent alcohol and CNS-acting medication 
use can be counselled to monitor, reduce or stop drinking. Falls significantly impact on the 
health and quality-of-life of older adults.
8,9
 Falls are widespread among older adults and are a 
common cause of hospital admissions. The total direct medical cost of fall-related injuries in 
older adults in 2010 was estimated to be $30 billion, adjusting for inflation.
10
 It is projected that 
by 2020, the annual direct and indirect cost of fall injuries will reach $54.9 billion (in 2007 
dollars).
11
 Therefore, generating evidence to identify risk factors for falls in order to inform the 
development and implementation of appropriate preventive measures to lower the risk for falls in 
older adults is crucial.  
 
6 
 
Chapter 2 
Section 2.1 Background 
2.1.1 Alcohol  
Alcohol is one of the oldest psychoactive agents and is widely used in our society for 
many reasons including stress relief, sleep induction, recreational purposes or for its apparent 
medicinal value.
12
 Currently, 59.6% of American adult women and 71.8% of American adult 
men reported having at least one drink in the past year.
13
  
Beer, wine, and spirits are three major types of alcoholic beverages consumed across the 
world.
14
 In the U.S., a standard drink is defined as any drink that contains about 14 grams of pure 
alcohol and is equivalent to 12 ounces (oz.) of beer, 8-9 oz. of malt liquor, 5 oz. of table wine 
and 1.5 oz. of distilled spirits.
15
 The pattern of alcohol consumption is a factor which has 
substantial impact on the health outcomes associated with alcohol use. The pattern of alcohol 
consumption is often characterized in the following scheme: lifetime abstainers, former drinkers, 
light drinkers, moderate drinkers, heavy drinkers, and binge or heavy episodic drinkers.
14
  
Alcohol consumption can impart a broad range of consequences on the physical and 
mental health of a drinker, depending on a variety of factors such as age and gender of drinkers, 
type of alcohol, and pattern of consumption.
14
 It may also have adverse social, legal, 
occupational consequences. Alcohol consumption is the world’s third largest risk factor for 
disease and disability; in middle-income countries, it is the greatest risk factor.
14
 Alcohol is a 
causal factor in 60 types of diseases and injuries and a component cause in 200 others.
14
 In the 
United States, alcohol contributes to 79,000 deaths and $223.5 billion in societal costs 
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annually.
16
 Almost 9% of U.S. adults (approximately 13% of those who drink) meet the criteria 
for an alcohol-use disorder.
17
  
A growing body of literature has shown the beneficial effects of moderate alcohol 
consumption. Epidemiological studies have found that moderate alcohol consumption (not more 
than 2 drinks per day) lowers risks for cardiovascular events, mortality, cognitive decline, and 
fractures.
18
 Current findings suggest a U or J-shaped relationship between alcohol consumption 
and coronary artery disease.
18
  Moderate alcohol consumption has an impact on the psychosocial 
functioning in older adults; by facilitating social interaction, improving mood and stimulating 
appetite.
18
   
2.1.2 Pharmacology of Alcohol  
Alcohol has a complex pharmacology and is known to affect a wide variety of 
neurotransmitter systems. Alcohol exerts its primary action via a number of central nervous 
system neurotransmitter or neuromodulator systems, including the N-methyl-D-aspartate 
(NMDA), Gamma-aminobutyric acid (GABAA), glycine, 5-hydroxytryptamine 3 (5-HT3) and 
nicotinic acetylcholine receptors (nAChRs) as well as L-type Ca2+ channels and G protein-
coupled inwardly-rectifying potassium channels (GIRKs).
19
 Basically, it acts by disrupting 
distinct receptor or effector proteins via direct or indirect interactions, whereas at very high 
concentrations it might even change the composition of lipids in the surrounding membrane.
19
 
The NMDA function was inhibited by alcohol in a concentration-dependent fashion.
19
 Alcohol 
enhances the function of GABAA and glycine receptors. In addition, alcohol potentiates 
serotonin (5-HT3) and nAChR functions. By acting on the aforementioned receptors, alcohol 
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increases endogenous serotonin, dopamine and opioid release.
19
 Ion channels also constitute a 
primary target of alcohol. Alcohol inhibits dihydropyridine-sensitive L-type Ca2+ channels.
19
 
Alcohol, a CNS depressant, can stimulate pulse, motor activity, and mood in small doses 
whereas higher dose of alcohol can impair cognitive and motor function, cause respiratory 
depression and in severe cases cause coma and death. Behavioral, psychomotor, and cognitive 
changes begin to occur at a blood alcohol concentration (BAC) of 0.02-0.03 (grams of alcohol 
per 100 grams of individual's blood).
19
   
Alcohol ingested by mouth reaches the stomach, where a small portion is metabolized by 
the enzyme alcohol dehydrogenase (ADH). The remaining alcohol enters the intestine, where 
most of it is absorbed into the blood and enters the portal system that leads to liver. 
20,21
 A part of 
that alcohol is metabolized in the liver by ADH and cytochrome P450 enzymes. The remaining 
alcohol enters the systemic circulation and from there gets distributed throughout the body 
water.
20,21
 The liver is the primary site of alcohol metabolism. ADH converts alcohol to 
acetaldehyde in an oxidative reaction. Acetaldehyde is further metabolized by aldehyde 
dehydrogenase (ALDH) to acetate and acetyl CoA.
20,21
   
2.1.3 Alcohol Consumption in Older Adults 
Alcohol consumption declines with age with older adults consuming less alcohol than 
their younger counterparts.
22
 Though a plethora of studies have been conducted to understand 
different facets of alcohol use, comparatively fewer studies have been performed to understand 
the effect of alcohol consumption on health-related outcomes in older adults.  
Alcohol has greater physiological impact on older adults than on younger adults for a 
variety of reasons. First and foremost, age-related changes in physiology significantly affect the 
9 
 
response of older adults to alcohol. As lean body mass decreases with age, the total body water 
also decreases while fat increases as a proportion of body weight. Since alcohol distributes in 
total body water, this alteration in the volume of total body water means that for a given dose of 
alcohol, the concentration of alcohol in the blood is greater in an older adult than in a younger 
adult. As a result, the same amount of alcohol that previously had little effect may now cause 
intoxication.
22,23
 Furthermore, it is postulated that this relative change in alcohol concentration in 
blood accompanied with slower reaction time observed among older adults could be responsible 
for the accidents or injuries that are observed in this age group.
23
 The reduced secretion of gastric 
alcohol dehydrogenase enzyme causes alcohol to be metabolized more slowly so the blood 
alcohol level remains raised for a longer time.
2
 The widespread use of alcohol and medication by 
older adults, especially in the presence of chronic comorbid conditions, renders them vulnerable 
to the adverse effects of alcohol-medication interactions as well. Older adults consume more 
medication than any other age group. According to the National Council on Patient Information 
and Education (NCPIE) 34% of all prescription medication and 30% of all over-the-counter 
medication is used by older adults.
24
 In addition, one-third of Medicare beneficiaries have four or 
more chronic conditions and these may be treated with medications.
24
 
Detection of alcohol problems in older adults is often difficult. The social stigma attached 
to alcohol consumption may prevent older adults from disclosing their actual amount of 
consumption.
22,25
 Driven by biases and stereotypes, healthcare practitioners may not enquire 
about older patients’ alcohol use. Healthcare professionals and older adults may avoid discussing 
alcohol consumption.
22,25
 Symptoms associated with heavy drinking, alcohol dependence or 
abuse may coincide with symptoms of other diseases such as depression, dementia, and 
10 
 
psychiatric disorders.
22,25
 Due to the aforementioned reasons alcohol use in older adults is 
described as a “hidden epidemic”.22  
The prevalence of alcohol use reported by various studies may differ in proportion but the 
pattern of consumption remains similar. According to the 2011 National Survey on Drug Use 
and Health (NSDUH) findings, the prevalence of current alcohol use (at least one drink in the 
past 30 days) is 40.3% among participants aged 65 years or older. 8.3% of older adults reported 
binge drinking (five or more drinks on the same occasion on at least 1 day in the past 30 days) 
while the rate of heavy drinking was 1.7% (five or more drinks on the same occasion on each of 
5 or more days in the past 30 days) in this group.
26
 Cross-sectional analysis of multisite 
screening data obtained from older patients in primary care older reported 70.0% had no 
consumption of alcohol in the past year, 21.5% were moderate drinkers (1-7 drinks/week), 4.1% 
were at-risk drinkers (8-14 drinks/week), and 4.5% were heavy drinkers (>14 drinks/week).
27
 On 
the other hand, analysis of the Medicare Current Beneficiary Survey (MCBS) data showed that 
65.5% of the sample reported drinking no alcohol, 25.4% reported drinking within guidelines 
(not more than 30 drinks per month), 3.8% exceeded the monthly limit only (more than 30 drinks 
per month), and 5.4% reported heavy episodic drinking (4 or more drinks in a single occasion), 
during a typical month in the past year.
28
 Thus, comparing the prevalence rates of alcohol use 
becomes difficult owing to the design and setting of the study, definitions and measures of 
alcohol consumption used in the study, and characteristics of the study sample. However, the 
prevalence rates of the aforementioned studies indicate that substantial proportion of older adults 
consumes alcohol. It is noteworthy that these proportions are likely to be an underestimation of 
the true proportion. Under-reporting of alcohol consumption, whether unintentional (due to recall 
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bias or type of survey questions), or intentional (due to social stigma attached to drinking) is 
common.
22
    
Alcohol use imparts various benefits and detriments to the health of older adults. 
Moderate alcohol consumption has been claimed to be beneficial in reducing the risk of the 
cardiovascular diseases and dementia.
18
 In addition, it is documented to improve cognition, 
psychological functioning, bone metabolism, and mortality.
18
 However, immoderate amount of 
alcohol intake has been found to have hazardous effects on physical and mental health.
18
 Chronic 
heavy drinking is associated with numerous health issues including but not limited to, hepatic 
disease, cardiovascular disease, various forms of cancer, diabetes mellitus, alcohol dependence 
or abuse, injuries, and accidents.
18
 
2.1.4 Alcohol and Medication Interactions  
A large number of medications have the potential to interact with alcohol. There are two 
types of alcohol-medication interactions: pharmacokinetic and pharmacodynamics 
interactions.
2,21,29
 Quantity and frequency of alcohol consumption also influences the outcome of 
alcohol-medication interactions.  
In a pharmacokinetic interaction, alcohol interferes with the absorption, distribution, 
metabolism and elimination of the medication or vice versa. Drinks with a high alcohol 
concentration will delay gastric emptying and this may affect the absorption of some drugs (for 
example propranolol, metoclopramide, and cisapride).
20
 Some drugs may block the first pass 
metabolism of the alcohol in the liver resulting in elevated blood alcohol levels. Examples of 
such medications are H2 receptor antagonists: cimetidine, ranitidine, and nizatidine. Cytochrome 
P450 enzymes (primarily CPY2E1) play an important role in the metabolism of alcohol. Hence 
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certain medications (such as benzodiazepines, barbiturates, warfarin, phenytoin, propranolol, 
tolbutamide, isoniazid, and highly active antiretroviral therapy (HAART) drugs) require the 
same enzyme for metabolism as alcohol and therefore compete with alcohol for metabolism.
21
 It 
must be noted that the effect of CYP enzyme related interaction is influenced by the pattern of 
alcohol consumption. In chronic heavy drinkers, CYP2E1 activity is induced up to tenfold. When 
such drinkers are sober with no alcohol in the body to compete with medications for metabolism, 
those medications undergo more rapid metabolic clearance. As a result, medications will require 
higher doses to achieve a therapeutic effect. However, acute heavy drinking inhibits the hepatic 
drug metabolism. Thus, the drug competes with alcohol for metabolism and these drugs will be 
metabolized more slowly.
2,21,29,30
 
Several medications can inhibit the ALDH enzyme and thereby increases the aldehyde 
level in blood causing flushing (dilation of blood vessels, low blood pressure, rapid heartbeat). 
Some examples of such medications are longer acting hypoglycemic agents, namely 
chlorpropamide, and tolbutamide, and beta-lactum cephalosporin such as cefamandole.
2
 Foods 
and beverages with tyramine, including red wine and beer, can increase the risk if hypertensive 
crisis when consumed with nonselective monoamine oxidase inhibitors.
2
 
In pharmacodynamic interactions, alcohol alters the effect/response of the medication. 
They do not involve enzyme inhibition or activation but rather refer to the additive effects of 
alcohol and certain medications on the body. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 
when combined with alcohol may increase the risk of gastrointestinal bleeding by injuring 
gastric mucosa and increasing bleeding time.
2,21,29
 Antiplatelet agents including aspirin, 
clopidogrel, and ticlopidine also increase the risk of bleeding.
28
 Alcohol, when consumed 
concomitantly with antihypertensive agents potentiates orthostatic hypotension.
2
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Antihypertensive agents such as vasodilators, hydralazine, nitrates, central-acting hydralazine, 
central-acting antihypertensives, and alpha-blockers, may cause a severe drop in blood pressure 
leading to dizziness and fall-related injuries when taken with alcohol.
2
 Another important class 
of medication that exhibits additive pharmacodynamic interaction with alcohol is CNS-acting 
medications.
2,21,29
 Alcohol can also have an adverse impact on disease conditions such as 
hypertension, diabetes mellitus, gout, hepatic diseases, depression, insomnia, and various forms 
of cancer.
2,21,29
 
2.1.5 Interaction between Alcohol and CNS-Acting Medications  
Both alcohol and CNS-acting medications are widely used. Both of the agents are 
psychoactive substances with similar mechanisms of action.
2,21,29
 There is more than one ways in 
which alcohol can interact with CNS-acting medications.
31
 The most prevalent type of 
interaction is the additive pharmacodynamics interaction between CNS depressants and alcohol. 
Concomitant use of CNS depressants and alcohol synergistically enhances the side effects 
(including sedation, impairment of judgment and motor functions) of these drugs. Alcohol and 
some CNS depressants act on the same neurotransmitter system (GABA receptors, release of 
dopamine, serotonin).
2,21,29
  Pharmacokinetic interactions between certain CNS depressants and 
alcohol also exist. Alcohol and certain CNS depressants such as phenytoin, benzodiazepines, and 
barbiturates, may compete to be metabolized by the same metabolic enzyme.
21,29
  Apart from 
interacting with CNS-acting medications, alcohol is also associated with behavioral health 
problems. The literature has documented a complex, bidirectional relationship between alcohol 
and depression. Problematic alcohol consumption accompanied by depression
32
 significantly 
increases the potential for poor mental and physical health outcomes. The overlapping signs and 
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symptoms of substance abuse and depression may lead to misdiagnosis, or missed diagnosis by 
clinicians. Heavy drinking also interferes with the quality of sleep.
2
  
2.1.6 CNS-Acting Medication Use in Older Adults  
Use of CNS-acting medication, including antidepressants, anxiolytics, sedatives-
hypnotics, anticonvulsants, antipsychotics, and opioid analgesics, is widespread among older 
adults living in all types of settings, including assisted-living facilities, nursing homes, or 
congregate retirement communities.
33,34
  A study using Medical Expenditure Panel Survey 
(MEPS) data from year 2004-2009 found that there was an increase in the use of  following 
classes of medications; psychotropic medication (from 57.4% to 63.8%, p-value <0.01), 
benzodiazepines (from 22.7% to 30.5%, p-value <0.01), atypical antipsychotics  (from 2.3 to 
3.9%, p<0.01) in the span of 5 years.
34
 These drugs are prescribed for various purposes including 
treating psychiatric conditions, sleep disorders, mood disorder, and alleviating pain, stress, and 
anxiety.
32
   
Unfortunately these medications are associated with several adverse effects including 
falls, fractures, accidents, cognitive impairment, and hospitalizations.
32
 Use of some of these 
drugs, by itself or at a certain dose, is deemed as inappropriate for older adults. Psychotropic 
drugs listed in the Beer’s criteria include, but not limited to, amitriptyline, clomipramine, 
imipramine, doxepine, atypical antipsychotics, long-acting and short-acting benzodiazepines, 
chronic use of zolpidem, and zaleplon,.
35
 
The growing use of CNS-acting medications and alcohol warrants an investigation on the 
effect of the potential concomitant use of alcohol and CNS-acting medication. A variety of 
factors influence the use and potential misuse of CNS-acting medications. The aging process, 
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coexisting disease conditions, increasing dependency, life-changing events such as retirement, 
bereavement and other psychosocial stressors may drive older adults to use psychotropic 
medications.
36
 
2.1.7 Falls in Older Adults  
The World Health Organization (WHO) defines a fall as “inadvertently coming to rest on 
the ground floor or other lower level, excluding intentional change in position to rest in furniture, 
wall or other objects”.37 Falls are the leading cause of injury-related deaths and are a common 
cause of non-fatal injuries inn older adults. In 2010, 2.3 million nonfatal fall injuries among older 
adults in the U.S. were treated in emergency departments and more than 662,000 of these 
patients were hospitalized.
38
 Accidental falls may result in fractures, concussions, bruises, 
dislocation, sprains, and open wounds. Fractures (41.0%) are the most common reason for 
injurious fall-related emergency department visits, followed by superficial/contusion injuries 
(22.6%) and open wounds (21.45%).
39
 
CNS-acting medications have been implicated as a risk factor for falls in older adults.
40
 
Acute and or heavy alcohol consumption has also been associated with the risk of falls in older 
adults.
1
 The pharmacodynamic interaction between the alcohol and CNS-acting medications is 
the basis of the biological plausibility that concomitant use of CNS-acting medication and 
alcohol may increase the risk of falling.
2
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 Section 2.2 Conceptual Framework  
2.2.1 Conceptual Framework for At-Risk Drinking  
This dissertation study is based on the concept that alcohol can interact with selected 
diseases, certain classes of medications, and health-related behaviors (such as falls, memory 
problem, or sleeping problem) and this interaction may lead to adverse health outcomes. Older 
adults are more susceptible to alcohol-medication or alcohol-disease interactions due to several 
age-related changes. These age-related physiologic changes
23
 include, i) decline in total body 
water in which alcohol distributes as a result of which older adults achieve higher blood alcohol 
concentration (BAC) than younger adults after consuming same volume of alcohol, ii) functional 
changes (including changes in the neurotransmitters, receptors, hormonal changes) in the aging 
brain increases the brain’s sensitivity to the psychoactive effect of alcohol, and iii) decrease in 
the secretion of gastric enzymes slowing down the metabolism (this may play a minor role).
2
 
Thus, due to the above mentioned age-related changes older adults may experience exaggerated 
response to alcohol. Besides, aging may also affect the body’s ability to develop tolerance.23 
Moreover, as older adults tend to suffer from comorbid conditions and take numerous 
medications, the probability of encountering alcohol-disease or alcohol-medication interaction 
increases.
2
 
The first objective of the study is to understand the extent of alcohol use in context with 
disease conditions, medication use, and health-related behaviors. The purpose is to measure the 
extent of risk a community-dwelling older adult may exhibit owing to their disease profile, 
medication use and other health related behaviors.  
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Figure 2.1 Conceptual Framework of At-Risk Drinking 
Depending upon the pattern, volume, duration of consumption, and type of alcoholic 
beverages consumed, alcohol may interact with certain medications or disease conditions causing 
adverse events.
41
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use that is excessive or potentially harmful in combination with select comorbidities or 
medications”.41 
This risk assessment tool incorporates a list of disease conditions that may be affected by 
alcohol intake. Table 2.1 describes the alcohol-disease interaction, the mechanisms of action and 
its repercussions on the health of older adults.
2
 There are other disease conditions that may 
interfere with alcohol use but this study focused on disease states listed in Table 2.1.  
Table 2.1 Alcohol-Disease Interactions
2,21
 
Disease  Mechanism of action  Effect  
Hypertension Alcohol can cause a dose-dependent 
increase in blood pressure 
Increases the risk of 
hypertension 
Diabetes Alcohol suppresses hepatic 
gluconeogenesis. Drinking without 
eating may increase the risk of 
hypoglycemia. Consuming sweet 
alcohol beverage may induce 
hyperglycemia.  
Affects blood glucose 
levels  
Hepatic disorders Alcohol worsens hepatic disease 
through inflammation and accelerates 
disease progression.   
Increases the risk of 
cirrhosis and hepatocellular 
cancer. 
Gout Alcohol induces a hyperuricemic 
effect  
Increases the risk of gout 
Depression  Alcohol affects mood and depressive 
symptoms. A strong bidirectional 
relationship exists between alcohol 
and depression 
Exacerbation of depressive 
symptoms 
 
The CARET questionnaire also includes selected medications that have the potential to 
interact with alcohol. There are other medications that may interact with alcohol to cause adverse 
effects but this study included medications listed in Table 2.2 which describes the mechanism of 
action as well as effects of each alcohol-medication interaction.
2
   
19 
 
 
Table 2.2 Alcohol-Medication Interactions
2,21
 
Medications  Mechanism  Effect  
CNS-acting medications 
including benzodiazepines, 
barbiturates, sedatives-
hypnotics, anticonvulsants,  
antidepressants, sedating-
antihistamines, opioid 
analgesics 
Alcohol enhances the side 
effects of these medications 
such as sedation, drowsiness, 
impairment of psychomotor 
functions, postural sway, 
affects gait and balance.  
Drowsiness, sedation, fall, 
accidents, injuries. 
Warfarin  During acute intake, alcohol 
may compete with liver 
enzymes decreasing warfarin 
metabolism resulting in 
increased anticoagulation. 
Chronic intake of alcohol 
induces enzymes resulting in 
increasing warfarin metabolism 
thereby decreasing 
anticoagulation 
Interferes with the 
effectiveness of the drug 
(may cause bleeding) 
Antiplatelet agents (aspirin, 
clopidogrel, ticlopidine) 
Affects gastric mucosa and 
increases gastric emptying 
Gastrointestinal bleeding 
Antihypertensives including 
nitrates, vasodilators, alpha-
blockers, diuretics, 
hydralazine, centrally-acting 
antihypertensives  
Impairs vasoconstriction 
leading to severe drop in blood 
pressure  
Hypotension 
NSAIDs Due to increase in production 
of metabolites toxic to the liver, 
damaging gastric mucosa 
Hepatic toxicity 
Anti-ulcer medications 
including proton pump 
inhibitors and H2 antagonists 
Interferes with alcohol 
metabolism by reducing ADH 
activity in gastric mucosa and 
increasing gastric emptying 
Increases blood alcohol 
levels 
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Understanding the factors associated with at-risk drinking is important in order to identify 
“high-risk” individuals and direct preventive measures to maximize the reduction of alcohol-
related adverse outcomes. Previous studies have documented relationships between at-risk 
drinking and other factors including demographic factors (such as age, gender, race, and marital 
status), socio-economic status (education, income, employment), and health and functional 
status.
42,43
 Few studies have explored the relationship between at-risk drinking, comorbidities, 
and medication use.
42
  
This study aims to identify the factors, including socio-demographic factors, perceived 
health status, functional status, comorbidities and medications that could be related to at-risk 
drinking in older adults.  
Figure 2.2 graphically depicts the complex inter-relationship between at-risk drinking and 
diverse factors. More research is needed to understand the directionality and magnitude of these 
associations and other mediating factors.  
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Figure 2.2 Inter-relationships Between Various Factors Associated with At-Risk Drinking 
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2.2.1 Conceptual Framework for Alcohol and CNS-Acting Medication Interaction 
As described in Table 2.2 pharmacodynamic interactions can occurs between alcohol and 
CNS-acting medications that may lead to sedation, drowsiness, and impairment psychomotor 
functions. The mechanism behind pharmacodynamic interaction can be explained by two ways: 
i) additive interaction where the two individual agents act separately to cause an effect that is the 
sum of the two effects, ii) synergistic interaction in which the observed response is greater than 
the sum of the individual effect of each drug.
31
  Some interaction can be attributed to the 
common receptor type that is associated with some of the CNS-acting medications and alcohol. 
This is the GABAA receptor which is the receptor for GABA, the primary inhibitory 
neurotransmitter in the CNS. Benzodiazepines, barbiturates, and other sedatives-hypnotics bind 
at separate sites in the receptor to potentiate the inhibitory action of GABA. Ethanol modifies the 
receptor by altering the membrane environment so that it has increased affinity for GABA.
44
 
Opioid analgesics depress the CNS, resulting in analgesia, sedation, drowsiness, mood changes, 
euphoria, lethargy, and depressed respiration.
31
 Alcohol enhances the sedating property of 
opioids. For antipsychotic drugs extrapyramidal symptoms, tardive dyskinesia (TD), elevated 
prolactin levels, and sedation contribute to falls and fractures.
45
 
Alcohol also interacts with certain types of CNS-acting agents in a pharmacokinetic 
manner. During acute heavy alcohol consumption, alcohol may compete with certain medication 
such as benzodiazepines, barbiturates, phenytoin, for cytochrome P450 enzymes (CYP2E1) 
causing decreased metabolism of the medication which results in higher effectiveness of the 
drug.
21
 This potentiates the effect of alcohol and those CNS-acting medications. For example, 
alcohol intake followed by tricyclic antidepressant ingestion can cause an over 200% increase in 
plasma amitriptyline concentrations in humans.
31
 In the scenario of acute alcohol ingestion by an 
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infrequent drinker, the metabolism of the drug is inhibited.
21
 On the other hand, regular ingestion 
of alcohol can induce the normal secretion of the CYP2E1 enzyme thereby increasing the 
metabolism of those drugs. Chlorpromazine (antipsychotic agent) inhibits alcohol dehydrogenase 
preventing alcohol metabolism.
21
 
Development of cross-tolerance is also a phenomenon altering the effect of the drug in 
the presence of alcohol.
31
 Tolerance is a phenomenon in which a repeated use of a psychoactive 
agent alters the response of the target tissue to the drug itself or other chemically-related 
agents.
31
 Cross-tolerance is seen when physiologic changes induced by prolonged exposure of 
the original chemical agent (such as alcohol) is carried over to another drug (such as a 
barbiturate) wherein the response to the second drug is diminished.
31
 An animal study, 
performed to assess the sedation achieved by co-administration if alcohol and antidepressants, 
reported the following strength of potentiating effect of alcohol sedation: amitriptyline ≥ 
imipramine > maprotiline = mianserine > desipramine ≥ chlorimpramine > iprindole ≥ 
alaproclate ≥ norzimelidine ≥ zimelidine.46 
Figure 2.3 illustrates the pharmacodynamic interactions between alcohol and CNS-acting 
medications. Another important aspect of this interaction is the age related changes occurring in 
older adults that causes an exaggerated response to alcohol and CNS-acting medication. This can 
be explained by the functional changes in the aging brain which includes alterations in 
neurotransmitters, number of receptors, hormonal changes, and impaired glucose metabolism.
47
 
For example, age-dependent changes in GABAA benzodiazepine receptor complex leads to 
increased sensitivity to benzodiazepines which may result in negative effects on cognition, gait, 
and balance.
47
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Figure 2.3 Conceptual Description of the Interaction Between Alcohol and CNS-
Acting Medications 
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 Based on the concept of pharmacodynamic interactions, concurrent use of alcohol and 
CNS-acting medications may enhance sedation, loss of balance and gait, postural sway, and 
impairment of psychomotor function, all of which increases the risk of falls, accidents, and 
injuries.  Hence the idea was to investigate if increased risk of falls was associated concurrent 
use of alcohol and CNS-acting medications.  
  Before investigating the effect of the combined use of these agents, it was important to 
determine the prevalence of potential concurrent use if alcohol and CNS-acting medications as 
there were no recent data available indicating the extent of potential concurrent use of these 
agents.   
 Review of literature showed a dearth of studies looking at the prevalence and extent of at-
risk drinking. There is lack of evidence on the effect of the combined use of alcohol and CNS-
acting medications on risk for falls in older adults. Based on the conceptual framework and gaps 
in the literature, the study objectives of this dissertation were formed.  
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Chapter 3 
Section 3 Review of Literature  
3.1. Introduction  
Consumption of large amounts of alcohol, in an acute or chronic manner, may increase 
the risk of experiencing alcohol-attributable heath disorders. The volume, pattern and quality of 
alcohol and duration of exposure impact the health outcomes encountered by drinkers.
48
 In 
addition, consumption of alcohol in the presence of certain disease conditions may have harmful 
effects.
2
 Alcohol may interact with selected medications to cause adverse effects.
2
 Even 
moderate drinking may place older adults at risk of experiencing adverse events owing to their 
disease profile or medication use.
49
 A survey of 17,000 Medicare beneficiaries found that 2 out 
of 5 patients reported taking five or more prescription medications.
50
 More than 90 percent of 
non-institutionalized older adults in the United States take at least one prescription medication, 
and those who are seen in physicians’ ofﬁce take six to eight medications on average.51 
Considering the high use of medication in the older population, it is imperative to understand the 
magnitude of potential concurrent alcohol and medication use.  
A literature review was conducted to identify, select, and evaluate the available research 
studies and synthesize evidence providing insight into the nature of alcohol and medication use 
among older adults. This review will provide a comprehensive look at the issue of alcohol and 
medications use in older adults thereby providing evidence to support decision-making by 
different stakeholders including healthcare professionals, policymakers, and researchers. The 
objective is to conduct a systematic review to identify and evaluate epidemiological studies 
describing the use of alcohol and medication in older adults.   
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3.2 Methods  
Peer-reviewed literature published from January 1990 to 19
th
 September 2013 was 
searched in Pubmed/Medline. Additionally, the reference lists of relevant reviews and research 
articles were also assessed. Studies were included if: i) they were conducted in older adults (aged 
60 years or older), ii) the objective of the research article was to understand alcohol and 
medication use, and iii) the abstract or full text was available in the English language. Systematic 
reviews, case reports, and case series were not included in this study. The age limit for older 
adults was considered to be 60 years since that is the cutoff accepted in many countries. 
The search terms included a combination of Medical Subject Headings (MeSH) terms 
and non-MeSH terms along with Boolean operators. The search terms accompanied with filters 
(including publication date from 1990/01/01 to 2013/09/19, humans, English language, age: 45-
64 years, 65+ years, and 80+ years) were employed to retrieve relevant articles. The search terms 
included “alcohol drinking AND aged AND medication AND epidemiology”, “alcohol AND 
aged AND medication”, and “at-risk drinking AND (older adults OR aged) AND alcohol”.  
Screening was performed by reviewing the title and abstract for potential eligibility, 
followed by further examining the full-text for potential eligibility. References of retrieved 
articles and review papers were screened to find possible articles. A research study with multiple 
publications is discussed as a single study in this review. Frequency or percentage of combined 
use of alcohol and medication is discussed in this review.  
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Table 3.1 Summary of Studies 
 
Study  Country Setting and sample 
size 
Assessment  Inference 
Immonen 
et al, 2013 
59
 
Finland  A stratified random 
sample of 1,395 
home-dwelling adults 
aged ≥65 years 
Alcohol interactive drugs 
examined using Swedish, 
Finnish, Interaction X-
referencing interaction database 
Among 1,142 drug users, 62.6% consumed 
alcohol. The use of alcohol-interactive drugs 
was found to be 42.2%, 34.9%, and 52.7% 
among at-risk users, moderate users and 
minimal/non-users 
Barnes et 
al, 2010 
42
 
U.S.A 3,308 drinkers aged 60 
years or older, 
recruited from non-
profit, outpatient clinic  
Comorbidity Alcohol Risk 
Evaluation Tool (CARET) was 
used  
Of the 1,147 at-risk drinkers, 21.2% and 21.5% 
were at-risk owing to their alcohol use with 
medication and co-morbidity, respectively.  
Moore et 
al, 2006 
61
 
U.S.A NHANES I, 1971-
1974 and NHANES 
Epidemiologic 
Follow-up Survey, 
1992 
Some of the items from 
Comorbidity Alcohol Risk 
Evaluation Tool (CARET) were 
used 
Prevalence of at-risk drinking was 10%. 69% 
of at-risk drinkers were identified as such 
because of their alcohol use in the presence of 
comorbidities. Pain medication and medication 
for anxiety disorders were most commonly 
used by drinkers.  
Aira et al, 
2005
63
 
Finland 523 home-dwellers  
(≥ 75 years of age) 
Community-based random 
survey 
86.9% of alcohol drinkers use medication on 
regular basis.  
Pringle et 
al, 2005 
57
 
U.S.A 83,321 PA-PACE 
cardholders 
 
Mailed survey to collect alcohol 
use data. Prescription drug 
claims were used. Alcohol 
interactive medications 
identified using First DataBank.  
19% of AI drug users reported concomitant 
alcohol use (p<0.001). Most common 
combination of alcohol and alcohol interactive 
medication occurred with NSAIDs (20.2%) 
 
Moore et 
al, 
2002 
62
 
U.S.A 166 drinkers aged 60 
years or older 
recruited from internal 
medicine clinic 
ARPS and shorter version of 
ARPS 
Out of 166 drinkers, 64 were identified at-risk 
because of their medication and alcohol use.  
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Study  Country Setting and sample size Assessment  Inference 
Fink et 
al, 
2002 
43
 
U.S.A 549 current drinkers aged 
65 years or older recruited 
from academic and 
community primary care 
clinics 
Alcohol-related Problem Survey 
(ARPS)  
11% were harmful drinkers and 35% hazardous 
drinkers. Most hazardous drinkers were identified 
by their alcohol and medication use. Anti-arthritic, 
pain medications, and aspirin were commonly used 
by drinkers. 
Johnson 
et al, 
1997 
69
 
U.S.A Volunteer sample of 155 
urban women over the age 
of 85 years was 
interviewed 
Data on health, sleep patterns, use of 
alcohol and OTC medication  
“Seventy-seven (85%) of the women who used 
alcohol before bedtime also used OTC medication. 
Of these, 33 (43%) used alcohol and OTC 
medication in combination each night.” 
Adams et 
al,
65
 
1995,  
 
U.S.A 311 independently living 
residents 
 
Alcohol use questions adapted from 
the Khavari questionnaire and the 
CAGE questionnaire. Prescription 
and non-prescription medication use 
was considered  
38% used both alcohol and high-risk medication.  
High-risk drugs commonly used were 
antihypertensives, aspirin, NSAIDs and 
medications for congestive heart failure. 
Forster et 
al,
58
  
 1993 
U.S.A 667 community dwellers 
in rural setting 
 
Prescription and OTC medications 
were included. Physician Desk 
Reference used for ascertaining ADI 
25% of the respondents were at risk for at least one 
alcohol-related ADR and 19% reported using OTC 
pain medications and alcohol.  
 
 
Alcohol and Psychotropic drugs 
Ilomaki 
et al, 
2013 
64
 
Australia  1,705 Australian men aged 70 
years or older. Data collected 
from 2005-2007.  
Alcohol and psychotropic drugs 
were studied  
Of the 135 antidepressant users 27.1% were daily 
drinkers, as were 42.7% of the 97 sedative-
anxiolytic drug users.  
Du et al, 
2008 
66
 
Germany 1,605 older adults aged 
between 60-79 years. Data 
from German National Health 
Interview and Examination 
Survey 1997-1999. 
Alcohol and psychotropic drugs 
were studied 
Last week prevalence of combined psychotropic 
and alcohol use was 7.6%. 
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3.3. Results  
3.3.1 Summary of Studies 
The search yielded a total of 10,180 articles. After removing duplicates or irrelevant 
articles and applying the inclusion and exclusion criteria, a total of 12 original research studies 
were selected. All studies were cross-sectional in design and most of them included community-
dwelling older adults. Most of the studies were conducted in the U.S. Some of the studies were 
excluded as they did not match the age criteria
52,53
 or they did not study potential combined use 
of alcohol and alcohol-interactive medications.
54-56
 Table 3.1 summarizes the studies included in 
this review.  
3.3.2 Review of Design of the Studies  
Interview or mailed survey methods were employed to collect the “usual” alcohol 
consumption in the past 12 months in the study population in these studies. Information on 
medication use was collected mostly from survey and/or interview where either participant 
reported medications they had been using in the past or the interviewer inspected the containers 
of all the medication products used by the subject and recorded the information. Pringle et al. 
collected the medication use information of their study sample from administrative claims data.
57
  
Potential interactions between alcohol and medications were determined by various 
methods in these studies. Some studies used a clinical information system such as Physician 
Desk Reference, First DataBank
57,58
, or a country-specific interaction database
59
 to ascertain 
interactions between alcohol and medications.  
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On the other hand some studies 
42,43,50,61
 introduced a novel paradigm to understand the 
combined use of alcohol and medication, referring to it as “at-risk drinking”. They defined the 
use of specific amounts of alcohol in the presence of certain medications, comorbid conditions 
and health-related behaviors as “at-risk drinking”.41 These studies have used validated 
questionnaires [Comorbidity Alcohol Risk Evaluation Tool (CARET), Alcohol Related Problem 
Survey (ARPS), and shorter version of ARPS (ShARPS)] to understand the potentially harmful 
use of alcohol and alcohol-interactive (AI) medications.
62
 These instruments have a series of 
questions enquiring about the quantity and frequency of alcohol use, heavy episodic alcohol 
intake, use of different classes of medications, the presence of certain comorbid conditions, and 
health-related behaviors. ARPS and ShARPS classify drinkers as harmful, hazardous or non-
hazardous drinkers while CARET categorizes them as at-risk-drinkers and non-at-risk 
drinkers.
42,61
 
The prevalence of alcohol and medication use was also estimated and reported in more 
than one manner. Some studies reported alcohol use among medication users.
57,59,63,64
 While 
some studies reported rate and magnitude of medication use among alcohol drinkers.
59,63
 Some 
studies estimated the potential concurrent use of alcohol and medication in the entire study 
sample.
58,61,65,66
 A few studies estimated at-risk drinking among the current drinkers.
42,43,61
 
Choice of the denominator is relevant in this case as extent of medication use widely differs from 
alcohol use in older adults. Hence the prevalence reported in these studies should be interpreted 
accordingly and comparison of these rates to each other should be made with caution. 
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3.3.3 Review of Prevalence Reported in the Studies  
Alcohol use is influenced by many factors including, but not limited to, gender, 
nationality, cultural or religious beliefs, educational background, life-changing events, health 
condition, environment, social life and history of substance abuse.
67,68
 Prevalence of alcohol use 
varies widely across the studies summarized in this review. Current alcohol use estimated by 
these studies ranged from 39% to 62% and heavy or risky alcohol consumption was estimated to 
be in the range of 7%-20%.  Moderate drinkers constituted the largest group among the older 
drinkers.  
At-risk drinking was prevalent among older adults. Fink et al. found that among 549 
current drinkers, 11% were harmful drinkers, 35% were hazardous drinkers, and the remaining 
were non-hazardous drinkers.
43
 Hypertension was the top indicator for harmful drinking and 
anti-arthritic and pain medications followed by aspirin, H2–antagonists (ranitidine, cimetidine), 
antihypertensives, and antidepressants were some of the most common indicators of hazardous 
drinking.
43
  Moore et al. studied the validity and reliability of ARPS and ShARPS and found that 
these instruments were “more sensitive than AUDIT and SMAST-G in identifying older drinkers 
at risk of experiencing harm as a result of alcohol and comorbidities”.62  
In the SHARE study, 34.7% of the 3,308 current drinkers were identified as at-risk 
drinkers. Among those, 61.0%, 61.9% and 64.3% were identified as at-risk drinkers owing to 
their alcohol-medication use, alcohol-comorbidity, and alcohol intake, respectively. Among the 
at-risk drinkers 56.1% fell into at least two risk categories and 31.0% fell into all three risk 
categories.
42
 Analysis of the 1971-1974 National Health and Nutrition Examination Survey I 
(NHANES I) revealed that among 4,691 older adults included in this study, 39% were current 
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drinkers and 10% were at-risk drinkers. 69% of the at-risk drinkers were identified as such 
because of their alcohol use in context of comorbidities. Gout, gastrointestinal ulcer, and anxiety 
disorder were the top three disease conditions associated with at-risk drinking. Medications for 
pain, indigestion, and insomnia were the most common medications responsible for a 
classification of at-risk drinking.
61
 
A recent Finnish study found widespread use of alcohol-interactive (AI) medications 
among community-dwelling older drinkers.
59
 It was reported that among at-risk alcohol users 
(n=90), 42.2% were on AI medication whereas among moderate users (n=625) and non/minimal 
users (427), 34.9% and 52.7% were on AI medication respectively. One in 10 at-risk users used 
warfarin, metformin or sedative-hypnotics. Another study conducted in Finland included 523 
community-dwelling older adults aged 75 or older. This study found that most alcohol drinkers 
(n=231) also used medications on a regular basis (86.9%) or as needed (87.8%). Alcohol use was 
common among hypertensive, diabetic and depressive patients.
63
    
Pringle et al examined the prevalence and pattern of concomitant alcohol and AI drug use 
in a total of 83,321 older adults enrolled in the Pennsylvania Pharmaceutical Assistance Contract 
for the Elderly (PA-PACE) program. A total of 20.3% (n=16,886) reported consuming alcohol. 
The study stated “of current drinkers with at least one concomitant AI medication claim, 44.9% 
used one AI drug, 28.6% used two, 14.1% used three, 6.9% used four, and 5.5% used five or 
more AI drug”. NSAIDs and prescription antihistaminics, and miscellaneous antihypertensives 
were the three most frequently used AI drugs in combination with alcohol.
57
  Forster et al. found 
that out of 667 older adults, 25% were at risk of one alcohol-related adverse drug reaction (ADR) 
while 15% were at risk for multiple ADRs due to their drug use and alcohol intake. Use of over-
the-counter (OTC) pain medication, antihypertensives, prescription diuretics, OTC cold 
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preparations, and prescription arthritis medications was observed in combination with alcohol.
58
  
A cross-sectional analysis of residents of three retirement communities estimated that 38% of the 
study sample was using both alcohol and high-risk medications.
65
 High-risk drugs commonly 
used by drinkers were antihypertensives (50%), aspirin (27%), non-steroidal anti-inflammatory 
drugs (20%), medication for congestive heart failure (18%), antacids or H2 blockers (16%), 
sedatives (11%), narcotics (5%), and warfarin (5%).
65
 
3.3.4 Factors Associated with Concurrent Alcohol and Medication Use 
Many studies consistently demonstrate that older men compared to older women were 
more likely to concurrently use alcohol and AI medications.
42,57,58,61
 Advanced age (75-84 years, 
or 85 years or older) was associated with low alcohol consumption, thus, these groups are less 
likely to be at-risk drinkers.
42,57
  High educational level was positively associated with combined 
alcohol and medication use.
57,58,61
  Moore et al. found that smokers and married individuals were 
more likely to be at-risk drinkers.
61
 Caucasians are at higher odds of being exposed to alcohol-
medication interactions.
42,57,61
  A study by Pringle et al. showed that older adults taking multiple 
AI medications were less likely to consume alcohol.
57
   
3.3.5 Alcohol and Psychotropic Medication Use  
Two studies assessed the potential combined use of alcohol and psychotropic medications 
in older adults based on the premise that the pharmacodynamic interactions between of alcohol 
and CNS-acting medications may cause enhanced sedation and impairment of psychomotor 
functions. A study conducted using the 1998 German National Health Interview and 
Examination Survey determined that out of 1605 participants, 7.6% reported combined use of 
alcohol and psychotropic medication.
66
 Higher prevalence of combined use of alcohol and 
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psychotropic medication was seen among participants who were aged between 70 and 79 years, 
lived alone, used more than one medication, had a history of cardiovascular disease or had poor 
health status. Psychotropic medications most likely to be concurrently consumed with alcohol 
were antidepressants, hypnotics/sedatives, and benzodiazepines.
66
 A cross-sectional population-
based study using the Concord Health and Aging in Men Project (CHAMP) was conducted 
including 1705 men aged 70 year or older.  Overall, 27% of the antidepressant users were daily 
drinkers and 42.7% of sedative/anxiolytic users were daily drinkers. Users of sedative-hypnotic 
medication were more likely to engage in daily drinking than non-users of those medications.
64
 
A study including a convenient sample of 155 older women interviewed about their sleep 
pattern, alcohol use and over-the-counter medication use. Of the 155 older women, 130 
consumed alcohol before bedtime and among those, 77 older women reported consuming 
medication before going to sleep.
69
 
3.4 Discussion 
This review was performed to understand and summarize the current literature in the area 
of alcohol and medication use among older adults. The search yielded twelve studies out of 
which two were focused on alcohol and psychotropic medication use, and the rest dealt with 
alcohol and alcohol-interactive medication use. A few studies (n=2) were not included because 
they did not meet the inclusion criteria, even though these studies focused on alcohol 
consumption in older adults having comorbid conditions, or taking psychotropic medications.
52,55
 
The alcohol interactive medications included, but were not limited to, antihypertensives, 
psychotropic agents, NSAIDs, antihistaminics, opioid analgesics, antihistaminics, H2-antagonists, 
warfarin, antiplatelet agents, and non-prescription medications. Older adults may use alcohol for 
medicinal purposes for certain conditions such as cardiovascular disease, sleep disturbance, 
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common cold, relaxation, and pain relief.
12,63
 On the other hand, some medications used in 
alleviation of the aforementioned conditions may interact with alcohol to produce undesirable 
effects. 
All the studies included in this review were cross-sectional in design and collected 
information on alcohol consumption using surveys or through interviews. Most of the studies 
focused on understanding alcohol and medication use during a reference period/recall time. 
However, none of the studies could definitively ascertain the concurrent use of alcohol and 
medications. Methodologically, some of the ways to determine use of alcohol and AI 
medications concurrently are: i) to determine the emergency department (ED) visits occurring 
due to alcohol and medication interaction, ii) to use the Drug Abuse Warning Network (DAWN) 
database that collects ED visits associated with substance abuse, iii) to combine administrative 
claims data with survey data (for example MCBS, NHANES) to obtain both medication use and 
alcohol use information, iv) to use administrative claims data coupled with interview, survey or 
diary methods for data collection to ascertain both medication and alcohol use. With technical 
advances and upsurge of linked databases, creative ways to collect data to perform such studies 
may be discovered.  
Due to significant variations in the study design and settings, comparing the results of 
studies of alcohol and medication use may be difficult. However, the proportion of older adults 
at risk of potential concurrent use of alcohol and medication ranges from 7-50%. Underreporting 
of alcohol intake is a potential threat in these studies. Questions about “average number of 
drinks”, “overall frequency” or “typical” amount of alcohol consumption over a period of time 
can lead to underestimation of alcohol use.
70,71
 Besides, questions regarding “standard drinks” of 
alcohol may not be understood uniformly or accurately among older adults adding to the 
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variability in estimation.
71,72
 Both recent recall and long term drinking patterns should be 
investigated to obtain more clear and precise data on alcohol use. Social stigma may also 
discourage older adults from revealing the actual amount of alcohol use.  
3.5 Conclusion  
The review of recent literature suggests that alcohol consumption is prevalent among 
older adults with chronic conditions or taking alcohol interactive medications. However, there is 
wide variation among the prevalence rates reported by these studies. Older adults taking AI 
medications and consuming alcohol could potentially be at risk of encountering adverse events 
attributable to the interaction between alcohol and medication, or alcohol and disease. There is a 
dearth of studies investigating alcohol consumption in the context of disease profile and 
medication use among American older adults. Moreover, understanding the impact of alcohol 
and medication use on the health and quality-of-life in older adults is important. There is lack of 
studies investigating the impact of concurrent use of alcohol and AI medications on health 
outcomes such as falls, accidents, and cognitive impairment.  
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Chapter 4 
Section 4 At-risk Drinking Among Community-Dwelling Older Adults 
4.1 Introduction  
Traditionally, alcohol use is studied in the context of quantity and frequency of alcohol 
intake or through questionnaires addressing behavioral features related to alcohol consumption.
41
 
These methods may not capture the alcohol-related problems experienced by older adults as 
older adults, apart from being more sensitive to alcohol, are also likely to suffer from co-morbid 
conditions and take multiple medications that may interact with alcohol.
29,41
 Considering these 
issues, a new paradigm was introduced that defines at-risk drinking as alcohol use that is 
excessive or potentially harmful in combination with select comorbidities or medications.
41
 At-
risk drinking may inflict adverse effects on the health of older adults. For instance, combined use 
of non-steroidal anti-inflammatory agents and alcohol are associated with increased risk of 
gastric bleeding.
73
 Combined use of alcohol and CNS-acting medications have the potential to 
cause adverse events such as traffic accidents, injuries, falls, and fractures.
2
 Patients with hepatic 
problems/liver disease are advised against consuming alcohol. Screening tools such as the 
Alcohol Related Problem Survey (ARPS), shorter version of ARPS and CARET, have been 
developed to detect at-risk drinking.
62 
 
It is noteworthy that there is a lack of consensus over the definition of at-risk drinking. 
Often it is defined only in terms of quantity and frequency of alcohol consumption. The 
American Geriatric Society’s clinical guidelines describe at-risk drinking as consuming two or 
more drinks per day on average
74
 while the National Institute on Alcohol Abuse and Alcoholism 
(NIAAA) guideline defines it as consuming 4 or more drinks on a given day or 8 or more drinks 
39 
 
in a week.
76
 The British Medical Association (BMA) describes at-risk drinking for older adults 
as the consumption of >20g of alcohol for women and >30g of alcohol for men.
74-76
 
A study by Barnes et al., reported that of 3,308 current drinkers, 34.7% were at-risk 
drinkers, of which 64.3% were at-risk drinkers due to their alcohol behaviors, 61.9% and 61.0% 
of the at-risk drinkers were categorized as such due their alcohol use in presence of particular co-
morbidities and certain classes of medication use, respectively.
42
 Examination of NHANES 
1971-1975 and NHANES Epidemiologic Follow-up Survey 1992 (NHEFS) showed that 10% 
(n=425) of the study population consisted of at-risk drinkers. Of the 425 at-risk drinkers, 31% 
were identified as at-risk drinkers solely because of their alcohol intake, and 69% were regarded 
as at-risk drinkers for their alcohol use in the presence of selected comorbid conditions.
61
 
Analysis of the 2005-2006 National Survey on Drug Use and Health (NSDUH) data found that 
13% of older men and 8% of older women reported at-risk alcohol use (defined as two or more 
drinks on a usual drinking day within the past 30 days).
74 
A Finnish study defined at-risk drinkers 
as those who consume: i) more than 7 drinks per week, ii) 3 or more drinks several times in a 
week, or iii) 5 or more drinks on a typical drinking day.
67
 This study found that 8.2% of the study 
sample (n=1395) were at-risk drinkers. A German study conducted among 3,224 non-demented 
subjects aged 75 years and over and attending general practitioners in an urban area of Germany, 
found that 6.5% (95% CI: 5.6-7.4) reported at-risk drinking (defined as consuming more than 20 
g of alcohol for women and more than 30 g for men).75 Analysis of alcohol consumption among 
older adults in primary care showed 4.1% of the 24,863 older adults were at-risk drinkers (8-14 
drinks/week).
27
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There is a dearth of studies examining at-risk drinking among American older adults, 
especially in the context of their comorbidities and medication use. It is also important to identify 
the factors associated with at-risk drinking in older adults so that preventive measures can be 
channeled judiciously. This study aims to determine the prevalence and the pattern of at-risk 
drinking in a nationally representative sample of older Americans and factors associated with at-
risk drinking in this population.  
4.2 Objective   
The objectives of this study were to determine the prevalence and pattern of at-risk drinking and 
to identify the factors associated with at-risk drinking among non-institutionalized older adults.  
4.3 Methods 
4.3.1 Description of the Data Source 
The 2009 Medicare Current Beneficiary Survey (MCBS) data was utilized to conduct this 
study.
77
 The MCBS is conducted by the Centers for Medicare and Medicaid Services (CMS) 
Office of Research, Development, and Information (ORDI) through its contractor, Westat, Inc, a 
survey research firm located in Maryland. It is described as “a continuous, multi-purpose survey 
of a representative sample of the Medicare beneficiary population, including both aged and 
disabled enrollees”. The MCBS is unique in combining both survey information and Medicare 
claims data obtained from the CMS administrative files. It also collects data from community-
dwelling as well as institutionalized beneficiaries. The objectives of the MCBS are to estimate 
the amount and sources of overall expenditures of all types of healthcare services used by 
Medicare beneficiaries including copayment, deductibles, non-covered services, and Medicare 
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covered services; and collect data on the overall health status of the beneficiary over a specified 
period of time.  
The MCBS employs a stratified multistage area probability sampling design with three 
stages of selection. In the first stage of sampling, 107 geographic primary sampling units (PSUs), 
consisting of groups of counties chosen to represent the nation, are selected. In the second stage, 
ZIP code clusters are selected from within the PSUs. In the third stage, the beneficiaries residing 
in these ZIP code areas are selected by systematic random sampling within age strata. The 
sampling probability varied in the following age groups (0-44, 45-64, 65-69, 70-74, 75-79, 80-
85, and 85 or over) in order to over represent the disabled and oldest old by a factor of 
approximately 1.5.  
The MCBS is a longitudinal rotating panel survey wherein “each sample person or an 
appropriate proxy respondent, are interviewed three times a year over four years and the 
average interview recall period is about 4 months”. A rotating panel is followed for up to 12 
interviews. At any given time, there are four panels active and each panel has approximately 
3,000 to 5,000 active sample persons depending on when the panel was originally selected. Each 
year in the fall round new panels are introduced that replace the oldest panel that subsequently 
retires in the following summer. The 2009 MCBS file consists of selected interview data from 
the ongoing Medicare Current Beneficiary Survey (MCBS), which were collected during Round 
55 (September through December of 2009) or earlier rounds for some variables for individuals in 
the continuing sample.  
  MCBS public use files are released as two modules: the “Access to Care” file and the 
“Cost and Use” file. The Access to Care file is designed to provide early release of MCBS data 
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related to Medicare beneficiaries’ access to care. The focus of this file is to provide information 
on access to care, satisfaction with care, and usual source of care. The Cost and Use file 
integrates the survey reported events, expenditure, and other health-related information, collected 
from Medicare beneficiaries, to Medicare claims data, thus, providing a comprehensive picture 
of healthcare utilization. The Access to Care module is comprised of those beneficiaries that are 
part of four separate MCBS panels: round 46, round 49, round 52, and round 55.  The Cost and 
Use module comprises of those beneficiaries that are part of five separate MCBS panels: round 
46, round 49, round 52, round 55, and round 58.  Both the Access to Care and Cost and Use 
modules were utilized in this study.  Participants included in both of the modules were included 
in the study, resulting in exclusion of round 58 participants. The unique identifier (BASEID) 
variable was used to link beneficiary information across various files.  
4.3.2 Eligibility of Study Participants  
Medicare beneficiaries aged 65 years or older, non-institutionalized, surviving through 
2009, and continuously enrolled in Medicare were included in this study. Beneficiaries present in 
both Access to Care and Cost and Use modules were included in the study. Older adults with 
complete or partial paralysis, absence or loss of one arm or leg would were excluded from the 
study as the risk of falls will differ in these individuals. Hence, the study sample represents 
continuously enrolled community-dwelling Medicare beneficiaries aged 65 years or older. 
4.3.3 Selection of the Study Sample from 2009 MCBS Data 
Figure 4.1 illustrates the process of sample selection. The data files Key Record (RIC K) 
and Administrative Identification record (RIC A) consist of both community-dwelling and 
institutionalized subjects. Survey Health Status and Functioning Record – Community (RIC 2 
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and 2P) contains community-dwelling older adults participating in the survey. In the Access to 
Care module, the administrative file contained 14,695 Medicare beneficiaries of which 13,751 
were non-institutionalized. Similarly in the Cost and Use module, the administrative file 
contained 10,859 Medicare beneficiaries of which 10,700 were non-institutionalized. The 
institutionalized beneficiaries in both the modules and the enrollees of round 58 were excluded. 
After merging the non-institutionalized beneficiaries from both the modules, 8,978 in 
beneficiaries (mutual to both modules) remained. After excluding beneficiaries younger than 65 
years, those who did not survive through 2009, and those who have complete/partial paralysis or 
absence of arm or leg, a total of 7,163 community-dwelling, continuously enrolled Medicare 
beneficiaries aged 65 years or older were eligible to be included in this study. 
4.3.4 Selection of Covariates  
Socio-demographic Variables: Demographic factors including age, gender, marital status, 
income, educational level, race, perceived health status, limitations to social activity, activities of 
daily living, instrumental activities of daily living, number of medications used and number of 
selected co-morbid conditions were studied. All of the covariates were collected from the MCBS 
survey. Older adults were categorized into three age groups (in years): 65-74, 75-84, and 85 and 
above. Race was categorized as white or non-white (includes all other races except white). 
Marital status was characterized as: married or non-married (includes never married, divorced, 
separated, and widowed). Annual income was grouped into subjects earning $25,000 or less, or 
more than $25,000. Employment status records whether the beneficiary is currently working at a 
job or business (yes/no). Educational status was classified as beneficiaries with no education, 
less than high school education, high school education, more than high school education. 
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Figure 4.1 Flowchart Depicting the Selection of the Study Sample 
Access to Care module Cost and Use module 
Administrative file  
(RIC A and RIC K) 
(n=14,695) 
Survey file for 
community-dwelling 
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Administrative file  
(RIC A and RIC K) 
(n=10,859) 
Remaining subjects in 
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Survey file for 
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(n=10,070) 
Institutionalized 
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removed (n=789) 
 
Institutionalized 
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removed (n= 944) 
Deleting Round 58 
participants (n=379) 
Subjects common in both files  
(n=8,978) 
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Removing subjects with 
Loss of arm/leg=62 
Paralysis=207 
Inner join of the data files 
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Health and Functional Status: The “limitations to social activity” variable inquired if the 
beneficiary experienced limitations in their social activities due to health conditions in the past 
month (categorized as no limitations /some of the time/and most of the time). The health status 
variable was obtained from the survey question asking beneficiaries to rate their current general 
health condition compared to health condition in the previous year (categorized as 
better/same/worse). Functional status was measured using the Activities of Daily Living (ADL) 
scale (including questions addressing difficulty in bathing, dressing, eating, transferring, 
toileting, and walking) and Instrumental Activities of Daily Living (IADL) scale [including 
questions addressing difficulty in using the telephone, doing light housework (like washing 
dishes, straightening up, or light cleaning), heavy housework (like scrubbing floors or washing 
windows), preparing meals, shopping for personal items (such as toilet items or medicines), and 
managing money (like keeping track of expenses or paying bills)].
78,79
 Variables capturing 
difficulties in performing ADLs and IADLs were categorized into whether or not the subject had 
difficulty in performing at least one activity (dichotomous).  
To determine chronic comorbidities among the beneficiaries survey data (inquiring about 
the presence selected disease conditions in the past year) was used. The number of selected 
comorbid conditions included arthritis, rheumatoid arthritis, diabetes, depression, emphysema, 
hypertension, osteoporosis, congestive heart disease, myocardial infraction, arrhythmia, cardiac 
failure, other heart problem, stroke, urinary incontinence, Alzheimer’s disease, and Parkinson’s 
disease. The number of medications, both prescription and non-prescription, consumed by 
beneficiaries in the past year were also included in the analysis.  
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Regrouping of the covariates: While assessing the factors associated with at-risk drinking the 
categories of some variables were collapsed and regrouped. This was done to achieve adequate 
size in each cell. Initially, educational status was classified as beneficiaries with: no or less than 
high school education, high school education, or more than high school education. Since the 
number of older adults with no education was very small, they were merged with older adults 
with less than high school education. The variable, limitations in social activities, was 
categorized as whether or not beneficiaries experienced limitations in social activities due to 
health conditions (yes/no). Older adults whose social activity was limited, either some of the 
time or most of the time, were grouped together as “yes”.    
4.3.5 Missing Data 
Data for most of the variables were collected from the MCBS survey. Some of the survey 
questions contained response items such as “don’t know”, “refused to answer”, and “cannot be 
ascertained”. As these responses could not be utilized in the study, they were deemed as “not 
available” and were not included in the analysis. Since the frequencies of these “not available” 
responses were less than 5%, any kind of imputation or sensitivity analyses were not performed. 
The footnote below Table 4.3 shows the frequency of “not available” response for each of the 
variables.  
4.3.6 Determination of Alcohol Consumption  
Data on alcohol use was collected from the MCBS survey. Every alternate year 
participants of the MCBS are asked three questions addressing their “usual” alcohol use over the 
past year. The first question is “Please think about a typical month in the past year. On how 
many days did [you/(sample person (SP))] drink any type of alcoholic beverage?”. The second 
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question enquires about the quantity of alcoholic drinks consumed, “On those days that 
[you/(SP)] drank alcohol, how many drinks did (you/he/she) have?”. The third questions pertain 
to heavy episodic drinking “On how many days did [you/(SP)] have 4 or more drinks in a single 
day?” 
The typical monthly alcohol consumption in the past year was measured using the 
Quantity-Frequency (QF) method.
80
 The first two questions inquiring about i) overall frequency 
of alcohol consumption in the past year and ii) the usual number of drinks consumed on days 
when the respondent drank were multiplied to estimate monthly alcohol consumption. If the 
monthly alcohol consumption was estimated to be 31 drinks per month or less then it was 
considered as within-limit drinking assuming respondents considered 31 days in a month. The 
monthly alcohol consumption was further categorized into three following groups: i) non-
drinkers (respondents who did not consume a single alcoholic beverage in the past year), ii) 
within-limit drinkers (respondents who consumed 31 drinks or less per month), and iii) 
exceeding-limit drinkers (respondents who consumed more than 31 drinks per month). Binge 
drinking or heavy episodic drinking was determined utilizing the third survey question (number 
of days respondent consumed 4 or more drinks in a single day). Any respondent consuming 4 or 
more drinks, in a single day, at least once in a month was regarded as a binge-drinker.  
4.3.7 Estimation of At-Risk drinking  
At-risk drinking was determined by two methods: using the CARET questionnaire and 
NIAAA definition of at-risk drinking in older adults. According to the NIAAA definition, older 
adults consuming 4 or more drinks on a given day, or 8 or more drinks in a week, are considered 
at-risk drinkers.
76
 Primarily, at-risk drinking was identified using the CARET, a 7-item validated 
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questionnaire which classifies subjects into two categories: at-risk or non-at-risk drinkers, based 
on their alcohol intake, co-morbid conditions as well as medication use.
41,60
 It includes 1) 
comorbid conditions such as high blood pressure, diabetes, depression, gout, hepatitis and other 
liver conditions, 2) symptoms of feeling sad, memory problems, falling, problem sleeping, heart 
burn/stomach pain/vomiting/nausea, and tripping/bumping into things, and 3) alcohol-interactive 
medications including warfarin, antiplatelet medications, nitrates, ulcer medications, 
antihypertensive agents, opioid analgesics, anticonvulsants, sedatives-hypnotics, sedating 
antihistaminics, arthritis and pain medications, and psychotherapeutic agents (antidepressants, 
and anxiolytic). Any older adult satisfying at least one of the conditions (items in the CARET 
questionnaire) was deemed to be a at-risk drinker. The total number of items that any subject 
satisfies was also calculated.  
The presence of hypertension, diabetes, depression, and history of falls, in the past 12 
months, was determined from the MCBS survey questions. ICD-9-CM codes
81
 from the inpatient 
and outpatient records were utilized to determine the presence of acute or chronic hepatitis, 
cirrhosis or any other liver condition, heart burn/stomach pain/nausea/vomiting, and acute and 
chronic gout. Additionally, use of uricosuric medications (allopurinol, probenecid, colchicine, 
febuxostat) was indicative of the presence of gout. A problem with memory was determined 1) 
from the survey question enquiring about the presence of Alzheimer’s disease or dementia, and 
2) use of any of the following medications: memantine, donezepil, rivastigmine, galantamine.  
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Table 4.1 Diagnostic Codes for Selected Disease Conditions 
Disease Conditions  ICD-9-CM codes  
Hepatitis, cirrhosis or any 
other liver condition 
570, 571.0-571.9, 572.0-572.8, and 573.0-573.9 
Heartburn/stomach 
pain/nausea/vomiting 
530, 531, 532, 533, 534, 525, 577.0-577.1 
Acute or chronic gout 274.0-274.9 
 
The information on medication was derived from the medication file that contains both 
survey and administrative claims data. Selection of alcohol-interactive medications was achieved 
in two steps. First, the classes of medication enlisted in the CARET questionnaire were selected 
from the data file. The brand name of the medication was used to do so as that was the 
medication identifying variable available in the data file. Second, the nature of potential 
interaction between alcohol and that medication was appraised based on available published 
literature.
21,29,41
 The categories of medications were mutually exclusive. Only those drugs that 
have been documented to interact with alcohol were included. Medications such as 
methylphenidate, modafinil-provigil, glargine, prolix, ridilin, memantine, levodopa-carbidopa, 
fenofibric acid were not included.  
A few of the items in the CARET questionnaire including “driving after drinking 
alcohol” and “bumping or tripping into things” were not collected by the MCBS survey. These 
variables were not considered while assessing at-risk drinking in the current study. Although the 
survey did not include question on “problem sleeping”, information on assessment of at-risk 
drinking using CARET was performed based on pre-specified decision rules that have been 
validated Table 5.3. Respondents who met one or more criteria for at-risk drinking were 
classified as at-risk drinkers.  
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Table 4.2 Description of the CARET Questionnaire 
Items  Quantity and frequency of alcohol  
Comorbid conditions  
High blood pressure 
Diabetes 
Acute or chronic gout 
Depression  
Acute or chronic hepatitis, cirrhosis  
or other liver conditions 
 
≥3 drinks at least 4 times per week,  ≥4 drinks at least 2 times 
per month, ≥5 drinks at any frequency 
≥2 drinks at least 4 times per week,  ≥3 drinks at least 2 times 
per month, ≥4 drinks at any frequency 
Any number of drinks at any frequency 
Health-related behaviors  
Memory problems occurring often 
Heart burn/stomach ache/ 
nausea/vomiting occurring often 
Falling once or twice 
Memory problems occurring sometimes 
Heart burn/stomach ache/ 
nausea/vomiting occurring sometimes 
Falling more than twice 
 
 
         ≥3 drinks at least 2 times per week,  
         ≥4 drinks at least 2 times per month,  
         ≥5 drinks at any frequency 
 
         ≥2 drinks at least 2 times per week,  
         ≥5 drinks at any frequency 
Medications 
(at least 3-4 times a week) 
Antihypertensive medications 
 
Blood agents: clopidogrel, aspirin, 
ticlopidine, dipyridamole, warfarin 
Gastric medication: proton pump 
inhibitors, H2 antagonist 
Nitrates: ISM, ISD, nitroglycerine 
Pain medications used in arthritis 
(NSAIDS) 
Opioid analgesics, Sedatives-hypnotics 
Anticonvulsants, Psychotherapeutics 
(antidepressants, anxiolytics, 
antipsychotics, except CNS stimulants) 
Non-prescription medication for 
allergies (anti-histaminics, cough and 
cold preparations) 
 
 
≥3 drinks at least 4 times per week, ≥4 drinks at least 2 times 
per month, ≥5 drinks at any frequency 
 
 
 
 
 
 
               ≥2 drinks at least 4 times per week,  
               ≥5 drinks at any frequency 
 
 
Excessive alcohol use 
 
Binge drinking  
≥3 drinks at least 4 times per week, ≥4 drinks at least 4 times 
per month, ≥5 drinks at any frequency 
≥4 drinks on one occasion at least once a week or more 
*adapted from the CARET questionnaire.  
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4.3.8 Statistical Analyses 
Analysis of the complex survey: The complex sampling design was taken into account during 
the analysis. Cross-sectional full sample weights have been developed to compensate for non-
response, under-coverage, and overlapping coverage of constituent panels. Cross-sectional 
weights provided for each beneficiary in the dataset reflect the overall selection probability of 
each sample person. A total of 100 replicate cross-sectional weights developed using Fay’s 
balanced repeated replication (BRR) method, with the Fay coefficient being 0.30, for variance 
estimation to account for the complex features of the sampling design. The principle behind the 
replication is “to select subsamples (replicates) from full sample, calculate the statistics of 
interest for each replicate, and then use these replicate statistics to estimate the variance of full 
sample statistic”.77,82,83  Thus, both the full-sample weight and the replicate weights are used to 
compute weighted estimates and their variance.
77,82,83
   
Analysis plan for this study: Frequencies and weighted estimates were calculated to describe 
the study population representing continuously enrolled non-institutionalized Medicare 
beneficiaries aged 65 years or older surviving through 2009. Chi-square tests were performed to 
study the bivariate association between at-risk drinking and other covariates. Multi-nominal 
logistic regression analysis (using SAS procedure PROC SURVEYLOGISITC) was performed 
to identify the factors associated with at-risk drinking.
84
 The multinomial logistic regression 
model was used to predict probabilities of being either an at-risk drinker or a non-at-risk drinker, 
compared to non-drinker, given a set of regressor variables (predictors). 
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Sensitivity analyses were performed to understand the impact of the methodological 
decisions or assumptions made during the execution of this study. Different definitions of 
alcohol use were adopted and analyzed to determine the prevalence of at-risk drinking. Weighted 
analyses were performed to account for the complex sampling design of the study. All analyses 
were conducted in the SAS version 9.2 and 9.3, at the significance level of α= 0.05.  
4.4 Results  
4.4.1 Characteristics of the Study Sample 
Of the 7,163 older adults, 47.5% were aged between 65 and 74 years, 37.0% were 
between 75 and 84 years of age, and the remaining 15.5% were 85 years or older. The study 
sample was predominantly white (87.2%), not currently employed (87.5%) and educated (with 
77% having high school or advanced level of education). Approximately 57% were female, 
53.8% were married, and 53.9% earned more than $25,000 per year.  The majority of the older 
adults (71.8%) did not experience any restriction in their social activity due to health, 18.3% 
faced it some of the time, and the remaining 9.9% faced it most of the time. A total of 65.5% 
perceived their general health condition to be same as in the preceding year, however, 20.1% 
said it worsened and 14.4% said it improved. Although approximately 26% reported having 
difficulty in performing at least one of the activities of daily living, 74% reported having no 
difficulty in performing any of the ADLs. A total of 33.5% reported having difficulty in 
performing at least one of the IADLs but the remaining 66.5% reported having no difficulty in 
performing any of the IADLs. Most of the study sample have either no smoking history (41.5%) 
or were former-smokers (49.7%) but only 8.8% reported smoking currently. Approximately 
6.7% of the older adults reported not having any disease and 5.1% did not take any medication. 
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Assessment of comorbidities showed that 34.7% of older adults had 1-2 diseases, 35.4% had 3-4 
diseases, and 23.2% had 5 or more diseases. Distribution of medication use reflected 
polypharmacy with 35.9% older adults taking 1-5 medications, 35.3% taking 6-10 medications, 
and 23.7% taking more than ten medications. Table 4.3 summarizes the demographic 
characteristics of the study sample.  
Table 4.3 Demographic Characteristics of the Study Population  
Variables Sample persons 
interviewed 
Weighted percent  
(95% CI) 
 
Age (years) 
65-74 
75-84 
85 and older 
 
 
2919 
2890 
1354 
 
 
47.51 (46.56-48.47) 
36.95 (35.95-37.94) 
15.54 (14.73-16.34) 
Gender 
Male 
Female 
 
3094 
4069 
 
43.03 (42.06-44.01) 
56.97 (55.99-57.94) 
Race 
White 
Black 
Others 
 
6241 
  586 
  336 
 
87.23 (86.41-88.06) 
  8.12 (7.54-8.69) 
  4.65 (3.99-5.31) 
Marital status 
Married 
Others 
 
3723 
3436 
 
53.80 (52.47-55.12) 
46.20 (44.88-47.53) 
Education 
No education  
Less than high school 
High school 
More than high school 
 
    77 
1707 
2189 
3164 
 
  0.92 (0.70-1.15) 
22.16 (21.08-23.25) 
30.75 (29.67-31.82) 
46.17 (44.75-47.59) 
Income 
Less than $25,000 
More than $25,000 
 
3478 
3685 
 
46.06 (44.44-47.68) 
53.94 (52.32-55.56) 
Employment 
No 
Yes  
 
6381 
  778 
 
87.52 (86.67-88.37) 
12.48 (11.63-13.33) 
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Limitations in social activity 
No 
Some of the time 
Most of the time 
 
4965 
1378 
  768 
 
71.78 (70.55-73.02) 
18.32 (17.30-19.35) 
  9.89 (9.15-10.64) 
Perceived health status 
Better 
Same 
Worse 
 
1015 
4594 
1506 
 
14.38 (13.31-15.45) 
65.50 (64.40-66.59) 
20.12 (19.36-20.89) 
Difficulties in ADL  
No  
Yes 
 
5166 
1997 
 
74.06 (72.83-75.30) 
25.94 (24.70-27.17) 
Difficulties in IADL  
No 
Yes  
 
4603 
2560 
 
66.53 (65.37-67.69) 
33.47 (32.31-34.63) 
Smoking status 
Never-smoker 
Former-smoker 
Current-smoker 
 
3003 
3543 
  595 
 
41.53 (40.39-42.67) 
49.66 (48.58-50.75) 
  8.81  (8.09-9.53) 
Chronic comorbidities 
No disease 
1-2 
3-4 
5 or more 
 
  434 
2380 
2584 
1765 
 
  6.75  (6.17-7.33) 
34.67 (33.35-35.99) 
35.42 (34.41-36.42) 
23.16 (22.04-24.29) 
Number of medications  
No medication 
1-5 
6-10 
11 or more 
 
  346 
2482 
2557 
1778 
 
  5.13  (4.52-5.74) 
35.89 (34.58-37.20) 
35.29 (34.18-36.41) 
23.69 (22.49-24.89) 
The following indicates covariates and its corresponding frequencies for 
responses deemed as “not applicable (NA)” 
Income=4                          Marital status=4           Education=26 
Social activity=52             Smoking status=22      Perceived health=48 
     
 
               
4.4.2 Prevalence and Pattern of At-Risk Drinking 
The prevalence of current drinkers who reported drinking at least one drink in the past 12 
months was estimated to be 34.9% (95% CI: 33.2-36.7 %, n=2316, missing=73). Binge 
drinking, defined as consuming 4 or more drinks in a single day, was reported to be 4.6% 
(95% CI: 3.9-5.3 %, n=295). Table 4.4 compares rates of at-risk drinking measured by 
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more than one method. According to NIAAA guidelines, 11.5% (95% CI: 10.3-12.6 %) 
of the study population were determined to be at-risk drinkers and 23.2% (95% CI: 22.0-
24.4 %) were non-at-risk drinkers. Older adults are advised to consume not more than 
one drink per day or seven drinks in a week by NIAAA guidelines.
76
 As per this 
recommendation, 28.4% (95% CI: 27.0-29.8 %) of the older adults consume alcohol 
within the NIAAA recommended limits and 6.3% (95% CI: 5.8-7.2 %) drink alcohol 
more than the NIAAA recommended limits. Ninety-six older adults provided responses, 
for at least one of the first two survey questions enquiring alcohol use, which could not 
be utilized in the analysis. Of the 7163 community-dwelling older adults included in this 
study, 5.6% (95% CI: 4.8-6.4 %) were assessed to be at-risk drinkers and 29.1% (95% 
CI: 27.6-30.5 %) were non-at-risk drinkers based on the CARET questionnaire. Non-
drinkers comprised 65.3% (95% CI: 63.6-67.1 %) of the study population.  
Table 4.4 Prevalence of At-Risk Drinking 
Variables Total  Men  Women  
 N Weighted Percent   
(95% CI) 
N Weighted Percent   
(95% CI) 
N Weighted Percent   
(95% CI) 
Pattern of alcohol use  
(NIAAA guidelines) 
Non-drinker 
Within-limit drinker 
Exceeding-limit 
drinker 
 
 
4774 
1890 
  403        
 
 
65.32 (63.56-67.07) 
28.39 (27.01-29.78) 
6.29 (5.39-7.19 )          
 
 
1800 
  957 
  290 
 
   
57.21 (54.79-59.63) 
32.54 (30.57-34.51) 
10.25 (8.53-11.97) 
 
 
2974 
  933 
  113 
 
 
71.43 (69.54-73.32) 
25.27 (23.59-26.95) 
  3.30 (2.64-3.97) 
At-risk drinking 
(NIAAA guidelines) 
Non-drinker 
Non-at-risk drinker 
At-risk drinker 
 
 
4774 
1544 
  749 
 
 
65.32 (63.56-67.07) 
23.23 (22.02-24.44) 
11.45 (10.29-12.61)                
 
 
1800 
  760 
  487 
 
 
57.21 (54.79-59.63) 
25.92 (24.18-27.65) 
16.87 (14.87-18.88) 
 
 
2974 
  784 
  262 
 
 
71.43 (69.54-73.32) 
21.21 (19.64-22.78) 
  7.36  (6.36-8.37) 
At-risk drinking  
(based on CARET) 
Non-drinker 
Non-at-risk drinker 
At-risk drinker 
 
 
4774 
1927 
  366 
 
 
65.32 (63.56-67.07) 
29.07 (27.63-30.52) 
  5.61 (4.82-6.40)           
 
 
1800 
 977 
 270 
 
   
57.21 (54.79-59. 63) 
33.27 (31.27-35.28) 
  9.52 (8.05-10.98) 
 
 
2974 
  950 
    96 
 
 
71.43 (69.54-73.32) 
25.91 (24.15-27.66) 
  2.67 (2.04-3.29) 
* N= No. of sample persons interviewed 
Total sample persons =7067, weighted frequency of total sample persons= 19760750, No. of missing = 96 
Bivariate analysis (chi-square test) between gender and at-risk drinking was significant p-value <0.05 
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Table 4.5 Pattern of At-Risk Drinking (Based on CARET Items) 
Reasons for identifying at-
risk drinker 
 At-risk drinkers Non-at-risk drinker  
Sample 
persons 
Weighted percent 
95% CI 
Sample 
persons 
Weighted percent 
95% CI 
Regular alcohol use 155         6.86 (5.66-8.07) 2139 93.14 (91.94-94.34) 
Heavy episodic drinking 131 5.98 (4.77-7.19)      2163 94.02 (92.82-95.23) 
Medical conditions  
High blood pressure 
Gout 
Diabetes 
Depression 
Liver diseases 
 
68 
26  
21  
31 
- 
 
3.13 (2.21-4.04) 
1.24 (0.80-1.68) 
1.13 (0.62-1.65) 
1.32 (0.85-1.78) 
 
 
2224 
2267 
2270 
2261 
2293 
 
96.87 (95.96-97.79) 
98.76 (98.32-99.20) 
98.87 (98.35-99.38) 
98.68 (98.22-99.15) 
100.00 
Health-related behavior 
Memory problems 
Heartburn/stomach pain/ 
nausea/vomiting 
History of a  fall 
 
17 
18 
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0.68 (0.37-0.99) 
0.73 (0.34-1.12) 
 
2.32 (1.64-3.00) 
 
2275 
2276 
 
2232 
 
99.32 (99.01-99.63) 
99.26 (98.88-99.65) 
 
97.68 (96.99-98.36) 
Medication use  
Antiplatelets 
Arthritis and pain medicines 
Ulcer/stomach medicines 
Antihypertensive medicines 
Nitrates 
Warfarin 
Non-prescription medicines 
Psychotherapeutics 
Anticonvulsants 
Sedatives/hypnotics 
Opioid analgesics 
 
29 
44 
88 
91 
17 
34 
32 
68 
24 
25 
82 
 
1.36 (0.79-1.93)       
2.02 (1.39-2.65) 
3.89 (2.95-4.83) 
4.14 (3.13-5.15) 
0.79 (0.39-1.19)  
1.32 (0.82-1.82)  
1.40 (0.88-1.92) 
3.00 (2.30-3.70)  
1.01 (0.65-1.37)   
1.13 (0.74-1.52)  
3.45  (2.61-4.29) 
 
2264 
2249 
2205 
2203 
2276 
2259 
2261 
2225 
2269 
2268  
2211  
 
98.64 (98.07-99.21) 
97.98 (97.35-98.61) 
96.11 (95.17-97.05) 
95.86 (94.85-96.87) 
99.21 (98.81-99.61) 
98.68 (98.18-99.19) 
98.60 (98.09-99.12) 
97.00 (96.29-97.70)    
98.99 (98.63-99.35)    
98.87 (98.48-99.26) 
96.55 (95.71-97.39) 
*Denominator: 2293 older adults (includes drinkers only). The rows add up to 100 and are statistically 
different with p-value less than 0.0001 (Rao-Scott Chi-square analyses).  
 
Of the 2,293 drinkers, 7.6% (95% CI:6.3-8.9 %, n=167) were regarded as “at-risk 
drinker” owing to their alcohol consumption in the presence of selected disease states. Similarly, 
12.2% (95% CI: 10.5-13.8 %, n=276) of the drinkers were considered “at-risk” due to alcohol 
and medication use, and 8.9% (95% CI: 7.5-10.3 %, n=198) for their higher than recommended 
alcohol intake.  
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Of the 2,293 drinkers, 7.4% (95% CI: 6.2-8.6 %) satisfied three or more items in the 
CARET questionnaire, 3.7% (95%CI: 2.9-4.5 %) fulfilled two items, and 5.1% (95%CI: 4.0-
6.2%) fulfilled one item in the CARET questionnaire. Use of antihypertensive medications, anti-
ulcer medications, and opioid analgesics, presence of hypertension and history of falls (in the 
presence of alcohol use of a specified amount) were some of the common factors rendering older 
adults at-risk drinkers (Table 4.5).  
4.4.3 Predictors of at-risk drinking  
Bivariate analyses were conducted to study the association between each covariate and 
at-risk drinking (Table 4.6). The Rao-Scott Chi-square analyses found that age, gender, race, 
marital status, education, employment, income, perceived health status, difficulties in ADL, 
difficulties in IADL, chronic comorbidities, polypharmacy, and limitations in social activity were 
significantly associated with at-risk drinking with p-value <0.0001.  
 
Table 4.6 Distribution of Socio-demographic Characteristics in the Drinking Groups 
Variables  Non-drinker Non-at-risk drinker At-risk drinker  
N Weighted Percent   
(95% CI) 
N Weighted Percent   
(95% CI) 
N Weighted Percent   
(95% CI) 
Age (years) 
65-74 
75-84 
85 and older 
 
1775 
1980 
1019 
 
59.99 (57.75-62.23) 
67.65 (65.47-69.82) 
75.94 (73.55-78.34) 
 
889 
757 
281 
 
32.73 (30.78-34.69) 
27.70 (25.84-29.57) 
21.22 (19.06-23.38) 
 
203 
125 
  38 
  
7.28 (6.07-8.48) 
4.65 (3.76-5.55) 
2.84 (1.90-3.78) 
Gender 
Male 
Female 
 
1800 
2974 
 
57.21 (54.79-59.63) 
71.43 (69.54-73.32) 
 
977 
950 
 
33.27 (31.27-35.28) 
25.91 (24.15-27.66) 
 
270 
  96 
 
9.52 (8.05-10.98) 
2.67 (2.04-3.29) 
Race 
White 
Others 
 
4039 
735 
 
63.19 (61.27-65.11) 
80.10 (77.10-83.10) 
 
1783 
144 
 
30.72 (29.14-32.31) 
17.59 (14.68-20.50) 
 
345 
  21 
 
6.09 (5.20-6.97) 
2.31 (1.16-3.45) 
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Marital Status   
Married 
Others 
 
2298 
2475 
 
60.20 (57.91-62.48) 
71.30 (69.49-73.11) 
 
1161 
  765 
 
33.17 (31.22-35.12) 
24.28 (22.74-25.83) 
 
222 
144 
` 
6.63 (5.64-7.63) 
4.42 (3.52-5.32) 
Education 
No or less than high 
school 
High school 
More than high school 
 
1475 
1553 
1724 
 
82.37 (79.87-84.88) 
70.25 (67.71-72.80) 
53.24 (50.84-55.63) 
 
230 
525 
1170 
 
14.15 (12.03-16.27) 
24.80 (22.87-26.73) 
39.60 (37.46-41.74) 
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218 
 
3.48 (2.26-4.71) 
4.95 (3.53-6.37) 
7.16 (6.05-8.28) 
Income 
$25,000 or less 
More than $25,000 
 
2729 
2045 
 
78.46 (76.50-80.42) 
54.09 (52.05-56.14) 
 
600 
1327 
 
18.46 (16.79-20.12) 
38.14 (36.31-39.97) 
 
98 
268  
 
3.08 (2.32-3.85) 
7.77 (6.71-8.83) 
Employment 
No 
Yes  
 
4353 
  420 
 
67.10 (65.31-68.99) 
52.82 (48.72-56.92) 
 
1635 
 291 
 
27.61 (26.10-29.14) 
39.35 (35.25-43.46) 
 
314 
  51  
 
5.29 (4.50-6.08) 
7.83 (5.45-10.20) 
Limitations of social 
activity 
No 
Yes 
 
3074 
1692 
 
60.32 (58.36-62.28) 
77.94 (76.11-79.76) 
 
1566 
 360 
 
33.43 (31.75-35.10) 
18.06 (16.39-19.72) 
 
286 
  80 
 
6.25 (5.36-7.15) 
4.00 (3.13-4.89) 
Perceived health status 
Better 
Same 
Worse 
 
693 
2948 
1128  
 
66.99 (62.70-71.27) 
62.37 (60.46-64.28) 
73.61 (71.17-76.06) 
 
  265 
1356 
  306 
 
27.35 (23.70-31.01) 
31.63 (29.92-33.33) 
22.07 (19.70-24.45) 
 
  54 
253 
  59 
 
5.66 (3.96-7.37) 
6.00 (5.08-6.93) 
4.32 (3.18-5.45) 
Difficulties in  ADL 
No  
Yes 
 
3247 
1527 
 
61.55(59.46-63.65) 
75.96 (73.95-77.97) 
 
1547 
  380 
 
32.30 (30.49-43.10) 
19.95 (18.05-21.86) 
 
292 
  74 
 
6.15 (5.28-7.02) 
4.09 (2.99-5.18) 
Difficulties in  IADL 
No 
Yes  
 
2810 
1964 
 
59.79 (57.74-61.85) 
76.18 (74.26-78.10) 
 
1443 
  484 
 
33.76 (31.98-35.54) 
19.85 (18.21-21.50) 
 
270 
  96 
 
6.45 (5.44-7.46) 
3.97 (3.16-4.77) 
Smoking status 
Never-smoker 
Former-smoker 
Current-smoker 
 
2241 
2151 
  381 
 
72.96 (71.02-74.90) 
59.14 (56.75-61.52) 
64.25 (60.31-68.20) 
 
  660 
1126 
  141 
 
24.48 (22.65-26.31) 
33.59 (31.62-35.56) 
25.12 (21.44-28.79) 
 
  65  
239 
  62 
 
  2.56  (1.93-3.18) 
  7.27  (6.12-8.43) 
10.63 (7.69-13.57) 
Chronic comorbidities 
No disease 
1-2 
3-4 
5 or more 
 
  240 
1394 
1773 
1367 
 
52.97 (47.52-58.42) 
57.69 (55.29-60.09) 
67.61 (65.19-70.03) 
76.68 (74.42-78.95) 
 
157 
792 
662 
316 
 
39.83 (34.47-45.20) 
35.60 (33.31-37.89) 
27.05 (25.04-29.07) 
19.38 (17.35-21.40) 
 
  30 
145 
125 
  66 
 
7.20 (4.63-9.76) 
6.71 (5.44-7.98) 
5.34 (4.38-6.29) 
3.94 (2.78-5.10) 
Number of medications  
No medication 
1-5 
6-10 
11 or more 
 
  203 
1524 
1728 
1319 
 
58.73 (52.30-65.15) 
60.10 (57.97-62.23) 
66.09 (63.50-68.68) 
73.44 (71.19-75.70) 
 
116 
786 
667 
358 
 
34.79 (28.31-41.27) 
34.17 (32.15-36.19) 
28.22 (26.11-30.34) 
21.43 (19.36-23.49) 
 
  23 
128 
132 
  83 
 
6.48 (3.86-9.11) 
5.73 (4.48-6.98) 
5.69 (4.56-6.81) 
5.13 (4.08-6.18) 
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Table 4.6 shows the distribution of at-risk drinking for each covariate. Compared to other 
age groups, 65-74 years age group had higher proportions of at-risk drinkers. Similarly, greater 
number of males and whites were at-risk drinkers compared to females and older adults of other 
races, respectively. Relatively higher proportions of at-risk drinkers had attained more than high 
school education, earned more than $ 25,000 per year, and were employed. Proportions of at-risk 
drinkers with no difficulties in performing ADLs or IADLs; with either no disease or having1-2 
disease; with health status not limiting to their social activity; and with perceived health status 
being same as previous year, were higher than other corresponding covariate category, 
suggesting that at-risk drinkers seemed to have better functional status.  
Table 4.7 Factors Associated with At-Risk Drinking 
Variables  Non-at-risk 
drinker 
p-value  At-risk drinker  p-value 
Age  
85 and older 
75-84 
65-74 
 
1 (ref) 
1.18 (1.01-1.37) 
1.24 (1.04-1.48) 
 
 
0.0356 
0.0151 
 
(ref) 
1.47 (0.99-2.18) 
2.22 (1.50-3.30) 
 
 
0.0568 
<.0001 
Gender 
Female 
Male 
 
(ref) 
1.15 (1.01-1.30) 
 
 
0.0356 
 
(ref) 
3.16 (2.31-4.34) 
 
 
<.0001 
Race 
White 
Others 
 
(ref) 
0.65 (0.52-0.82) 
 
 
0.0002 
 
(ref) 
0.39 (0.22-0.67) 
 
 
0.0007 
Marital status 
Married 
Others 
 
(ref) 
1.04 (0.91-1.18) 
 
 
0.6095 
 
(ref) 
1.42 (1.09-1.87) 
 
 
0.0107 
Education 
More than high 
school 
High school 
No or less than high 
school 
 
(ref) 
0.57 (0.49-0.66) 
0.36 (0.29-0.44) 
 
 
<.0001 
<.0001 
 
(ref) 
0.69 (0.50-0.97) 
0.50 (0.33-0.77) 
 
 
0.0327 
0.0018 
Income 
More than 25,000 
Less than 25,000 
 
(ref) 
0.53 (0.45-0.63) 
 
 
<.0001 
 
(ref) 
0.41 (0.31-0.53) 
 
 
<.0001 
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Employment 
No 
Yes  
 
(ref) 
1.14 (0.92-1.40) 
 
 
0.2294 
 
(ref) 
1.01 (0.69-1.49) 
 
 
0.9309 
Limitations in social 
activity 
No 
Yes 
 
(ref) 
0.65 (0.54-0.77) 
 
 
<.0001 
 
(ref) 
0.75 (0.56-1.00) 
 
0.0476 
Perceived health 
status 
Worse  
Same 
Better 
 
(ref) 
1.07 (0.89-1.28) 
0.93 (0.72-1.20)
  
 
 
0.4770 
0.5933 
 
(ref) 
1.20 (0.84-1.71) 
1.08 (0.70-1.67) 
 
 
0.3144 
0.7172 
Difficulties in  ADL 
No  
Yes 
 
(ref) 
0.95 (0.79-1.14) 
 
 
0.5552 
 
(ref) 
0.98 (0.68-1.43) 
 
 
0.9305 
Difficulties in  IADL 
No 
Yes  
 
(ref) 
0.88 (0.75-1.03) 
 
 
0.1071 
 
(ref) 
1.00 (0.71-1.40) 
 
 
0.9827 
Smoking status 
Never-smoker 
Former-smoker 
Current-smoker 
 
(ref) 
1.64 (1.44-1.87) 
1.29 (1.02-1.63) 
 
 
<.0001 
0.0308 
 
(ref) 
2.55 (1.89-3.43) 
3.89 (2.56-5.90) 
 
 
<.0001 
<.0001 
Chronic comorbidities 
5 or more 
3-4 
1-2 
No disease 
 
(ref) 
1.20 (1.02-1.42) 
1.53 (1.29-1.81) 
1.71 (1.27-2.32) 
 
 
0.0287 
<.0001 
0.0005 
 
(ref) 
1.26 (0.87-1.81) 
1.72 (1.18-2.53) 
1.85 (1.06-3.25) 
 
 
1.5018 
0.0053 
0.0313 
Number of 
medications  
11 or more 
6-10 
1-5 
No medication 
 
 
(ref) 
1.15 (0.97-1.37) 
1.19 (1.00-1.42) 
1.17 (0.81-1.69) 
 
 
 
0.1195 
0.0536 
0.4169 
 
 
(ref) 
0.94 (0.70-1.27) 
0.77 (0.55-1.07) 
0.74 (0.41-1.35) 
 
 
 
0.6808 
0.1155 
0.3267 
 
A multi-nominal logistic regression model was built to identify factors associated with at-
risk drinking and non-at-risk drinking (results in Table 4.7). Older adults belonging to the 65-74 
year age group were at higher odds (odds ratio: 2.22, 95%CI: 1.50-3.30) of being at-risk drinkers 
than older adult aged 85 years or older. Similarly, older adults aged between 65 to 74 years were 
at 24% higher odds (odds ratio: 1.24, 95%CI: 1.04-1.48) of being non-at-risk drinkers than older 
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adult aged 85 years or older. Older men were at higher odds of being at-risk drinkers (odds ratio: 
3.16, 95%CI: 2.31-4.34) and non-at-risk drinkers (odds ratio: 1.15, 95%CI: 1.01-1.30) compared 
to women. Older adults of non-white race were less likely to be at-risk drinkers (odds ratio: 1.42, 
95%CI: 1.09-1.87). Compared to married older adults, non-married older adults were at higher 
odds (odds ratio: 1.42, 95%CI: 1.09-1.87) of indulging in at-risk drinking. Older adults with a 
high school or less than a high school education were at lower odds of being at-risk drinkers and 
non-at-risk drinkers than older adults with more than a high school education (includes college 
educated or graduate degree). Older adults with annual income less than $25,000 were less likely 
to be at-risk drinkers (odds ratio: 0.41, 95%CI: 0.31-0.77). A similar association was observed 
between non-at-risk drinking and lower income. Employment status was not significantly 
associated with at-risk drinking in this population where many of the participants were no longer 
in the workforce.  
Perceived health status and functional status as measured by ADLs, and IADLs were not 
significantly associated with at-risk drinking. Older adults experiencing limitations in social 
activity owing to their health were less likely to be a non-at-risk drinker (OR: 0.65, 95%CI: 0.54-
0.77). The number of chronic comorbidities was found to be significantly associated with at-risk 
drinking. Compared to older adults suffering from five or more chronic conditions, older adults 
with no or with less than five disease conditions were more likely to indulge in at-risk drinking 
as well as non-at-risk drinking. A linear relationship was observed wherein as the number of 
comorbidities decreases the magnitude of odds of at-risk drinking increases. Number of 
medication taken by older adults was not significantly associated with at-risk drinking. Former 
smokers (OR: 2.55, 95% CI: 1.89-3.43) and current smokers (OR: 3.89, 95% CI: 2.56-5.90) 
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showed greater odds of being at-risk drinkers compared to those who have never smoked before 
(never-smoker).  
4.4.4 Sensitivity Analyses     
Sensitivity analyses were performed to understand how the results are affected by changing 
the methodological decisions or assumptions made during the process of data analysis. Quantity 
and frequency of alcohol use is the principal component of at-risk drinking. In addition, 
measuring alcohol consumption is subject to high variability. Hence, it is essential to determine 
how the prevalence of at-risk drinking changes by altering the alcohol use limits. 
 
A. Sensitivity Analysis on Prevalence of At-risk Drinking: Different definitions of at-risk 
drinking were applied and the following are the conditions and the results of those 
scenarios: 
1) At-risk drinkers were defined as those who experience the diseases and health-related 
behaviors and/or take medications mentioned in CARET, and consume alcohol 
(including those who drink within-limit and exceeding limit recommended by NIAAA). 
In this analysis, older adults consuming 4 or more drinks in a single day were also 
regarded as at-risk drinkers. 30.98% (95% CI: 29.38-32.58, n=2061) were found to be at-
risk drinkers, 3.70% (95% CI: 3.19-4.21, n=232) were non-at-risk drinkers. The Rao-
Scott Chi-square test showed proportions were significantly different (p-value <0.0001). 
2) At-risk drinkers were defined as those who experience the diseases and health-related 
behaviors and/or take medications mentioned in CARET, and consume alcohol at an 
exceeding limit (by NIAAA definition). 5.36% (95% CI: 4.52-6.20, n=343) were 
considered as at-risk drinkers and 29.33% (95% CI: 27.92-30.73, n=1950) were non-at-
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risk drinkers. Heavy episodic drinkers were not included in this analysis. The Rao-Scott 
Chi-square test showed proportions were significantly different (p-value <0.0001). 
3) At-risk drinkers were defined as those who experience the diseases and health-related 
behaviors and/or take medications mentioned in CARET and exhibit heavy episodic 
drinking only. 3.78% (95%CI: 3.20-4.37, n=242) were at-risk drinkers and 30.95% (95% 
CI: 29.38-32.51, n=2053) were non-at-risk drinkers. The Rao-Scott Chi-square test 
showed proportions were significantly different (p-value <0.0001). 
4) At-risk drinkers were defined as those who show the presence of diseases, medications, 
and/or health-related behaviors mentioned in CARET and exhibit heavy episodic 
drinking as well as drinking that exceed limit. 6.77% (95% CI: 5.85-7.69, n=436) were 
at-risk drinkers and 27.96% (95% CI: 26.6-29.3 %, n=1,859) were non-at-risk drinkers. 
The Rao-Scott Chi-square test showed the proportions were significantly different (p-
value <0.0001). 
5) At-risk drinkers were defined as those who show the presence of diseases, medications, 
and/or health-related behaviors mentioned in CARET and consume alcohol ≥4 drinks/day 
or ≥8 drinks/week (NIAAA guideline for at-risk drinking). 9.82% (95% CI: 8.74-10.89 
%, n=645) were at-risk drinkers and 24.87 (95% CI: 23.56-26.17 %, n=1648) were non-
at-risk drinkers. The Rao-Scott Chi-square test showed the proportions were significantly 
different (p-value <0.05). 
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B. Alcohol use among excluded subjects  
Alcohol use among those excluded for having partial/complete paralysis and/or amputation 
leading to loss of arm or leg was studied. A total of 371 subjects were excluded from the final 
sample. After removing two subjects from analysis due to missing data on alcohol consumption, 
70.2% (95% CI: 64.8-75.6 %) were non-drinkers, 26.3% (95% CI: 21.3-31.3 %) were within 
limit drinkers, 3.5% (95% CI: 1.5-5.6 %) were exceeding limit drinkers, and 7.7% (95% CI: 4.7-
10.7 %) were at-risk drinkers (NIAAA definition). 
C. Alcohol use among all the subjects in Access to Care module 
Alcohol use among all community-dwelling older adults, aged 65 years or older and surviving 
through 2009, present in the Access to Care module was studied. A total of 11,393 community-
dwelling older adults surviving through 2009, were present in Access to Care module. After 
removing 119 subjects from the analysis due to missing data on alcohol consumption, 63.7% 
(95% CI: 62.1-65.2 %) were non-drinkers, 29.8% (95% CI: 28.5-31.0 %) were within limit 
drinkers, 6.5% (95% CI: 5.9-7.2 %) were exceeding limit drinkers, and 11.9% (95% CI: 11.1-
12.8 %) were at-risk drinkers. 
D. Proxy Respondents 
Proxies were designated when participants were too ill or could not complete the community 
interview for other reasons. Among the 7,163 study subjects, 7.4% were proxy respondents 
(n=531). The relationship between the participants and their proxy was collected and assessed. 
Of the 531 proxy respondents 46.7% were the spouse, 30.1% were a daughter, and 8.5% were a 
son of the participants.  
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4.4 Discussion  
This population-based cross-sectional study was conducted to understand the prevalence 
and pattern of at-risk drinking and factors associated with at-risk drinking among community-
dwelling Medicare beneficiaries, aged 65 years or older, surviving through 2009. The prevalence 
of at-risk drinking, based on the CARET questionnaire, was estimated to be 5.6% (95% CI: 4.8-
6.4). Age, gender, race, marital status, educational level, income, smoking status, comorbidity, 
and limitations to social activity were the factors associated with at-risk drinking in this 
population.  
In this study, at-risk drinking was assessed by more than one method. Apart from using 
the CARET questionnaire, the NIAAA definition of at-risk drinking for older adults was also 
utilized to determine at risk drinking.
76,41,60
  Based on the NIAAA definition, the prevalence of 
at-risk drinking was estimated to be 11.5% (95% CI: 10.3-12.6). The substantial difference 
between the two rates could be attributed to the criteria for the NIAAA guidelines and the 
CARET decisions. The NIAAA guideline defines at-risk drinking in terms of quantity and 
frequency of alcohol use i.e. consuming 4 or more drinks on a given day, or 8 or more drinks in a 
week. The CARET describes at-risk drinking not only in terms of quantity and frequency of 
alcohol use, but also addresses use of alcohol in the presence of alcohol interactive disease and 
medication use. Hence, sensitivity analyses were performed to understand how the prevalence of 
at-risk drinking varies under different conditions of alcohol consumption. In the sensitivity 
analyses, prevalence of at-risk drinking was determined by using different definitions of “risky” 
alcohol use while keeping the CARET specified disease conditions, health-related behaviors, and 
medications constant. Sensitivity analyses showed that depending upon the different definitions 
of alcohol use, at-risk drinking may range from 4% to 31%.  
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Two studies have investigated at-risk drinking in U.S. older samples employing the 
CARET tool. Analysis of 1971-1974 NHANES I data estimated 10% at-risk drinking (n=425) 
among 4,691 U.S. civilian non-institutionalized older adults aged 60-74 years.
60
 
 
Barnes et al 
found 34.7% of the 3,308 currently drinking older adults aged 60 years or more, in Santa 
Barbara, California area were at-risk drinkers.
42
 It must be noted that the above two studies 
included adults aged between 60 to 64 years that has not been included in the current study. In 
addition, a Finnish study examining at-risk drinking, using the NIAAA guideline definition of at-
risk drinking among a randomly selected sample of older adults aged 65 year or older found that 
8.2% of the 2,100 older adults were at-risk drinkers.
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In this study, 75.1% (95% CI: 70.0-80.2 %) of the at-risk drinkers were categorized as 
such due to their alcohol interactive medication use, 46.8% (95% CI 40.6-53.0 %) due to their 
disease profile and health-related behaviors, and 55.2% (95% CI: 50.1-60.4 %) due to their 
pattern of alcohol use. Patterns of at-risk drinking in the NHANES I study showed that 69% of 
at-risk drinkers were classified as such because of their alcohol consumption combined with 
comorbidities.
60
 The SHARE study found that 64.3% were at-risk drinkers due to alcohol 
behavior, 61.9% were deemed at-risk drinkers owing to alcohol use in the presence of select 
comorbidities, and 61.0% were classified as at-risk drinkers due to medication use combined 
with alcohol consumption.
42
 Our study found antihypertensive medications, ulcer/stomach 
medications and, opioid analgesics, presence of hypertension, and history of falls, to be some 
commonly identified items responsible for classification as an at-risk drinker. The NHANES I 
study reported presence of gout, ulcer, and anxiety disorder as the three most common 
comorbidities associated with at-risk drinking, medication for pain and indigestion, and insomnia 
as the three most frequently consumed medications associated with at-risk drinking.
 60
 The study 
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by Ryan et al. assessed the drinking pattern of older adults with chronic medical conditions. 
Seven percent of the Medicare beneficiaries with one or more of the seven chronic conditions 
(Alzheimer’s disease and other senile dementia, chronic obstructive pulmonary disease, 
depression, diabetes, heart failure, hypertension, and stroke) reported at-risk drinking (defined as 
those who exceeded monthly limits but not the single-day limit and heavy episodic drinkers who 
exceeded the single day limit, with or without exceeding the monthly limit).
55
 6.9% of the older 
adults with hypertension reported drinking in excess of current guidelines. At-risk drinking 
prevalence was reported as 3.4% in persons with Alzheimer’s disease, 7.4% in persons with 
COPD, and 4.5% in persons with diabetes.
55
  
Many studies have defined unhealthy drinking based on the NIAAA recommendation of 
“not more than one drink per day or seven per week” for older adults. Examination of 2003 
MCBS data showed that 3.8% of 10,523 older adults (community-dwelling, fee-for-service 
Medicare beneficiaries aged 65 years or older) reported consuming more than 30 drinks per 
month, and 5.4% reported heavy episodic drinking.
28,55,56
 This pattern of heavy alcohol 
consumption is very similar to that found in our study. Secondary analysis of the 2005 and 2006 
National Survey on Drug Use and Health data performed among 4,236 older adults aged ≥65 
years established that 13% of men and 8% of women were at-risk drinkers (defined as two or 
more drinks on a usual drinking day within the past 30 days).
74
 A study in the non-
institutionalized Belgian elderly population (n=4,825) found 50.4% were non-or-occasional 
drinkers (mean of zero glasses/week), 29.1% were moderate drinkers (1-7 glasses/week), 10.4% 
were at-risk drinkers (8-14 glasses/week), 4.6% were heavy drinkers (15-21 glasses/week), and 
5.5% problematic drinker (>21 glasses/week).
85
 A German study conducted on 3,224 non-
demented subjects aged 75 years or older and attending general practitioners, identified 6.5% 
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(95% CI: 5.6-7.4), of the sample as at-risk drinkers (defined as intake of >30g/day of alcohol for 
men and >20g/day of alcohol for women).
75
 
 In this study we identified that older adults aged between 65-74 years were more likely to 
be at-risk drinkers than those aged 85 years or older. Most studies have reported comparatively 
higher intake of alcohol by younger elderly than the older ones, thus, as age increases, alcohol 
consumption decreases.
 42,66,85
 As reflected by most of the studies, older men tend to drink more 
than older women.
42,66,75,85,106
  Similar to the Barnes et al findings, we found that whites consume 
more alcohol than individuals of other races.
42
 Education and income were recognized as 
determinants associated with at-risk drinking. Older adults with higher education and higher 
income may be inclined to consume alcohol at a level considered harmful. Such association of 
at-risk drinking with education and income was also evident in other studies.
 42,61,66,106
  Contrary 
to the findings of other studies
42,61,66
 , older adults who lived alone (were separated, widowed, 
divorced, unmarried) were more likely to be at-risk drinkers when compared to those who were 
married or were living with partner. A similar observation was made by Merrick et al (2008) 
reporting higher prevalence of unhealthy drinking by divorced or single older adults. 
Interestingly, the aforementioned study was conducted using MCBS data.
28
 In light of the 
inconsistent association between marital status and at-risk drinking, a detailed analysis is 
warranted.  
 Having one or more comorbid conditions is inversely associated with at-risk drinking and 
even with non-at-risk drinking. This might suggest that healthier older adults tend to consume 
more alcohol. ADL, IADL, and perceived health status did not show any significant relationship 
with at-risk drinking. Not many studies have investigated ADL, IADL and alcohol consumption. 
A few studies that investigated the relationship between at-risk drinking and self-reported health 
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status also failed to establish any significant association.
61,67,85
 Several studies have established 
positive association between alcohol intake and at-risk drinking with smoking status.
 42,61,67
  This 
seems to strengthen the supposition that subjects, who are currently using a substance of abuse or 
with the history of the same, may be more prone to at-risk drinking, or problematic alcohol use. 
Besides, there may be a possibility that the data or this analysis has failed to capture other 
important aspect of at-risk drinking.  
 Comparison of our findings with other epidemiological studies is difficult because the 
setting of the study, the study population, definitions of at-risk drinking, and assessment tools 
vary from study to study. However, the pattern of alcohol consumption estimated by our study is 
comparable with the findings of other studies. This study assessed the relationship of at-risk 
drinking with various socio-demographic factors as well as health-related factors (ADL, IADL, 
health status, comorbidity, and medication use) providing an understanding of elements 
connected with at-risk drinking among older adults. The weighted estimates from the study 
represent the national population of older adults in U.S. in the year 2009. The MCBS consists of 
survey as well as administrative claims data, thus, enabling the analyses to include large number 
of variables in the analysis.  
Like all studies, our study also has some limitations. There may be underestimation of the 
prevalence of at-risk drinking determined by this study due to various reasons enlisted below:  
1. It could be due to inability to obtain data for all the items mentioned in the CARET. Items 
including “how many days did you drive a vehicle within 2 hours of drinking 3 or more 
drinks”, and “how much of the time you have the following problems: i) feeling sad and blue, 
and ii) tripping, bumping into things” were not included in this study due to lack of this 
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information in the dataset. The proportion of older adults who drink alcoholic beverage and 
drive exhibiting risky behavior were not captured in this study due to absence of that 
information in the dataset. A study found that among older drivers involved in fatal crashes, 
5% had blood alcohol concentration (BAC) of 0.08 grams per deciliter (g/dL) or higher.
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2. Besides translating and matching the MCBS data with the CARET questionnaire and 
decisions may have led to loss of information or misclassification. This could be due to the 
difference in the categorization of items in the CARET and the MCBS survey questions 
regarding alcohol use. For example, in the CARET questionnaire, subjects were asked to 
report frequency of their alcohol consumption by choosing one of the following items: never, 
once a month or less, 2-4 times a month, once a week, 2-3 times a week, 4-5 times a week, 6-
7 times a week. While in MCBS subjects are asked to provide the frequency (numerical) of 
alcohol use in a typical month. No items are provided in the frequency question (to 
categorize their frequency of consumption). So while matching the frequency of alcohol 
consumption of a subject to the items in CARET loss of information or misclassification may 
have resulted.  
3. Health utilization data for HMO-covered incidents were not available in the dataset; hence, 
the inpatient and outpatient hospitalization records of a proportion of individuals were not 
available. This may misclassify some older adults who could be at-risk drinkers due to their 
liver conditions or presence of gout, but due to lack of data were classified as non-at-risk 
drinker in this study. Moreover, mostly severe cases of gout or liver conditions require 
hospitalization hence the cases that did not result in hospitalization were not considered in 
this study.    
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4. Some studies assess at-risk drinking among the current-drinkers, and thus the denominator 
comprises of current drinkers. But in our study, the denominator comprised of the entire 
study population (except subjects with missing information n=96).  
5.  Some studies have included adults aged 60 years or older. This study defined older adults as 
aged 65 years or older. Hence, older adults aged 60-65 years were not included in the 
analysis.  
6. On comparing the prevalence of alcohol use reported using the NHANES data and the 
MCBS data, it can be seen that the number of older adults identifying themselves as non-
drinkers was 47.85% (95% CI: 44.07-51.63) in the NHANES study while it was 65.32% 
(95% CI: 63.56-67.07) in the MCBS study. This may suggest that some proportion of under-
reporting could be attributed to the source collecting the information. It should be noted that 
CMS collects MCBS data so some older adults may be hesitant revealing their alcohol intake 
to the federal health insurance agency. 
7. Proxy responses and inability to accurately recall may lead to underreporting of alcohol use.  
8. There is likelihood that alcohol dependent or abuse patients may be under-represented in the 
survey itself.  
9. There is a possibility that some non-drinkers may include former drinkers who stopped 
drinking due to health conditions, side effects of alcohol, or other factors.  
Another important limitation is the possibility of intentional under-reporting of alcohol 
consumption by older adults driven by social desirability response bias.
87,88
 Studies have shown 
that individuals are reluctant to admit indulging in unpopular behaviors such as alcohol intake, to 
avoid creating a negative impression.
87,88
 A study involving undergraduate students found that 
students who were impression managers reported 20 to 33% less alcohol consumption, and were 
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about 50% less likely to report risky drinking.
87,88
 Social desirability response bias results in 
underestimating the rate of heavy drinking, however, this bias does not compromise the study of 
predictors of heavy drinking.
87,88
 And self-reporting of alcohol consumption is regarded as a 
reliable and valid approach of estimating alcohol consumption.
87
  
Another factor correlated to possible under-reporting was the quantity-frequency (QF) 
approach of measuring alcohol consumption. Questions about “typical” frequency of alcohol 
consumption or “on average” number of alcoholic beverage consumed, may lead to 
underestimates alcohol consumption.
71,89
  When subjects are questioned about their average 
intake over the past period they tend to report median rather than mean, apparently because they 
fail to consider the occasional high drinking episodes.
71,89
  Studies have shown that the diary 
method of data collection yields higher mean quantity of alcohol consumed than QF measure.
71,89
  
Questions about alcohol consumption pertained to “standard drinks” of alcohol that may 
be misinterpreted by older adults providing biased information.
55,90
  The assumption that older 
adults can consider the definition of size of standard drink while reporting their alcohol 
consumption may not hold leading to misclassification bias. Information on types of alcoholic 
beverages consumed (i.e. wine, beer, spirits) was not collected. Different types of alcoholic 
beverage have different impact on health. For example two glasses of hard liquor or wine will 
have different health implications.
90
  
There was no way to ascertain if the alcohol consumption was concurrent with 
medication use in older adults. The CARET question inquires about the medication used by older 
adults “at least 3-4 times a week”. Since the dose and frequency of medication use could not be 
determined from the MCBS data, it was assumed that all of the medications were consumed at 
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least 3-4 times a week. This may lead to an over-estimation of medication use. Nonetheless, most 
of the CARET enlisted medications are used for chronic conditions and taken regularly by older 
adults, such as antihypertensives, nitrates, antidepressants, anticonvulsants, arthritis and pain 
medications, warfarin, aspirin, and anxiolytics/sedatives. There is a possibility of individuals 
with dementia or memory problem not being able to provide accurate information. Moreover, a 
reference period of 12 months could be too long resulting in recall bias or misclassification bias. 
Proxy responses may not provide accurate insights on health related behaviors.
91
  Association 
between at-risk drinking and past use of illicit drugs has been documented in the literature.
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Apart from information on smoking, the MCBS does not capture data on current or past use of 
other substances of abuse such as heroin, cocaine, and marijuana. Combined use of alcohol and 
illicit drugs is also considered “risky” behavior but it could not be captured in this study.  
This study is generalizable to community-dwelling older adults and does not include 
institutionalized older adults. The MCBS data only includes older Medicare beneficiaries (older 
adults who are eligible for Social Security payments), thus, older adults not enrolled in Medicare 
were not included. As the MCBS is a survey including Medicare beneficiaries voluntarily 
participating in the survey, the results of this study are not applicable to non-responders. 
However, it should be noted that the weighting process takes into account the non-responder’s 
bias, attrition rate and post-stratification bias.  
This study shows that at-risk drinking is prevalent among older adults and identifies 
factors associated with at-risk drinking. Considering the proportion of at-risk drinkers, it is 
imperative to understand the effect of at-risk drinking on health-related outcomes, quality of life, 
or mortality of older adults. Several studies have assessed the effect of at-risk drinking on health-
related outcomes such as fall, gastrointestinal bleeding, injuries/accidents, mortality, and 
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economic cost of alcohol-related disorders. Previous research had shown that at-risk drinking is 
associated with greater mortality rates in older men.
60
 At-risk drinkers are also more prone to 
falling or injuring themselves and missing taking their medications.
66
 High alcohol consumption 
is also associated with falling.
1,73,93
  Concurrent use of alcohol and NSAIDs or aspirin heightens 
the risk of gastric bleeding in older adults.
73
 Further research needs to be conducted to confirm 
the impact of at-risk drinking on health outcomes, quality of life, or mortality in American older 
adults.  
Harmful effects of at-risk drinking can be averted by implementing preventive measures. 
Creating awareness among older adults by providing educational interventions, behavioral or 
motivational counseling, educational workshops or programs with healthcare professional, may 
help in reducing at-risk drinking. Previous research has shown that such interventions have been 
helpful in creating awareness about potential risks associated with alcohol use among older 
adults and have played a significant role in altering their alcohol consumption.
94,95
 A secondary 
analysis of data obtained from a randomized controlled trial in older at-risk drinkers established 
“older adults reduce their drinking when they recognize that their drinking habits may be causing 
them harm”. Older adults have cited environment and circumstances as major factors influencing 
their drinking habits.
111 
Table 4.9 summarizes the studies investigating at-risk drinking measured in different ways. 
Some of these studies have determined at-risk drinkers from among the current drinkers. The 
SHARE study conducted the study in a population that may report higher alcohol consumption 
compared to a nationally representative sample.
42
. 
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Table 4.8 Summary of Studies 
Studies  Setting  Sample 
size 
Subjects Assessment tool Prevalence of at-
risk drinking  
Other findings  Factors associated 
with at-risk 
drinking 
Wilson,
50  
2013  
U.S.A 
NHANES  
2005-2008  
1,083 Older adults aged 
65 years or older 
who consume 
alcohol. 
ARPS. 47 of the 
63 items applied 
in this study 
Harmful drinkers 
= 37.4 % of older 
drinkers (95 % CI: 
34.9 %, 40.0 %).  
Hazardous or 
harmful drinkers = 
53.3 % (95 % CI: 
50.1 %, 56.6 %).  
14.5 % of older drinkers 
(95 % CI: 12.1 %, 16.8 
%) consumed alcohol 
above the NIAAA’s 
recommended limits.  
Male drinkers had 
higher odds of 
being hazardous or 
harmful drinkers.  
Barnes,
42
 
2010  
U.S.A 
Analysis of 
survey data 
collected from 
subjects visiting 
primary care 
clinics in Santa 
Barbara, CA 
3,308  
 
Current drinkers 
aged ≥60 years 
visiting  
CARET 
7-item 
questionnaire 
34.7% of the total 
sample were at-
risk-drinkers 
61.9% deemed at-risk 
due to alcohol and 
comorbid conditions and 
61.0% due to medication 
and alcohol use and 
64.3% only due to 
alcohol use.  
At-risk drinking 
decreased for 
female gender; 
adults aged over 80 
years; Asians; and 
individuals with 
higher education.  
Moore,
61
 
2006 
U.S.A 
NHANES I 
(1971-1974) and 
NHANES 
Epidemiologic 
Follow-up 
study, 1992 
4,691 Older adults aged 
60-74 years at 
baseline and who 
provided alcohol 
use data 
CARET 
(few selected 
items of CARET 
were employed) 
39% (n=1,658) of 
the sample were 
drinkers.  And 
10% (n=425) were 
at-risk drinkers.  
 
69% of the drinkers 
were deemed as such 
due to their alcohol use 
and comorbidities, and 
31% solely based on 
their alcohol use.  
Pain medication 
use, gout, ulcer 
diseases, anxiety 
disorder were most 
commonly 
implicated 
Items.    
Fink,
43
 2002 
U.S.A 
Survey 
conducted in 
primary care 
clinics 
549 Older adults aged 
65 years or older, 
English 
proficiency, and 
reported drinking at 
least 1 drink in the 
past year 
ARPS  
60 item 
questionnaire 
Harmful 
drinkers=11% 
Hazardous 
drinkers=35% 
 
Anti-arthritic and pain 
medications were most 
common followed by 
antiulcer medications. 
Hypertension was 
common comorbidity.  
Harmful drinkers 
were more common 
in older men, and 
older adults aged 
<75 years.  
76 
 
Blazer,
74
 
2009,  
U.S.A 
Data from 
National Survey 
on Drug Use 
and Health 
(2005 and 2006) 
4,236 Non-
institutionalized 
older adults aged 
65 years or older  
At-risk drinking 
defined as use 
having two or 
more drinks on a 
usual drinking 
day within the 
past 30 days 
13% of men and 
8% of women 
reported at-risk 
use 
More than 14% of men 
and 3% of women 
reported binge drinking 
 
Immonen,
67
 
2011, 
Finland  
Data gathered 
using postal 
questionnaire 
sent to a random 
sample 
2,100 Older adults aged 
65 years or older 
living in the 
medium sized city 
of Espoo in Finland 
Structured 
questionnaire. 
At-risk drinking 
defined as i) 
more than 7 
drinks per week, 
ii)  five or more 
drinks on a 
typical day, or 
iii) using 3 or 
more drinks 
several times a 
week.  
Of the 1395 
responders, 8.2% 
(n=114) were at-
risk drinkers 
At-risk drinkers were 
prone to falling and 
forgetting to take 
medications.  
At-risk drinking 
was associated with 
male gender, older 
adults aged 
between 65-70 
years, married or 
living with partner, 
good income, high 
level of education, 
current smoking, 
and better 
functional status.  
Weyerer,
75
 
2009  
Germany 
A part of multi-
center 
longitudinal 
study  
3,224 Non-demented 
subjects aged 75 
years or older, 
attending general 
practitioners in an 
urban area. 
Structured 
clinical 
interview.  
At-risk drinking 
defined as >20 g 
of alcohol for 
women and >30 
g for men.  
At-risk drinking 
was 6.5% (95% 
CI: 5.6- 7.4 %).  
At-risk drinking was 
significantly higher 
among men, current 
smokers. 
At-risk drinking 
rate decreased with 
age, was lower in 
women, higher 
among current 
smokers, and was 
associated with 
better mobility and 
fewer depressive 
symptoms.  
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4.5 Conclusion 
This study determines at-risk drinking, based on the CARET questionnaire, in a 
nationally representative sample of older adults. It further identifies the socio-demographic or 
health-related risk factors associated with at-risk drinking in this population. This study not only 
helps fill gaps in literature, but also builds evidence that can be used to develop and target 
preventive programs to mitigate alcohol-related problems. Furthermore it underscores the need 
for additional research to understand the impact of at-risk drinking in this population. Adverse 
events associated with at-risk drinking are largely preventable. Thus, identifying older adults 
who are likely to be at-risk drinkers and providing then with an educational intervention may 
help prevent alcohol-related adverse events, and avert expenditure of healthcare resources. 
Screening older adults for problematic alcohol use based on the socio-demographic or health-
related risk factors determined in this study may streamline the screening process saving time 
and resources.  
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Chapter 5 
Section 5. Potential Concurrent Use of Alcohol and Central Nervous System-Acting 
Medications  
5.1 Introduction  
Combined use of CNS-acting medications and alcohol, even in moderate quantities, may 
enhance sedation and impairment of psychomotor functions resulting in traffic accidents, 
injuries, falls, and fractures. Retrospective review of all zolpidem related cases reported, in the 
span of two-years, to the Illinois Poison Center showed that co-ingestion of alcohol and 
zolpidem was associated with intensive care unit admissions.
96
 A German study found the 
weighted prevalence of combined use of psychotropic medication and alcohol to be 7.6% among 
non-institutionalized older adults.
66
 Analysis of community-dwelling Australian men aged 70 
years or older showed that among 135 men taking antidepressants, 27% were daily drinkers. 
Among sedative or anxiolytic users (n=97), approximately 43% were daily drinkers. This study 
also found that use of sedative or anxiolytics was associated with daily drinking.
64
  
5.2 Objective 
A descriptive, cross-sectional analysis was undertaken to determine the prevalence and 
pattern of potential alcohol and CNS-acting medication use among non-institutionalized older 
adults, and to understand the predictors of alcohol use among older adults taking CNS-acting 
medication.  
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5.3 Methods  
5.3.1 Data Source 
The National Health and Nutrition Examination Survey (NHANES) is a continuing, 
cross-sectional, nationally representative survey of the U.S. non-institutionalized civilian 
population that employs a complex, stratified, multistage, probability sampling design. The 
results of this study were obtained by combining the three data cycles (2005-2006, 2007-2008, 
and 2009-2010). The NHANES data consist of in-person household interviews and standardized 
health examinations administered in a mobile examination center (MEC).The details on the 
methods used for data collection and coding can be obtained from the NHANES website.
97
 The 
demographic details, information on medication use, and other covariates were obtained during 
household interview. The overall response rates for the unweighted interview sample in 
NHANES 2005-2006, 2007-2008, 2009-2010 were 80.45%, 78.4%, and 79.4%, respectively. 
Information on alcohol use and depression were obtained during the medical examination. The 
overall unweighted examination response rates of the sample in NHANES 2005-2006, 2007-
2008, 2009-2010 were 77.36%, 75.4%, and 77.3%, respectively. 
5.3.2 Study Population 
The study population consisted of non-institutionalized adults, aged 65 years or older at 
the time of interview, taking at least one prescription medication and with complete information 
on alcohol and medication use. After merging relevant data files and applying eligibility criteria, 
the final study sample consisted of 3320 individuals (Figure 4.1).  
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5.3.3 CNS-Acting Medication Use 
Prescription medication use information was collected during household interviews. 
Participants were asked, ‘‘have you taken or used any prescription medicines in the past 
month?’’ and if the response was affirmative, they were asked to present the medication 
container. To classify medications, NHANES uses Lexicon Plus®, a proprietary, comprehensive 
database of Cerner Multum, Inc. that consists of all prescription and some non-prescription drug 
products available in the U.S. drug market.
98,99
  For the purpose of this study, CNS-acting 
medication was defined as “those medications which, when consumed concomitantly with 
alcohol, could intensify the effects of alcohol resulting in increased sedation, drowsiness, and 
impairment of psychomotor function”.2 CNS medications were classified into ten mutually 
exclusive categories; opioid analgesics, anticonvulsants, anxiolytics, antidepressants, 
antipsychotics, anti-emetics, barbiturates, benzodiazepines, muscle relaxants, and respiratory 
agents. NHANES does not capture any information on the disease condition for which the 
medication was prescribed for. Some medications are used for more than one indication, for 
example, benzodiazepines and barbiturates can be used as either an anticonvulsant agent or an 
anxiolytic/sedative agent. Hence, the aforementioned categorization was adopted in this study to 
form mutually exclusive medication groups. A total of 157 CNS-acting medications were 
included in this study. Combination medications were counted as single medications for the 
purpose of calculating total number of medications. For example, acetaminophen with codeine 
was counted as one medication. Information on the dosage and frequency of use were not 
collected by NHANES. Interviewers could record up to 20 prescription medications.  
 
81 
 
Lexi-Interact, Lexicomp®, Wolters Kluwer Health (Philadelphia) and Micromedex®, 
Thomson Reuters Healthcare Inc. were used to ascertain the level of interaction between alcohol 
and CNS-acting medication.
98,99
  Based on Micromedex® any CNS-acting medication suspected 
of moderate, major or contraindicated types of interactions with alcohol were included in this 
study.
99
 Similarly, based on Lexi-Interact®, C (the use of drugs require monitoring), D (the use 
of drugs require change in therapy) and X (combined use those drugs should be avoided) types of 
interactions between any CNS-acting medications and alcohol were included in the study.
98
  
5.3.4 Alcohol Use 
Alcohol use was recorded by administering an alcohol use questionnaire, using the 
Computer Assisted Personal Interview (CAPI) system, to participants during mobile examination 
center interview.  The alcohol use questionnaire enquired about lifetime and current alcohol 
consumption of the participants. Questions were not specific to type of alcohol and one drink 
was defined as 12 oz. of beer, 5 oz. of wine, or one and half ounces of liquor.  
By using the Quantity*Frequency method, the average daily alcohol consumption was 
calculated.
70,80
 To calculate frequency, the number of days respondent’s had alcohol (whether 
recorded as weekly, monthly or yearly) was converted into drinking days per week. Average 
number of drinks consumed (quantity) was multiplied with “drinking days per week” to obtain 
average weekly consumption which was further divided by 7 to obtain average daily alcohol 
consumption.
80
 Based on the average daily alcohol consumption, subjects were classified into 
different drinking categories. The drinking categories were determined depending upon the level 
of alcohol consumption and drinking guidelines. 
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According to the NIAAA recommendations, older adults should consume no more than 
one standard drink per day or seven drinks on average per week.
76
 Considering the questions in 
the alcohol questionnaire and the drinking guidelines for older adults, drinking pattern was 
described in the following categories: 
 Non-drinkers: This category included respondents who, (1) never had at least 12 drinks of 
any type of alcoholic beverage in their entire life (never drinker), or (2) reported consuming 
zero drinks in the past 12 months (former drinkers).  
 Light-infrequent drinkers: subjects who consumed alcohol but not on a daily basis i.e. the 
average daily alcohol consumption might be zero but they have reported using alcohol in 
past 12 months. 
 Moderate drinkers: subjects who consumed one drink per day or seven drinks per week  
 Heavy drinkers: subjects who consumed more than one drink per day or 7 drinks per week 
 
5.3.5 Concurrent Users 
Concurrent users were defined as subjects who consumed alcohol on a daily basis 
(including moderate and heavy drinkers) and reported using at least one CNS-acting medication 
from in the past month. Individuals were categorized into concurrent users or non-concurrent 
user.  
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5.3.6 Covariates 
Demographic factors including age, sex, marital status, educational level, and 
race/ethnicity were studied. As NHANES truncates the age at 80 years, older adults were 
categorized into four age groups: 65-69, 70-74, 75-79, and 80 and above. Older adults who were 
either married or were living with a partner were grouped under one category while those who 
were divorced, widowed, separated or unmarried were grouped together. Educational level was 
categorized into three groups: less than high school, high school graduate and more than high 
school which included college graduates or any higher degree. Non-hispanic white, non-hispanic 
black and others were the three categories for race/ethnicity. Other factors included smoking 
status (never smoker, former smoker, or current smoker), perceived health status 
(excellent/good/fair/poor), health insurance (yes/no), and insurance with prescription medication 
coverage (yes/no/ don’t know or refused). NHANES employs the Patient Health Questionnaire 
(PHQ-9), a nine-item validated screening instrument that enquires about the frequency of 
symptoms of depression over the past 2 weeks, to screen for depression.
100
 A total score can 
range from 0 to 27 and a score of 10 or higher is used to identify individuals with depression 
(yes/no).
100
  
5.3.7 Statistical Analyses 
Weighted prevalence estimates of alcohol use, CNS-acting medication use and the 
concurrent use of both, for the combined study period (2005-2010), were reported. The pattern of 
use of alcohol and CNS-acting medication, in terms of number of sample respondents, weighted 
percent and 95% confidence interval (CI) were also reported. The Cochran-Armitage trend test 
of unweighted sample and logistic regression of the weighted sample were done to assess the 
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change in daily alcohol use, CNS-medication use and concurrent use across the three data cycles. 
Chi-square analysis was carried out to assess the association between daily alcohol use and the 
covariates. Logistic regression was performed to identify the factors associated with the use of 
alcohol among CNS-acting medication users. The weight variables were recalculated since the 
three NHANES data cycles 2005-2006, 2007-2008, and 2009-2010 were combined. NHANES 
recommends use of the weight of the smallest sample subpopulation, so for all estimations 
involving alcohol variable, MEC6YR= 1/3*WTMEC2YR (2-year sample weights during 
examination at MEC) was used as weight variable while for medication related estimations 
INT6YR = 1/3 * (2-year sample weights during interview) was used as weight variable.
97
 SAS 
version 9.2 (SAS Institute, Cary, NC) was used to conduct the statistical analyses.
101
   
Ethical consideration: This study was reviewed and determined to quality as exempt from 
federal regulations by Virginia Commonwealth University Institutional Review Board.  
5.4 Results  
5.4.1 Sample Description 
A total of 31,034 persons were interviewed during 2005-2010, out of which 4,268 were 
older adults. Since the goal of the study was to understand the magnitude of potential alcohol-
drug interactions, non-medication users were not included in this study. A total of 3,753 
(89.52%, 95%CI: 88.45-90.59) older adults took at least one prescription medication in the past 
month, of which 3,577 attended the NHANES medical examination. After removing the subjects 
with missing information on alcohol use, 3,220 subjects were included as the final study 
population (Figure 5.1). The socio-demographic characteristics of the study population are 
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described in Table 5.1. Among the 338 sample persons having no information on alcohol use, 
6.87% (95%CI: 3.11-10.64, n=20) reported taking CNS-acting medications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample persons interviewed 
(n=31,034) 
Older adults completing household interview 
(n=4,268) 
Older adults taking at least one prescription 
medication 
(n=3,753) 
Older adults completing interview at Mobile 
Examination Center 
(n=3,577) 
Older adults with complete information on 
alcohol and CNS-acting medication use 
(n=3,220) 
Missing= 338 
Don’t know=19 
Figure 5.1 Flowchart Depicting Selection of the Final Study 
Population 
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Table 5.1 Socio-demographic Characteristics of the Study Population 
Characteristics Number of persons 
interviewed 
Weighted Percent  (95% CI)
α
 
Age  
65-69 
70-74 
75-79 
80 and above 
 
836 
844 
642 
898 
 
30.91 (28.67 – 33.16) 
25.44 (23.63 – 27.26) 
19.65 (17.87 – 21.43) 
24.00 (21.92 – 26.07)  
Sex 
Male  
Female 
 
1606 
1614 
 
44.39 (42.76 – 46.02) 
55.61 (53.98 – 57.24)  
Race/ethnicity 
White 
Black 
Others 
 
2101 
  536 
  583 
 
84.27 (81.22 – 87.33) 
  7.88 (6.09 – 9.67) 
  7.85 (5.64 – 10.06) 
Marital status 
Married/living with partner 
Divorced/separated/widowed/unmarried 
 
1822 
1398 
 
61.01 (58.43 – 63.59) 
38.99 (36.41 – 41.57) 
Educational level
&
 
Less than High school 
High school 
More than High School 
 
1127 
1261 
  826 
 
25.70 (22.74 – 28.78) 
45.97 (41.90 – 50.03) 
28.33 (25.90 – 30.76) 
Smoking status
@
 
Never smoker 
Former smoker 
Current smoker 
 
1501 
1437 
  280 
` 
47.30 (45.09 – 49.51) 
44.98 (42.70 – 47.27) 
  7.72 (6.81 – 8.63) 
Number of medications 
1-5 
6-10 
Greater than 10 
 
2097 
  926 
  197 
 
65.55 (63.60 – 67.52) 
28.04 (26.13 – 29.94) 
  6.41 (5.27 – 7.54) 
Perceived health status* 
Excellent 
Very good/good 
Fair 
Poor 
 
  212 
2046 
  782 
  179 
 
  7.60 (6.41 – 8.80) 
69.03 (67.07 – 70.98) 
19.15 (17.73 – 20.58) 
  4.22 (3.43 – 5.00) 
Depression
# 
No 
Yes 
 
2989 
  164 
 
95.44 (94.50 – 96.38) 
  4.56 (3.63 – 5.51) 
Alcohol Use 
Non-drinker 
Light-infrequent drinker 
Moderate drinker 
Heavy drinker 
 
1702 
  611 
  739 
  168 
 
47.85 (44.07 – 51.63) 
20.36 (18.13 – 22.59) 
26.23 (23.65 – 28.81) 
  5.56 (4.20 – 6.92) 
Health insurance^ 
Yes 
No 
 
3157 
     62 
 
99.02 (98.65 – 99.40) 
  0.98 (0.60 – 1.36) 
Prescription medication coverage® 
Yes 
No 
 
2708 
  447 
 
86.47 (83.96 – 88.97) 
13.53 (11.03 – 16.04)  
α Total sample person= 3220 and weighted frequency= 30236526 
& Don’t know=6                                                                                       # Missing=67    
@ Don’t know=1, refused=1                                                                     ^ Refused=1 
* Don’t know=1                                                                                         ® Missing=42,refused=4, don’t know=19  
 
87 
 
5.4.2 Alcohol Use 
Using the Quantity-Frequency method, it was found that 20.36% (95% CI: 18.13-22.59) 
were light-infrequent drinkers, 26.23% (95% CI: 23.65-23.81) were moderate drinkers, 5.56% 
(95% CI: 4.20-6.92) were heavy drinkers and the remaining 47.85% (95% CI: 44.07-51.63) were 
non-drinkers. On the days they drink, 33.55% (95% CI: 30.55–36.55, n=937) reported drinking 
one drink, 12.44% (95% CI: 11.02–13.85, n=363) reported drinking two drinks while 6.16% 
(95% CI: 5.11-7.21, n=218) reported drinking three or more drinks. 23.37% (95% CI: 19.92–
26.81, n=349) of the drinkers reported drinking more than 4 days per week. 5.76% (95% CI: 
4.83-6.70, n=192) of older adults reported binge-drinking (5 or more drinks on a single occasion 
at least once in the past 12 months). No significant difference in trend was observed in the 
pattern of daily alcohol use between the three data cycles (Figure 5.2).   
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Figure 5.2 Prevalence of Alcohol, CNS-Acting Medication Use, and 
Concurrent Use Across the Three Data Cycles 
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5.4.3 CNS-Acting Medication Use 
Approximately 33.5% (95% CI: 31.34-35.71, n=1,035) of older adults reported using at 
least one CNS-acting medication with a total of 1,534 CNS-acting medications being prescribed 
in the past month. Antidepressants were the most commonly used class of medication followed 
by opioid analgesics, benzodiazepines, and anticonvulsants (Table 5.2). Among CNS-acting 
medication users, 67.34% took one CNS-acting medication, 21.35% took two CNS-acting 
medications while the rest used more than two CNS-acting medications, in the past month. 
Gabapentin, combination of acetaminophen and hydrocodone, sertraline, alprazolam, 
fexofenadine, tramadol, zolpidem, citalopram, escitalopram, and fluoxetine were the ten most 
frequently used CNS-acting medications by the study population. CNS-acting medication use did 
not differ significantly over the three data cycles (Figure 5.2).  
Table 5.2 Use of CNS-Acting Medications by Therapeutic Class 
CNS-medication 
class 
Prescription 
frequency* 
Sample 
persons^ 
Weighted 
percentage
#
 
95% CI 
Antidepressants 422 (27.51%) 399 40.37 37.50 – 43.25 
Opioid analgesics  327 (21.32%) 297 26.87 24.04 – 29.70 
Benzodiazepines  201 (13.10%) 198 18.16 15.65 – 20.68 
Anticonvulsant  173 (11.28%) 168 14.77 12.71 – 16.84 
Respiratory agents 137 (8.93%) 136 12.99 10.69 – 15.29 
Anxiolytics    79 (5.15%)   77   7.06   5.25 – 8.86 
Anti-emetic   73 (4.76%)   73   6.63   5.12 – 8.13 
Muscle relaxants   69 (4.50%)   68   6.93   5.05 – 8.81 
Antipsychotics    39 (2.54%)   38    3.62   2.23 – 5.01 
*The total number of CNS-medications used by older adults=1534.  
^Out of 3220, the total number of participants taking CNS-medication=1035 
# Weighted frequency of users of the drug class/Weighted frequency of the 1035 CNS-medication users 
i.e. 9665992.48*100  
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5.4.4 Potential Concurrent Use of Alcohol and CNS-Acting Medication 
The prevalence of older adults taking at least one CNS-acting medication and drinking 
daily was found to be 8.85% (95%CI: 7.22-10.49, n=244). Approximately 81% of these 244 
older adults were moderate drinkers, and the 19% rest were heavy drinkers. The proportion of 
potential concurrent use of alcohol and CNS-acting medication did not differ significantly over 
the three data cycles. 19.74% (95% CI: 15.87–23.70, n=183) took one CNS-acting medication, 
4.26% (95% CI: 2.58 – 5.94, n=39) took two CNS-acting medications, and 2.41% (95%CI: 0.89 
– 3.93, n=22) took three CNS-acting medications while reporting daily alcohol consumption. 
Antidepressants, opioid analgesics and benzodiazepines have a greater possibility of being 
concomitantly consumed with alcohol as they were most commonly used by daily drinkers. 
Some of the CNS-acting medications most commonly used by drinkers were fexofenadine, 
combination of acetaminophen and hydrocodone, escitalopram, sertraline, gabapentin, 
alprazolam, and zolpidem. CNS-acting medication users were less likely to drink alcohol on a 
regular basis than non-users (OR=0.68, 95% CI: 0.54 – 0.86).  
The relationship between daily alcohol use and other covariates among CNS-acting 
medication users is described in Tables 5.3 and 5.4. Due to the small cell size, “non-Hispanic 
blacks” were combined with “other” race, and health status was grouped as “poor/fair” versus 
“excellent/good/very good”. A chi-square test of association demonstrated that sex, 
race/ethnicity, marital status, educational level, smoking status, and perceived health status were 
significantly associated with daily alcohol use (Table 5.3), while age and prescription medication 
insurance coverage were not. The association between health insurance and depression and daily 
alcohol use could not be computed due to low cell sample size.  
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Table 5.3 Demographic Factors among CNS-Acting Medication Users by Daily Alcohol Use 
Characteristics Daily alcohol users Non-daily alcohol users 
Sample 
persons 
Weighted percent 
(95%CI) 
Sample 
persons 
Weighted percent 
(95%CI) 
Age  
65-69 
70-74 
75-79 
80 and above 
 
65 
73 
45 
61 
 
27.92 (21.35-34.50) 
31.35 (24.30-38.40) 
24.82 (16.97-32.67) 
20.97 (16.33-25.62) 
 
222 
183 
154 
232 
 
72.08 (65.50-78.65) 
68.65 (61.60-75.70) 
75.18 (67.33-83.03) 
79.03 (74.38-83.67) 
Sex 
Male  
Female 
 
138  
106  
 
34.75 (28.40-41.09) 
21.69 (16.63-26.75) 
 
311  
480  
 
65.25 (58.91-71.60) 
78.31 (73.26-83.37) 
Race/ethnicity 
White 
Others 
 
196 
  48 
 
28.35 (23.00-33.70) 
14.74 (10.12-19.36) 
 
506 
285 
 
71.65 (66.30-76.99) 
85.26 (80.64-89.88) 
Marital status 
Married/living with partner 
Divorced/separated/widowed/unmarried 
 
152 
92 
 
30.35 (25.11-35.60) 
21.37 (15.55-27.19) 
 
397 
394 
 
69.65 (64.40-74.89) 
78.63 (72.81-84.45) 
Educational level
&
 
Less than High school 
High school 
More than High School 
 
 51 
 64 
129 
 
12.32 (7.99-16.66) 
26.44 (20.35-32.53) 
36.29 (29.47-43.11) 
 
348 
195 
248 
 
87.68 (83.34-92.01) 
73.56 (67.47-79.65) 
63.71 (56.89-70.53) 
Smoking status* 
Never smoker 
Former smoker 
Current smoker 
 
79 
141 
24 
 
20.33 (15.01-25.65) 
33.85 (27.84-39.87) 
21.26 (12.73-29.78) 
 
387 
313 
90 
 
79.67 (74.35-84.99) 
66.15 (60.13-72.16) 
78.74 (70.22-87.27) 
Number of medications 
1-5 
6-10 
Greater than 10 
 
 95 
113 
 36 
 
25.53 (19.35-31.71) 
27.74 (22.90-32.59) 
24.68 (15.28-34.08) 
 
314 
357 
120 
 
74.47 (68.29-80.65) 
72.26 (67.41-77.10) 
75.32 (65.92-84.72) 
Comorbid conditions  
No comorbid conditions 
1-2 
3 or more 
 
45 
142 
57 
 
39.09 (27.41-50.77) 
25.86 (21.32-30.39) 
20.76 (15.59-25.93) 
 
99 
484 
208 
 
60.91 (49.23-72.58) 
74.14 (69.61-78.68) 
79.24 (74.07-84.40) 
Perceived health status 
Good/very good/excellent 
Poor/fair 
 
183 
  61 
 
31.93 (25.81-38.05) 
15.15 (11.07-19.23) 
 
441 
350 
 
68.07 (61.96-74.19) 
84.85 (80.77-88.93) 
Depression
# 
No 
Yes 
 
226 
14 
 
27.85 (23.09-32.61) 
13.84 (8.75-18.94) 
 
684 
77 
 
72.15 (67.39-76.91) 
86.16 (81.06-91.25) 
Health insurance 
Yes 
No 
 
224 
0 
 
26.61 (21.98-31.23) 
 
776 
15 
 
73.39 (68.77 -78.02) 
Prescription medication coverage® 
Yes 
No 
 
215 
27 
 
27.27 (22.23-32.32) 
19.88 (12.01-27.75) 
 
674 
100 
 
72.73 (67.68-77.77) 
80.12 (72.25-87.99) 
#
Depression: missing=34, ®Prescription medication coverage: missing 19, *Smoking: missing=1  
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The logistic regression model was built to identify factors associated with daily alcohol 
consumption. Males had 49% (OR= 1.49, 95% CI: 1.02–2.60) higher odds of consuming alcohol 
daily when compared to females. Former smokers were more likely (OR=1.79, 95% CI: 1.21–
2.63) to consume alcohol daily compared to never smokers. Older adults who did not complete 
high school are less likely to drink daily (OR=0.33, 95%CI: 0.21-0.54) compared to college 
graduates. Older adults with comorbidities were less likely to be daily drinkers compared those 
with no chronic condition. Good health status and being white were predictors of daily alcohol 
use.  
5.5 Discussion  
This cross-sectional study found the prevalence of potential concurrent use of alcohol and 
CNS-acting medications among non-institutionalized older adults to be 8.8%. Though the 
majority of concurrent users were moderate drinkers, alcohol consumption juxtaposed with 
prescription medication use may render them susceptible to adverse effects of interactions 
between alcohol and CNS-acting medication. The comparison of alcohol use between studies is 
difficult owing to the differences in measures of alcohol consumption, definition of drinking 
categories, and settings of the studies. Nonetheless, the pattern of alcohol use reported in this 
study is consistent with other published studies adhering to the NIAAA alcohol consumption 
guidelines for older adults.
27,56,57
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Table 5.4 Factors Associated with Daily Alcohol Use  
Factors Unadjusted odds 
Ratio 
Adjusted odds 
Ratio 
Age  
80 and above 
75-79 
70-74 
65-69 
 
Reference 
1.24 (0.76-2.05) 
1.72 (1.20-2.47)* 
1.46 (1.01-2.11)* 
 
Reference 
1.08 (0.68-1.73) 
1.43 (0.93-2.19) 
0.98 (0.57-1.69) 
Sex 
Female 
Male 
 
Reference 
1.92 (1.39-2.67)* 
 
Reference 
1.49 (1.02-2.6)* 
Race 
White 
Others  
 
Reference 
0.44 (0.27-0.70)* 
 
Reference 
0.68 (0.39-1.16) 
Marital 
Married or living with partner 
Divorced/separated/widowed/unmarried 
 
Reference 
0.62 (0.43-0.90)* 
 
Reference 
0.76 (0.51-1.14) 
Perceived health status 
Good/very good/excellent 
Poor/fair 
 
Reference 
0.38 (0.25-0.57)* 
 
Reference 
0.51 (0.31-0.83)* 
Education 
More than high school/college 
High school 
Less than high school 
 
Reference 
0.63 (0.41-0.96)* 
0.25 (0.16-0.38)* 
 
Reference 
0.67 (0.44-1.03) 
0.33 (0.21-0.54)* 
Smoking Status 
Never smoker 
Former smoker 
Current smoker 
 
Reference 
2.01 (1.42-2.83)* 
1.06 (0.63-1.76) 
 
Reference 
1.79 (1.21-2.63)* 
1.19 (0.68-2.09) 
No. of medications  
1-5 
6-10 
Greater than 10 
 
Reference 
1.12 (0.81-1.55)  
0.96 (0.61-1.50) 
 
Reference 
0.99 (0.72-1.40) 
0.80 (0.51-1.24) 
Chronic comorbid conditions 
No chronic conditions  
1-2 
3 or more 
 
Reference 
0.54 (0.34-0.88) 
0.41 (0.24-0.69) 
 
Reference 
0.54 (0.31-0.95)* 
0.44 (0.24-0.78)* 
#Number of observations used in the multivariable logistic regression model is 1034 
* p-value <0.05 
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Our findings suggest that antidepressants, opioid analgesics, and benzodiazepines are not 
only widely used but are also consumed by daily drinkers. The pattern of use of CNS-acting 
medications observed in this study is similar to other published studies.
66,102,103
 Consistent with 
the findings of previous studies, selective serotonin reuptake inhibitors (SSRIs), namely 
sertraline, escitalopram, citalopram, and fluoxetine, were the most frequently prescribed class of 
antidepressant in our study.
66,102-104
 Detection of high use of acetaminophen and hydrocodone 
combination medication was similar to previous findings.
66
 Importantly, both of these 
medication components interact with alcohol, albeit through separate mechanisms of action, 
increasing the risk of liver toxicity and injuries.
29
 As sedatives/hypnotics/anxiolytics grouped as 
one category did not include benzodiazepines in this study, the proportion of users was lower 
compared to other studies.
66,102,103
 It should be noted that certain CNS-acting medications 
included in this study such as naltrexone, topiramate, and SSRIs, are also used in the treatment of 
alcohol dependence. Such medication use would be considered intentional and, possibly, more 
controlled; however, due to the absence of information on diagnosis, the proportion of older 
adults undergoing alcohol dependence treatment could not be ascertained.
105
 
Trend analysis revealed no significant change in the use of CNS-acting medications, 
daily alcohol use, and potential concurrent use of alcohol and CNS-acting medications across the 
data cycles. Using data collected over a greater number of years may be required to understand 
the trend of use of these variables within the older adult population. Some researchers have 
reported higher alcohol consumption in the recent cohort of older adults compared to their 
predecessors.
106
 The absence of significant change in the prevalence of concurrent use of alcohol 
and CNS-acting medications indicates that the magnitude of the problem is consistent and 
warrants further investigation. Several studies have documented an increase in the use of CNS-
94 
 
acting medications in the U.S. adult population over a span of 6-10 years.
106,107
 A cross-sectional 
study conducted in Spain showed an increase in the use of prescription anxiolytics and 
antidepressants among older adults.
108
 Considering these findings, longitudinal trend analysis of 
CNS-acting medication utilization and alcohol consumption in older adults is necessary.  
Some factors associated with daily alcohol use in older adults taking CNS-acting 
medications identified in this study are comparable to those stated in other studies.
57,66,109
   
Previous studies found that females are more likely to use psychotropic medications while males 
report drinking more often than females.
110
 Even among CNS-acting medication users, males are 
more likely to drink daily than females (as shown in Table 4.4). As demonstrated in the 
literature, other races consume less alcohol than whites. Level of education is a factor associated 
with daily alcohol use. While some studies have shown that older adults with less than a high 
school education were more likely to be moderate or heavy drinkers
41,109
 others have 
demonstrated the reverse.
56,66 
Unlike previous findings, living alone was not found to be a risk 
factor of daily alcohol use in our study population.
66
 Education is an indicator of socio-economic 
status, as is income and employment status. Our findings suggest that former smokers showed 
higher risk of consuming alcohol on a daily basis. The association between current smoking and 
daily alcohol use could be biased due to a small sample size. Current or previous history of 
health risks such as smoking, major depression, and substance abuse has been associated with 
alcohol use.
27,66,106,111
 In our study, however, the relationship between depression and daily 
alcohol use could not be assessed due to small sample size. Older adults who perceive their 
health status as either poor or fair are less likely to drink daily.
66
 Conversely, Kirchner el al. 
found alcohol use to be positively associated with perceived poor health among older adults in 
the primary care setting
27
. The absence of significant change in potential concurrent use of 
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alcohol and CNS-acting medications indicates that daily alcohol use is not associated with 
medication use unlike the inverse associated observed between daily alcohol use and co-morbid 
conditions. It was observed that as co-morbid conditions increased the likelihood of being daily 
drinker decreased but this relationship was not observed between daily alcohol use and 
medication use which raises concern.   
This study has several limitations. It could not be definitively ascertained whether alcohol 
was consumed concomitantly with CNS-acting medications. NHANES data does not permit 
studying the type and size of alcoholic drink consumed by respondents or the dose and frequency 
of CNS-acting medication used. This study did not include employment status and income of 
older adults. These two factors would have provided insight on the relationship between socio-
economic status and alcohol use. Previous research has shown that questions regarding typical 
quantity and frequency of alcohol consumed can lead to underestimation of actual 
consumption.
71
 Deliberate under-reporting of alcohol use and CNS-acting medication use has 
also been documented in this population.
22
 Although questions on alcohol use focused on 
average frequency and amount of alcohol consumed by respondents certain events such as loss of 
spouse, retirement, and dependence, may influence the drinking pattern of older adults.
22
 It could 
not be determined if non-drinkers in this study stopped drinking alcohol due to any health-related 
issues in the past. The possibility of error in reporting or recall bias due to potential cognitive 
impairment or memory loss experienced by the older adult respondent is also present. In 
addition, small sample sizes in certain subgroups could have influenced the precision of our 
estimates.   
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Several review articles have emphasized the need to understand alcohol and psychotropic 
medication use among older adults.
92,110
  This study makes a unique contribution to the literature 
by determining the pattern, prevalence and associated factors of alcohol and CNS-acting 
medication use among community-dwelling older adults. Some strengths of the study are that, 1) 
it utilizes a recent, nationally representative sample of non-institutionalized older adults, 2) 
NHANES data collection follows a specified protocol and quality assurance process, 3) potential 
concurrent use of alcohol and CNS-acting medications is estimated in a conservative manner (by 
including only moderate and heavy drinkers), and 4) employing an broader definition of “CNS-
acting medication” for the purpose of the study.  
There are few studies assessing the adverse outcomes resulting from alcohol-medication 
interactions. Understanding the consequences of the combined use of alcohol and CNS-acting 
medication and determining its impact on healthcare utilization is essential. Duru et al. reported 
that the probability of an alcohol-related discussion between older adults and their physician 
declined with the patient’s age, and factors such as having comorbidities and using medications 
were not associated with alcohol-related discussions.
112
 The findings of our study underscore the 
need to address issues related to alcohol use among older adults. Alcohol and prescription drug 
misuse among older adults is regarded as a “hidden” epidemic facing the country which needs to 
be further explored.
92,110
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5.6 Conclusion  
In summary, a considerable proportion of older adults are susceptible to consume alcohol 
and CNS-acting medications, concurrently, and are therefore at risk of experiencing enhanced 
sedation and impaired psychomotor functions, leading to adverse events such as falls, fractures 
and accidents. Early identification of older adults at risk for alcohol-CNS-acting medication 
interactions may prevent adverse events. Initiation of prescription monitoring programs and 
screening for harmful alcohol use may be useful to overcome some of the alcohol use-related 
problems in the older population. Discussions or counseling about safe alcohol use are necessary 
between healthcare professionals and older adults.  
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Chapter 6 
Section 6 Effects of Alcohol and Central Nervous System-Acting Medications on  
Risk of Falling 
6.1 Introduction  
One out of three community-dwelling older adults falls each year.
113
 Falls may result 
from multiple risk factors that can be broadly classified into three the following categories; 
environmental (poor lighting, slippery floor, loose carpet), intrinsic (chronic disease conditions 
such as arthritis, vision impairment, dementia), and extrinsic (medications, alcohol).
114,115
 
Several studies have documented CNS-acting medications to be a risk factor for falls. A 
meta-analysis of observational studies found a small but consistent association between 
psychotropic medication use and falls in older adults (weighted odds ratio 1.7 and 95% CI: 1.5 to 
2.0).
40
 Antidepressants, antipsychotics, sedatives, hypnotics and anxiolytics are some of the drug 
classes implicated as risk factor for falls.
40
  Other classes of CNS-acting medications such as 
opioid analgesics and anticonvulsants have also been associated with falls.
40
 A prospective 
cohort study found that compared to non-users, older women taking benzodiazepines 
(multivariate odds ratio: 1.51, 95% CI: 1.14-2.01), and anticonvulsants (multivariate odds ratio: 
2.56, 95% CI: 1.49-4.41) were at higher risk for falls.
 116
  
Age-related pharmacokinetic and pharmacodynamic changes render older adults more 
sensitive to the pharmacological effects of CNS-acting medications.
47,117,118
 Consequently, 
adverse effects of most of the psychotropic drugs such as dizziness, sedation, cognitive 
impairment, impaired psychomotor function and postural sway are exacerbated in older adults, 
contributing to risk of falling.
40,116
 In addition, older adults using CNS-acting medications are 
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likely to have depression, sleeping problems, psychiatric disorders, or poor health status that may 
augment their risk of falling.
40,116
  Initiation of CNS-acting medication therapy, use of multiple 
CNS-acting medications and any sudden change in the psychotropic drug regimen may increases 
the risk of fall in older adults.
116,117, 118
 
Alcohol is a CNS depressant that acts via various neurochemical systems in the brain and 
causes sedation, dizziness, and also altered gait and balance.
2
 Longitudinal analysis of the 
Cardiovascular Health Study (CHS) data showed that risk of falls increases by 25% in consumers 
of 14 or more alcoholic drinks per week.
1
 A systematic review concluded that acute alcohol use 
is an important risk factor for falls among young and middle-aged adults.
119
 A review of the 
literature showed that studies examining the association between alcohol use and falls among 
older adults have documented an inconsistent relationship between the two.
120 
A few studies 
have shown that high alcohol use is associated with increased risk of falls in older adults
 1,108, 120
 
while other others fail to find a significant relationship.
120
 Inconsistent findings could be 
attributed to under-reporting of alcohol use, deficiencies of study design resulting in selection 
and information biases or confounding effect, or publication bias.
 120
 
Both alcohol and CNS-acting medications act on the CNS via various neurochemical 
systems causing alterations in mood, behavior, cognition and physical movement which may 
result in falls, fractures, and other injuries, especially in older adults.
2
 In 2009, the Drug Abuse 
Warning Network (DAWN) detected that 519,650 emergency department visits were associated 
with use of alcohol in combination with other drugs, out of which 44.1% were CNS-acting 
agents (sedatives, anxiolytics and analgesics) and 8.5% were psychotherapeutic agents 
(antidepressants and antipsychotic drugs).
7
 This indicates that combined use of alcohol and CNS-
acting medications may cause adverse events requiring medical care. Thus, the central 
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hypothesis of the proposed study is to determine if the combined use of alcohol and CNS-acting 
medications increases the risk of falls in older adults.    
6.2 Objective  
The objectives of this study were to determine if alcohol use was associated with risk for falls, 
injurious falls, and recurrent falls. It is also of interest to determine if varying levels of alcohol 
consumption with CNS-acting medication use is associated with risk for falls among older 
adults.  
6.3 Methods 
6.3.1 Study population 
The study sample was obtained from the 2009 MCBS study.
77
 Community-dwelling 
Medicare beneficiaries aged 65 years or older, surviving through 2009 were included in this 
study. Subjects with complete or partial paralysis and/or amputation were excluded from this 
study. The description of the data source, sample selection, sample characteristics, and weighting 
process has been described in Chapter 4.  
6.3.2 Alcohol consumption  
Data on alcohol use was collected from the MCBS survey. Every alternate year 
participants in the MCBS are asked three questions probing about their “usual” alcohol use over 
the past year. The first question is “Please think about a typical month in the past year. On how 
many days did [you/(SP)] drink any type of alcoholic beverage?”. The next question enquires 
about quantity of alcoholic drinks consumed; “On those days that [you/(SP)] drank alcohol, how 
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many drinks did (you/he/she) have?”. The third question pertains to heavy episodic drinking “On 
how many days did [you/(SP)] have 4 or more drinks in a single day?” 
Monthly alcohol consumption was assessed using the quantity-frequency method.  
Beneficiaries were categorized into three groups based on alcohol consumption; i) non-drinkers 
(those who did not consume alcohol in past 12 months) ii) within-limit drinkers (those who 
drank not more than 30 or 31 drinks in a month) iii) exceeding-limit drinkers (those who drank 
more than 30 or 31 drinks in a month).
56
 These categories are based on the NIAAA 
recommendations for alcohol use among older adults. Binge drinkers were described as those 
who consumed more than 4 drinks in a single day over the past 12 months.  
6.3.3 CNS-Acting Medication Use 
The five mutually exclusive categories of CNS-acting medications utilized for this study 
included opioid analgesics, non-benzodiazepine anticonvulsant agents, non-benzodiazepine 
sedative-hypnotics, and non-benzodiazepine psychotherapeutics (antidepressant, antipsychotic) 
and benzodiazepines. The information on CNS-acting medication use was collected using survey 
as well as claims data. Number of refills was not included since that information was not 
available on every study subject.  
Both CNS-acting medication use (users vs. non-users) and alcohol use (non-drinkers, 
within-limit drinkers, and exceeding-limit drinkers) were combined to form a variable with six 
subcategories. Similarly binge drinking (non-drinker, non-binge drinker, and binge-drinker) and 
CNS-acting medication use (users vs. non-users) were combined to form a variable with six 
subcategories. These subcategories of exposure variables are described in Table 6.1.   
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Table 6.1 Subcategories of Exposure Variables 
CNS-acting medication use and  
drinking status 
CNS-acting medication use and  
binge drinking 
1. Non-user and non-drinkers 1. Non-user and non-drinkers 
2. Non-users and within-limit drinkers 2. Non-users and non-binge drinkers 
3. Non-users and exceeding limit drinkers 3. Non-users and binge drinkers 
4. Users and non-drinkers 4. Users and non-drinkers 
5. Users and within-limit drinkers 5. Users and non-binge drinkers 
6. Users and exceeding limit drinkers 6. Users and binge drinkers 
 
6.3.4 Outcome Variables 
During the interview, subjects were asked seven questions regarding falls including 
number and severity of falls, how it affected their lives, and fear of falling. To elaborate, subjects 
were asked, “Since the last interview have you fallen down?”. If subjects answered affirmatively, 
they were further asked about the number of times they had fallen, if the most recent fall hurt 
them badly enough to seek medical help, and the kind of injury they suffered. Fear of falling was 
rated on a 6 point scale ranging from “not at all afraid” to “extremely afraid”.  
The outcome variable (dichotomous) was described in two ways: i) subjects who either 
fell or not (fallers and non-fallers), and ii) among fallers, whether subjects had an injurious fall or 
not. Subjects who required medical help after the most recent fall were considered to have an 
injurious fall. Non-fallers were considered the reference group for the logistic regression model.  
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6.3.5 Covariates 
Several variables have been documented as risk-factors of fall in older adults. Some of 
these factors could confound the relationship between use of CNS-acting medication and 
alcohol, and risks of falls. In this study, a fall risk assessment tool known as “Falls Risk for 
Older People-Community setting (FROP-Com) was followed to select the variables regarded as 
risk factors for falls in older adults.
121
 Not all variables enlisted in FROP-Com were available in 
MCBS dataset. Variables such as fear of fall, eye impairment, body mass index, use of 
antihypertensive medications, functional status, chronic co-morbid conditions, health status, and 
other socio-demographic characteristics have been found to be associated with risk of falls in the 
literature (Table 6.2).  
Table 6.2 Confounders Included in the Regression Model 
Categories Variables 
Socio-demographic factors Age, gender, race, marital status, education level 
Fall risk factors Eye impairment 
Use of blood pressure medication 
Fear of fall 
Body Mass Index (BMI) 
Functional status Activities of daily living 
Instrumental activities of daily living 
Limitations to social activity 
Health status Perceived health status 
Polypharmacy 
No. of chronic co-morbid conditions 
 
Most of the variables were categorized as described earlier in chapter 5. Older adults 
were categorized into two groups based on history of eye impairment (no impairment vs. 
presence of impairment). The body mass index of the older adults was calculated using their 
weights (in kilograms) and heights (in meters). The following formula was used to calculated the 
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BMI weight (kg) / [height (m)]
2
. BMI lower than 18.5 was considered as underweight, BMI 
ranging between 18.5 and 24.9 was considered normal weight, BMI ranging from between 25.0 
to 29.9 was regarded as overweight, and BMI of 30.0 or above was regarded as obese.
122
 The 
total number of chronic conditions was calculated as a sum of the number of disease conditions a 
respondent suffered from in the past year. The disease conditions included arthritis, rheumatoid 
arthritis, osteoporosis, diabetes, depression, emphysema, hypertension, congestive heart disease, 
myocardial infraction, arrhythmia, cardiac failure, other heart problem, urinary incontinence, 
Alzheimer's Disease (AD), and Parkinson’s Disease (PD).  
6.3.6 Statistical Analyses 
Frequency and weighted percent were used to describe the characteristics of the study 
sample. Bivariate association was studied by performing Chi-square tests. Separate logistic 
regression was employed to determine the association between outcome variables (falls, 
injurious falls and recurrent falls) and exposures (use of alcohol and CNS-acting medications), 
controlling for confounders. Confounders were identified based on available evidence in the 
literature, bivariate association with exposure variables and outcome variable, and if there is a 
10% change in the odds ratio of exposure variable when the potential confounder was added to 
the regression model. In case the association between the confounder and the outcome variable 
was not found to be significant in this study but there is sufficient evidence in the literature 
indicating that the variable is a risk factor for falls, then the variable is added to the model to 
control for its effect.  
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Multi-nominal logistic regression was used to study the association between injurious 
falls or recurrent falls with exposure variables where non-fallers were the reference group. The 
effect of CNS-acting drug classes included in this study and the number of CNS-acting 
medications being prescribed on the risk of falls were also investigated. Adjusted odds ratio 
(with 95% CI) and the p-value described the relationship between the outcome variable and 
exposure variables. Multicollinearity between explanatory variables was investigated by 
assessing the correlation between continuous variables, or chi-square test between categorical 
variables. Test of multicollinearity was also performed in the regression model using variance 
inflation factor (VIF). If the VIF was greater than 10 then the variables were said be multi-
collinear. SAS statistical software versions 9.2 and 9.3 were employed to perform all of the 
statistical analysis
78, at significance level of α=0.05. 
6.4 Results 
6.4.1 Description of the Sample Characteristics  
A total of 7,163 (weighted frequency=20070176 and standard deviation= 116981) 
community-dwelling older adults were included in this study.  A total of 21.5% (95% CI: 20.5-
22.5 %, n=1601) of the individuals in the study sample reported falling in the past month. Fifty-
four (0.8%, 95% CI: 0.5-1.2 %) older adults did not provide a usable response to this question in 
the study. Among those who fell in the past 12 months, 28.2% (95% CI: 25.57-30.88 %, n=462) 
had an injurious fall requiring medical help. Approximately 53% (95% CI: 95% CI: 50.9-55.8 %, 
n=818) experienced a single fall and 47% (95% CI: 44.2-49.1 %, n=755) had recurrent falls, in 
the past year. Among the fallers, 28 older adults did not respond to how many times they fell in 
the previous year and one older adult did not mention if he or she had needed medical help after 
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the fall. Thus, these individuals are considered missing in the analyses. The distribution of 
outcome variables is described in Figure 6.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Flowchart Depicting Outcome Variables 
 
The socio-demographic characteristics of the fallers and non-fallers are described in 
Table 6.3.  The fallers were likely to be older in age (21% of the fallers were aged 85 years or 
older while 14% were of the fallers were aged the same). A greater proportion of fallers were 
identified as Caucasians than non-fallers though smaller proportions of African American were 
fallers than non-fallers.  
 
Final study sample 
N=7,163 
 
Non-fallers 
n=5,508 
78.5% (95% CI: 77.3-79.3 %) 
 
Recurrent fallers 
n=755 
46.7% (95% CI: 44.2-49.1 %) 
 
Non-recurrent fallers 
n=818 
53.3% (95% CI: 50.9-55.8 %) 
 
Injurious fallers 
n=462 
28.2% (95% CI: 25.6-30.9 %) 
 
Non-injurious fallers 
n=1,138 
71.8% (95% CI: 69.1-74.4 %) 
 
Fallers 
n=1,601 
21.5% (95% CI: 20.5-22.5 %) 
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Table 6.3 Socio-demographic Characteristics of Fallers and Non-fallers 
Variables  
Fallers Non-fallers 
Frequency 
Weighted 
Percent (95% CI) 
Frequency 
Weighted Percent 
(95% CI) 
Age  
85 and older 
75-84 
65-74 
 
396 
662 
543 
 
21.1 (19.3-22.8) 
37.7 (35.3-40.2) 
41.2 (38.3-43.9) 
 
  950 
2210 
2348 
 
14.0 (13.1-14.9) 
36.8 (35.5-38.1) 
49.2 (48.0-50.3) 
Gender 
Female 
Male 
 
938 
663 
 
58.7 (56.0-61.3) 
41.3 (38.7-44.0) 
 
3099 
2409 
 
56.4 (55.5-57.4) 
43.6 (42.6-44.5) 
Race 
Caucasian  
African American  
Others 
 
1415 
   87 
   94  
 
88.4 (86.5-90.3) 
  5.8 (4.4-7.1) 
  5.8 (4.4-7.2) 
 
4662  
  482  
  350 
 
84.8 (83.8-85.8) 
  8.6 (7.9-9.3) 
  6.6 (5.8-7.3) 
Marital  
Married 
Non-married 
 
766 
835 
 
49.6 (46.7-52.4) 
50.4 (47.6-53.3) 
 
2931 
2573 
 
55.0 (53.6-56.5) 
45.0 (43.6-46.4) 
Education 
More than high 
school 
High school 
Less than high school 
No Education 
 
713 
472 
396 
  18 
 
46.2 (43.8-48.7) 
29.1 (26.9-31.2) 
23.8 (21.7-25.9) 
  0.9 (0.5-1.3) 
 
2423 
1708 
1295 
   59 
 
46.0 (44.5-47.6) 
31.3 (30.1-32.6) 
21.7 (20.5-22.8) 
  1.0 (0.7-1.2) 
Income 
More than 25,000 
25,000 or less 
 
781 
820 
 
48.5 (45.6-51.5) 
51.5 (48.5-54.4) 
 
2878 
2630  
 
54.6 (53.0-56.2) 
45.4 (43.8-46.9) 
Employment 
No 
Yes  
 
1462 
  139 
 
89.9 (87.9-91.8) 
10.1 (8.2-12.0) 
 
4876 
  628 
 
87.0 (86.0-88.0) 
13.0 (11.9-14.0) 
Social activity 
No 
Yes 
 
916 
684 
 
58.6 (55.7-61.4) 
41.4 (38.6-44.2) 
 
4044 
1456 
 
75.5 (74.2-76.7) 
24.5 (23.3-25.8) 
Health status 
Worse  
Same 
Better 
 
523 
855 
220 
 
31.8 (29.2-34.4) 
54.2 (51.6-56.8) 
14.0 (12.2-15.9) 
 
  980 
3733 
  793  
 
16.9 (16.1-17.7) 
68.6 (67.3-69.9) 
14.5 (13.2-15.7) 
Difficulties in ADL 
No difficulty 
1-2 
3-6 
 
888 
455 
258 
 
57.8 (55.0-60.6) 
27.2 (24.8-29.6) 
15.0 (13.2-16.8) 
 
4228 
  980 
  300 
 
78.3 (77.0-79.6) 
16.5 (15.5-17.6) 
  5.2 (4.4-5.8)  
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Difficulties in ADL 
No difficulty 
1-2 
3-6 
 
 
766 
510 
325 
 
 
50.1 (47.2-52.9) 
31.3 (28.6-34.1) 
18.6 (16.4-20.7) 
 
 
3790 
1234 
  484 
 
 
70.8 (69.5-72.1) 
21.4 (20.3-22.6) 
  7.7 (7.0-8.5) 
Smoking status 
Never-smoker 
Former-smoker 
Current-smoker 
 
694 
796 
111 
 
42.4 (39.6-45.3) 
50.1 (46.9-53.3) 
  7.5 (5.8-9.1) 
 
2280 
2743 
  483 
 
41.0 (39.7-42.3) 
49.8 (48.5-51.1) 
  9.2 (8.4-10.0) 
Chronic comorbidity 
5 or more 
3-4 
1-2 
No disease 
 
568 
606 
366 
  61 
 
34.2 (31.6-36.7) 
37.5 (31.6-36.7) 
24.1 (21.6-26.7) 
  4.2 (2.8-5.4) 
 
1187 
1961 
1991 
  369 
 
20.2 (19.0-21.4) 
34.9 (33.7-36.1) 
37.4 (35.9-39.0) 
  7.5 (6.7-8.2) 
Number of 
medications  
11 or more 
6-10 
1-5 
No medication 
 
575 
549 
423 
  54 
 
35.3 (32.7-37.8) 
33.8 (31.6-36.0) 
27.4 (25.1-29.6) 
  3.5 (2.5-4.5) 
 
1185 
1992 
2040 
  291 
 
20.4 (19.2-21.6) 
35.8 (34.5-37.0) 
38.2 (36.7-37.0) 
  5.6 (4.9-6.3) 
Eye impairment  
No impairment 
Impairment/Blind 
 
1011 
 588 
 
63.4 (61.1-65.7) 
36.6 (34.3-38.9) 
 
4046 
1447 
 
74.7 (73.3-76.2) 
25.3 (23.8-26.7) 
Use of 
antihypertensive 
medication  
No 
Yes 
 
 
  444 
1157 
 
 
28.5 (26.1-30.9) 
71.5 (69.1-73.9) 
 
 
1799 
3709 
 
 
34.3 (32.7-36.0) 
65.7 (64.0-67.3) 
Obesity 
Underweight  
Normal weight 
Over-weight 
Obese  
 
  11 
213 
442 
935 
 
  0.6 (0.2-0.9) 
12.7 (10.8-14.7) 
27.4 (25.1-29.7) 
59.3 (56.9-61.7) 
 
    54 
  753 
1504 
3197 
 
  1.0 (0.7-1.3) 
13.1 (12.2-14.0) 
26.9 (25.8-27.9) 
59.0 (57.8-60.2) 
Column percentages are significantly different 
(Rao-Scott-Chi-square test showed p-value <0.05) 
Bivariate analysis between the covariate and fall outcome showed significant association  
(p-value<0.05) 
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Fallers seem to suffer from higher numbers of chronic comorbid conditions and consume 
more medications. Approximately 35% of the fallers were taking 11 or more medications 
whereas 20% of the non-fallers were taking the same. Similarly, while 20% of the non-fallers 
reported suffering from 5 or more co-morbid conditions, 34% of the fallers reported the same. 
Functional status of fallers seemed to be worse than non-fallers. Greater proportion of fallers 
reported encountering limitations in social activity due to health, difficulties in performing usual 
and instrumental activities of daily living (ADL and IADL), and worsening of health in the past 
year. Moreover, 36.6% of fallers reported having eye impairment compared to 25% of the non-
fallers. Similarly greater proportions of fallers reported taking antihypertensive medications than 
non-fallers. Bivariate analysis was performed using Chi-square test of association which showed 
that variables including age, race, marital status, income, employment, perceived health status, 
limitations in social activity, comorbidities, number of medications used, eye impairment, and 
use of antihypertensive medications were significantly associated with the falls outcome 
variable.  
The relationship between the exposure variables and any fall in the past 12 months was 
studied using logistic regression analysis. As risk factors foe falls are multifactorial in nature so 
the confounding effect of age, sex, race, marital status, educational level, perceived health status, 
difficulty in social activity due to health conditions, ADLs, IADLs, presence of  eye impairment, 
use of blood pressure medications, number of  medications taken and comorbid conditions were 
controlled. 
6.4.2 Effect of CNS-Acting Medication on the Risk of Falling 
Of the 7,613 older adults included in this study 41.5% (95% CI: 40.0-43.0 %, n=3,019) 
took CNS-acting medications in the past year. The distribution of each class of CNS-acting 
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medication (figure 6.2) in the overall study sample comprised of; 22.5% (95% CI: 21.3-23.7 %, 
n=1637) taking at least one opioid analgesic; 17.9 % (95% CI: 16.8-19.0 %, n=1288) consuming 
at least one psychotherapeutic medication; 8.0% (95% CI: 7.3-8.7 %, n=611) taking at least one 
anticonvulsants; 6.8% (95% CI: 6.3-7.3 %, n=509) taking at least one benzodiazepines; and 5.5% 
(95% CI: 4.9-6.0 %, n=404) taking at least one sedative-hypnotics in the past 4 months. Figure 
6.2 shows the distribution of each class of CNS-acting medication use among CNS-acting 
medication users (denominator=3,019). Approximately 50% (95% CI: 48.18-51.56%, n=1482) 
of the CNS-acting medication user took one CNS-acting medication, 24.77% (95% CI: 23.07-
26.46 %, n=762) took two CNS-acting medications, while 25.36% (95% CI: 23.58-27.15, 
n=774) took more than two CNS-acting medications.  
 
 
Figure 6.2 Pattern of use of CNS-acting medication  
The effect of individual CNS-acting medication class on risk of falling is described in 
Table 6.4. It was observed that 32.8% of opioid analgesic users were fallers while 19.7% were 
non-fallers. The adjusted logistic regression analysis showed that use of opioid analgesics (OR: 
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1.41, 95% CI: 1.21-1.65) was associated with increased the odds of experiencing fall in older 
adults.  
Table 6.4 Relationship Between each Class of CNS-Acting Medication  
and the Risk of Falling 
Variables  Fallers Non-fallers Adjusted Odds 
Ratio (95% CI) 
Sample 
Persons 
Weighted 
Percent 
(95% CI) 
Sample 
Persons 
Weighted 
Percent 
(95% CI) 
Opioid analgesics 
 
Non-users 
Users 
 
 
1074 
  527 
 
 
67.2 (65.0-69.4) 
32.8 (30.6-35.0) 
 
 
4409 
1099 
 
 
80.3 (79.1-81.5) 
19.7 (18.5-20.9) 
 
 
1 (ref) 
1.41 (1.21-1.65)** 
Psychotherapeutics  
 
Non-users 
Users 
 
 
1192 
  409 
 
 
74.1 (71.9-76.2) 
25.9 (23.8-28.1) 
 
 
4640 
  868 
 
 
84.4 (83.2-85.6) 
15.6 (14.4-16.9) 
 
 
1 (ref) 
1.26 (1.08-1.47)** 
Benzodiazepines 
 
Non-users 
Users 
 
 
1439 
  162 
 
 
90.6 (89.2- 91.9) 
  9.4 (8.1-10.8) 
 
 
5164 
  344 
 
 
93.9 (93.3-94.5) 
  6.1 (5.5-6.7) 
 
 
1 (ref) 
1.30 (1.06-1.60)** 
Anticonvulsants 
 
Non-users 
Users 
 
 
1419 
  182 
 
 
89.3 (87.8-90.7) 
10.7 (9.3-12.2) 
 
 
5087 
  421 
 
 
92.8 (92.0-93.5) 
  7.2 (6.5-8.0) 
 
 
1 (ref) 
1.03 (0.84-1.25) 
Sedative-hypnotics 
 
Non-users 
Users 
 
 
1476 
  125 
 
 
92.7 (91.3-94.0) 
   7.3 (6.0-8.7) 
 
 
5232 
  276 
 
 
95.0 (94.4-95.6) 
   5.0 (4.4-5.6) 
 
 
1 (ref) 
1.13 (0.88-1.45) 
Total CNS-acting 
medication 
 
Zero  
One 
Two 
Three or more 
 
 
 
745 
338 
217 
301 
 
 
 
46.9 (44.5-49.4) 
21.5 (19.3-23.7) 
12.7 (11.0-14.4) 
18.8 (16.5-21.2) 
 
 
 
3366 
1134 
  545 
  463 
 
 
 
61.7 (60.0-63.3) 
20.5 (19.3-21.7) 
  9.7 (8.8-10.6) 
  8.1 (7.4-8.9) 
 
 
 
1 (ref) 
1.15 (0.96-1.37) 
1.21 (0.98-1.51) 
1.73 (1.36-2.20)** 
**Wald’s Chi-square test significant (p-value < 0.05) 
The bivariate Chi-square test of association between fall and each class of CNS-acting medication was 
found to be significant with p-value <0.0001.  
The Chi-square test of association between falls and total number of CNS-acting medication was found to 
be significant (p-value <0.0001). 
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The percentage of fallers taking psychotherapeutic agents was 25.9% compared to 15.6% 
non-fallers taking the same. The users of psychotherapeutic agents including antidepressants, 
anxiolytics, and antipsychotics, had 26% higher risk of falling than non-users (OR: 1.26, 95% 
CI: 1.08-1.47). Use of benzodiazepine was also found to be associated with higher risk of falls. 
The association between use of sedative/hypnotic and anticonvulsants was not found to be 
statistically significant. Moreover, taking three or more CNS-acting medications increases the 
odds of having a fall by 73% (OR: 1.73, 95% CI: 1.36-2.20). 
6.4.3 Effect of Alcohol and CNS-Acting Medication on the Risk of Falling 
Out of the total 7,163 study sample, 96 older adults did not provide useful response to 
alcohol intake questions in the survey. Hence these 96 older adults were not included in most 
analyses including the alcohol use variable. Among the 3,019 CNS-acting medication users, 
23.6% (95% CI: 21.8-25.4 %, n=656) were within-limit drinkers, 5.5% (95% CI: 4.4-6.6 %, 
n=148) consumed alcohol at an exceeding level, and 10.1% (95% CI: 8.7-11.5 %, n=277) were 
NIAAA-defined at-risk drinkers.  
Of the 7,067 study sample, the potential concurrent use of alcohol and CNS-acting 
medication was found to be 12.2% (95% CI: 11.3-13.2 %, n=814). Among the 814 potential 
concurrent users, 52.9% (95% CI: 49.7-56.1 %, n=425) took opioid analgesics, 36.2% (95% CI: 
32.9-39.5 %, n=289) used psychotherapeutic agents, 15.7% (13.0-18.3%, n=129) were 
anticonvulsant users; 15.0% (95% CI: 12.3-17.7 %, n=122) were benzodiazepine users; and 
14.9% (95% CI: 12.3-17.4 %, n=123) used sedative-hypnotic agents (Figure 6.3). 
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Figure 6.3 Pattern of CNS-Acting Medication use among Concurrent Users 
 
Among the potential concurrent users (Figure 6.4), approximately 81% (95% CI: 77.9-
84.3 %, n=656) consumed alcohol within limit; 18.9% (95% CI: 15.7-22.1, n=148) were 
exceeding-limit drinkers; and 34.5% (95% CI: 30.6-38.5 %, n=277) were at-risk drinkers 
(defined by NIAAA guidelines).  
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The majority of exceeding-limit drinkers were older men whereas a greater proportion of 
non-drinkers were older women. Interestingly, the proportion of older men and women was 
similar for within-limit drinkers suggesting moderate drinking is not only more prevalent but 
also common in both genders. A larger proportion of CNS-acting medication users were older 
women. Among concurrent users, 54.4% were women and 45.6% were men. Figure 6.5 depicts 
the proportion of older men and women across the exposure groups  
 
Figure 6.5 Gender Distributions in the Exposure Groups 
  
A logistic regression model was built to understand the effect of use of alcohol and CNS-
acting medication on the risks of fall, after adjusting for confounders (Table 6.5). After adjusting 
for confounders no significant association between alcohol consumption and fall was detected. 
CNS-acting medication was found to be a risk factor for falls in older adults (OR: 1.26, 95% CI: 
1.08-1.46).  Older adults taking at least one CNS-acting medication may have 26% higher odds 
of falling than non-users of CNS-acting medication.  
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Table 6.5 Effect of Alcohol and CNS-acting Medications on Risk of the Falling 
Variables Fallers    Non-fallers Adjusted  Odds 
Ratio (95% CI) 
Sample  
persons  
Weighted 
percent (95% 
CI) 
Sample  
persons 
Weighted 
percent (95% 
CI) 
Drinking status 
 
Non-drinkers 
Within-limit drinkers 
Exceeding-limit 
drinkers 
 
 
 1143 
   364 
     85 
 
 
69.8 (67.0-72.7) 
24.3 (21.9-26.7) 
  5.9 (4.3-7.4) 
 
 
 3626 
 1523 
   318 
 
 
64.1 (62.2-65.9) 
29.5 (28.0-31.0) 
  6.4 (5.4-7.4) 
 
 
1 (ref)  
0.91 (0.78-1.05) 
1.05 (0.76-1.45) 
CNS-acting 
medication use 
 
Non-users 
Users 
 
 
  
856 
 745 
 
 
 
46.9 (44.5-49.4) 
53.1 (50.6-55.5) 
 
 
  
2142 
3366 
 
 
 
61.7 (60.0-63.3) 
38.3 (36.7-40.0) 
 
 
 
1 (ref)  
1.26 (1.08-1.46)* 
CNS-acting 
medication user + 
drinking status  
 
Non-users + non-
drinkers 
Users + exceeding-
limit drinkers 
Users + within-limit 
drinkers 
Users + non-drinkers 
Non-users + 
exceeding-limit 
drinkers 
Non-users + within-
limit drinkers  
 
 
  
  
499 
    
  48 
 
 157 
 
 644 
   37 
  
  
 207 
 
 
 
 
30.4 (28.0-32.8) 
   
  3.2 (2.1-4.2) 
 
10.2 (8.5-11.8) 
 
39.4 (37.0-41.9) 
  2.7 (1.8-3.7) 
 
 
14.1 (12.3-15.9) 
 
 
  
  
2098 
    
  100 
  
   499 
   
 1528 
 499 
    
  
1024 
 
 
 
 
 
37.5 (35.7-39.2) 
   
  2.0 (1.6-2.5) 
 
  9.7 (8.8-10.5) 
 
26.6 (25.1-28.1) 
  4.4 (3.6-5.2) 
 
 
19.8 (18.5-21.2) 
 
 
 
 
1 (ref) 
 
1.72 (1.13-2.61)* 
 
1.05 (0.81-1.37) 
 
1.27 (1.07-1.51)* 
0.86 (0.56-1.32) 
 
 
0.97 (0.79-1.18) 
* Wald’s Chi-square test significant with p-value <0.05.  
Number of observations included in the model= 6988 and weighted frequency of these observations =19541101 
Number of observations deleted due to missing values in response or explanatory variables=175 
 
Comparing to those who neither use CNS-acting medication nor drink, it was observed 
that the odds of falling was 72% (OR: 1.72 95% CI: 1.13-2.61) higher among CNS-acting 
medication users who drink at an exceeding level. However, no significant association was 
observed among CNS-acting medication users who drink within limit and risk of fall. However, 
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CNS-acting medication use in the presence of drinking within limit did not show significantly 
greater odds of falling. Alcohol use in the absence of CNS-acting medication use did not 
demonstrate significant association with risk of falling.   
 
Table 6.6 Use of CNS-acting Medications and Binge Drinking and Risk of Falling 
Variables Fallers Non-fallers Adjusted  Odds 
Ratio (95% CI) 
Sample   
Persons  
Weighted 
Percent (95% 
CI) 
 Sample  
Persons 
Weighted 
Percent (95% 
CI) 
Binge drinking 
 
Non-drinkers 
Non-binge drinkers 
Binge drinkers 
 
 
1143 
395 
55 
 
 
69.6 (66.7-72.5) 
26.3 (23.8-28.7) 
  4.1 (2.9-5.3) 
 
 
3626 
1606 
 240 
 
 
64.0 (62.2-65.9) 
31.2 (29.6-32.9) 
  4.7 (4.0-5.5) 
 
 
1 (ref)  
0.93 (0.81-1.08) 
1.06 (0.72-1.54) 
Binge drinking +  
CNS-acting medication  
 
Non-users + non-drinkers 
Non-users + non-binge 
drinkers 
Non-users + binge drinkers  
Users + non-drinkers 
Users + non binge drinkers 
Users + binge drinkers 
 
 
 
499 
220 
 
 24 
644 
175 
  31 
 
 
 
30.3 (27.9-32.7) 
  2.3 (1.4-3.2) 
 
11.3 (9.6-13.0) 
39.3 (36.8-41.8) 
  1.9 (1.1-2.6) 
14.9 (13.2-16.7) 
 
 
 
2098 
1085 
  
 162 
1528 
  521 
    78 
 
 
 
37.4 (35.6-39.2) 
  1.5 (1.2-1.9) 
 
10.2 (9.2-11.1) 
26.6 (25.1-28.1) 
  3.2 (2.6-3.8) 
21.1 (19.6-22.5) 
 
 
 
1 (ref) 
0.97 (0.80-1.18) 
 
0.83 (0.49-1.41) 
1.27 (1.07-1.51)* 
1.12 (0.87-1.44) 
1.77 (1.07-2.92)* 
* Wald’s Chi-square test significant with p-value <0.05. 
Number of observations included in the model=6994 and weighted frequency of these observations =19568317 Number of 
observations deleted due to missing values in response or explanatory variables=169 
 
 
The association between binge drinking and risk of falling was also investigated (Table 
6.6). Binge drinking was not found to be associated with risk of falling.  The exposure variables, 
CNS-acting medication use and binge drinking, were combined to form six subcategories. Older 
adults who do not drink or take CNS-acting medications were the reference group. So compared 
to non-drinker and non-user, older adults taking CNS-acting medication and binge drinking were 
77% times (OR: 1.77, 95% CI: 1.07-2.92) more likely to encounter a fall in the past year. Similar 
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to the previous observation, CNS-acting medication use among non-drinkers was significantly 
associated with the risk of falls. However, CNS-acting medication use in the presence of non-
binge drinking was not significantly associated with higher odds of falling.  
 
Table 6.7 Use of Alcohol and Opioid Analgesics and Risk of Falling 
Variables  Fallers Non-fallers Adjusted  Odds 
Ratio (95% CI)  
 
Sample   
Persons 
Weighted 
Percent (95% CI) 
Sample  
Persons 
Weighted 
Percent (95% CI) 
Opioid  analgesics + Drinking status  
 
Non-users + non-drinkers 
Users + exceeding-limit drinkers 
Users + within-limit drinkers 
Users + non-drinkers 
Non-users + within-limit drinkers 
Non-users + exceeding-limit drinkers 
 
 
  748 
  26 
100 
395 
264 
  59 
 
 
45.7 (42.8-48.6) 
  1.7 (0.9-2.4) 
  6.6 (5.2-8.0) 
24.1 (21.8-26.4) 
17.7 (15.8-19.5) 
  4.2 (3.0-5.4) 
 
 
2835 
    51 
  248 
  791 
1275 
  267 
 
 
50.3 (48.4-52.0) 
  1.0 (0.7-1.3) 
  4.8 (4.3-5.4) 
13.8 (12.7-14.9) 
24.7 (23.3-26.1) 
  5.4 (4.5-6.3) 
 
 
1 (ref) 
1.87 (1.08-3.24)* 
1.26 (0.92-1.73) 
1.39 (1.16-1.66)* 
0.90 (0.76-1.07) 
0.98 (0.69-1.41) 
* Wald’s Chi-square test significant with p-value <0.05.  
Number of observations included in the model=6994 and weighted frequency of these observations =19568317 Number of 
observations deleted due to missing values in response or explanatory variables=169 
 
 
Assessment of risk of falls associated with alcohol consumption and opioid analgesics 
(Table 6.7) revealed that exceeding-limit drinkers taking opioid analgesics had 87% (OR: 1.87, 
95% CI: 1.08-3.24) higher odds of having a fall though the sample size of this group was small 
(n=26). Older adults using opioid analgesic and drinking within limit did not demonstrate 
significantly greater risk of falls. However, older adults taking opioid analgesics but abstaining 
from alcoholic beverage seemed to have greater odds of falling compared to non-drinkers and 
non-users. Effect of combined use of alcohol and other classes of CNS medication could not be 
ascertained due to small sample sizes (n < 20) in these groups.  
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6.4.4 Effect of alcohol and CNS-acting medication on risk for injurious falls 
The fallers were further categorized into two groups (injurious falls and non-injurious 
falls) based on whether or not they experienced a fall that required medical assistance. Of the 
entire study sample, 6.1% (95% CI: 5.4-6.8 %, n=462) reported seeking medical assistance after 
the fall, and 15.6% (95% CI: 14.8-16.4 %, n=1,138) did not require medical assistance after the 
fall. The proportion of CNS-acting medication use was greater in fallers than non-injurious 
fallers and non-fallers. It can be observed in Table 6.8 that the proportions of alcohol use were 
lower as the severity of fall increased. Exceeding-limit drinking was reported by 5.5% of 
injurious fallers compared to 6.0% of non-injurious fallers and 6.4% of non-fallers. A similar 
trend was observed for within-limit drinkers as well. However, the proportion of non-drinkers 
was greater in injurious fallers followed by non-injurious fallers and further by non-fallers. It 
must be noted that the confidence interval of the percentage of alcohol use in three different 
groups of fallers overlapped. After joining the two exposure groups (alcohol use and CNS-acting 
medication use) the distribution of the six subcategories against fallers was studied. It was seen 
that many of the cell sizes were small (n <20).  
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Table 6.8 Distribution of Exposure Variables against Injurious Fallers 
Variables Non-fallers Non-injurious Fallers Injurious Fallers 
Sample  
persons  
Weighted 
percent  
(95% CI) 
Sample  
persons 
Weighted 
percent  
(95% CI) 
Sample  
persons 
Weighted 
percent  
(95% CI) 
Drinking status 
 
Non-drinkers 
Within-limit drinkers 
Exceeding-limit  
drinkers 
 
 
3626 
1523 
  318 
 
 
64.1 (62.2-65.9) 
29.5 (27.9-31.0)   
  6.4 (5.4-7.4) 
 
 
808 
264 
  61 
 
 
68.6 (65.3-71.9) 
25.4 (22.6-28.2)  
  6.0 (4.3-7.7) 
 
 
335 
  99 
  24 
 
 
73.1 (68.4-77.8) 
21.4 (17.6-25.2) 
   5.5 (2.9-8.1) 
CNS-acting 
medication use 
 
Non-users 
Users 
 
 
 
3366 
2142 
 
 
 
61.7 (60.0-63.3) 
38.3 (36.7-40.0) 
 
 
 
563 
575 
 
 
 
49.7 (46.7-52.6) 
50.3 (47.3-53.3) 
 
 
 
181 
281 
 
 
 
39.9 (35.7-44.2) 
60.1 (55.8-64.3) 
CNS-acting 
medication use + 
drinking status  
 
Users + exceeding-
limit drinkers 
Users + within-limit 
drinkers 
Users + non-drinkers 
Non-users + exceeding 
-limit drinkers 
Non-users + within 
limit drinkers 
Non-users +  
non-drinkers 
 
 
 
   
100 
 
  499 
 
1528 
  218 
 
1024 
 
2098 
 
 
 
   
  2.0 (1.6-2.5) 
 
  9.7 (8.8-10.5) 
 
26.6 (25.1-28.1) 
  4.4 (3.6-5.2) 
 
19.8 (18.5-21.2) 
 
37.5 (35.6-39.2) 
 
 
 
  
 35 
 
101 
 
435 
  26 
 
163 
 
373 
 
 
 
  
 3.4 (1.9-4.7) 
 
  9.5 (7.5-11.5) 
 
37.3 (34.5-40.1) 
  2.7 (1.7-3.7) 
 
15.8 (13.6-18.1) 
 
31.3 (28.6-34.0) 
 
 
 
 
   
13 
 
  56 
 
209 
  11 
 
  43 
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  2.7 (1.1-4.3) 
 
11.9 (8.8-15.0) 
 
45.0 (40.7-49.4) 
  2.8 (0.6-5.1) 
 
  9.5 (6.8-12.1) 
 
28.1 (23.6-3.6) 
Column percentages are significantly different (Rao-Scott Chi-square test showed p-value <0.05) 
 
Multi-nominal logistic regression (Table 6.9) was conducted to investigate the effect of 
alcohol and CNS-acting medication use on the risk of falls. Non-fallers were considered the 
reference group. Compared to non-users of CNS-acting medications, users were 61% (OR: 1.61, 
95% CI: 1.30-2.00, p-value <0.0001) more likely to experience an injurious falls. However, 
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CNS-acting medication use did not seem to affect the risk of non-injurious fall. Alcohol use was 
not found to be associated with risk of injurious falls as well as non-injurious falls. Due to small 
cell size the joint effect of alcohol and CNS-acting medication could not be analyzed.  
 
Table 6.9 Association Between Exposure Variables and Injurious Fallers 
Variables Non-injurious fallers Injurious fallers 
Adjusted  Odds Ratio 
(95% CI) 
p-value  Adjusted  Odds Ratio 
(95% CI) 
p-value 
Drinking status 
 
Non-drinkers 
Within-limit 
Exceeding-limit  
 
 
1 (reference) 
0.96 (0.81-1.12) 
1.03 (0.74-1.44) 
 
 
 
0.5772 
0.8458 
 
 
1 (reference) 
0.80 (0.61-1.04) 
1.13 (0.65-1.95) 
 
 
 
0.0912 
0.6627 
CNS-medications 
 
Non-users 
Users 
 
 
1 (reference) 
1.15 (0.95-1.39) 
 
 
 
0.1594 
 
 
1 (reference) 
1.61 (1.30-2.00) 
 
 
 
<0.0001* 
Number of observations included in the model= 6987 
Weighted frequency of these observations =19539027  
Number of observations deleted due to missing values in response or explanatory variables=176 
 
6.4.5 Effect of alcohol and CNS-acting medication on risk for recurrent falls 
Older adults falling more than once in the past year were defined as recurrent fallers. Of the 
overall study sample 10.0% (95% CI: 9.4-10.6 %, n=755) reported falling more than once in the 
past year and 11.4% (95% CI: 10.6-12.2%, n=818) reported a single fall in the previous year 
(Table 6.10). The proportion of CNS-acting medication use in the three groups reflected a 
pattern. Older adults taking CNS-acting medication were 60% among recurrent fallers, 48% 
among single fallers, and 38% among non-fallers. On the other hand, the proportion of non-users 
of CNS-acting medications was 61.7% in non-fallers, 52.4% in single fallers, and 41.1% in 
recurrent fallers. Recurrent fallers were demonstrated to have a higher proportion of exceeding 
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limit drinkers as well as non-drinkers compared to non-fallers. After joining the subgroups of 
alcohol use and CNS-acting medication use variables the resulting exposure variable had six 
subcategories. However, the cell sample size of few cells was less (n < 20).  
 
Table 6.10 Distribution of Exposure Variables against Recurrent Fallers 
Variables Non-fallers Non-recurrent fallers Recurrent fallers 
 Sample  
persons  
Weighted 
percent (95% 
CI) 
Sample  
persons 
Weighted 
percent (95% 
CI) 
Sample  
persons 
Weighted 
percent (95% 
CI) 
Drinking status 
 
Non-drinkers 
Within-limit drinkers 
Exceeding-limit  
drinkers 
 
 
3626 
1523 
  318 
 
 
64.1 (62.2-65.9) 
29.5 (27.9-31.0) 
  6.4 (5.4-7.4) 
 
 
577 
200 
  39 
 
 
68.9 (65.0-72.8) 
26.2 (23.0-29.4) 
  4.9 (2.7-7.0) 
 
 
 
546 
158 
  45 
 
 
70.9 (67.3-74.6) 
21.9 (18.7-25.1) 
  7.2 (5.1-9.2) 
CNS-acting 
medications use 
 
Non-users 
Users 
 
 
 
3366 
2142 
 
 
 
61.7 (60.0-63.3) 
38.3 (36.7-40.0) 
 
 
 
424 
394 
 
 
 
52.4 (48.8-56.1) 
47.6 (43.9-51.2) 
 
 
 
311 
444 
 
 
 
41.1 (37.7-44.4) 
58.9 (55.6-62.3) 
CNS medication use 
+ drinking status  
 
Users + exceeding-
limit drinkers 
Users + within-limit 
drinkers 
Users + non-drinkers 
Non-users + 
exceeding limit 
drinkers 
Non-users + within 
limit drinkers 
Non-users +  
non-drinkers 
 
 
 
  100 
 
  499 
 
1528 
  218 
 
 
1024 
 
2098 
 
 
 
  2.0 (1.6-2.5) 
 
  9.7 (8.8-10.5) 
 
26.6 (25.1-28.1) 
  4.4 (3.6-5.2) 
 
 
19.8 (18.5-21.2) 
 
37.5 (35.7-39.2) 
 
 
 
  23 
 
  80 
 
289 
  16 
 
 
120 
 
288 
 
 
 
  2.9 (1.6-4.1) 
 
  9.9 (7.6-12.2) 
 
34.6 (31.3-37.9) 
  2.0 (0.71-3.3) 
 
 
16.3 (13.5-19.1) 
 
34.3 (30.6-37.9) 
 
 
 
  25 
 
  75 
 
340 
  20 
 
    
  83 
 
 206 
 
 
 
3.6 (2.1-5.1) 
 
10.6 (8.0-12.9) 
 
44.6 (41.0-48.2) 
3.5 (2.0-5.1) 
 
 
11.4 (8.9-13.8) 
 
26.3 (23.2-29.4) 
 
Column percentages are significantly different (Rao-Scott Chi-square test showed p-value <0.05) 
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Multi-nominal logistic regression was conducted to investigate the effect of alcohol and 
CNS-acting medications on the risk of recurrent falls (Table 6.11). Non-fallers were considered 
as reference group. Compared to non-users of CNS-acting medications, users were 35% (OR: 
1.35, 95% CI: 1.15-1.59, p-value= 0.0002) more likely to experience a recurrent fall. However, 
CNS-acting medication use did not seem to affect the risk of non-recurrent falls. Older adults 
who were exceeding-limit drinkers were found that have 48% (OR: 1.48, 95% CI: 1.06-2.07, p-
value=0.0225) greater odds of being recurrent fallers compared to non-drinkers. Within-limit 
drinking did not demonstrate significant association with to the risk of recurrent falls. Due to a 
small cell size the joint effect of alcohol and CNS-acting medication could not be analyzed.   
 
Table 6.11 Association Between Exposure Variables and Recurrent Fallers 
Variables Non-Recurrent Fallers Recurrent Fallers 
Adjusted  Odds Ratio 
(95% CI) 
p-value  Adjusted  Odds 
Ratio (95% CI) 
p-value 
Drinking status 
 
Non-drinkers 
Within-limit 
Exceeding-limit  
 
 
1 (reference) 
0.89 (0.73-1.09) 
0.79 (0.48-1.31) 
 
 
 
0.2566 
0.3670 
 
 
1 (reference) 
0.92 (0.75-1.13) 
1.48 (1.06-2.07) 
 
 
 
0.4130 
0.0225* 
CNS-acting 
medication use 
 
Non-users 
Users 
 
 
 
1 (reference) 
1.19 (0.96-1.47) 
 
 
 
 
0.1181 
 
 
 
1 (reference) 
1.35 (1.15-1.59) 
 
 
 
 
0.0002* 
Number of observations included in the model=6961  
Weighted frequency of these observations =19472994        
Number of observations deleted due to missing values in response or explanatory variables=202 
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6.5 Discussion  
This study aims at to understand the effect of the combined use of CNS-acting 
medications and alcohol, at different consumption levels, on the risk of falls in community 
dwelling Medicare beneficiaries aged 65 years or older. The complex, non-linear relationship 
observed between risk of falls and the use of CNS-acting medication and alcohol at varying 
degrees is the most interesting and novel aspect of this study.  
The potential concurrent use of alcohol and CNS-acting medication in the past year was 
found to be approximately 12% (n=814), with almost 80% of these potential concurrent users 
being within-limit drinkers and 20% drinking at an exceeding limit. Approximately 40% of the 
concurrent users took more than one CNS-acting medication in the past year. The proportion of 
potential concurrent users was substantial. Hence, it was important to understand the effect of the 
potential concurrent use of alcohol and CNS-acting medications on the risks of falling.  
Our findings showed that the use of CNS-acting medication by older drinkers who 
exceeded the NIAAA recommended drinking guidelines (no more than one drink per day) 
experienced 77% higher odds of falling. In addition, binge drinking in the presence of CNS-
acting medication use also increases the odds of falling by 87% among older adults. Increased 
fall risk was also observed among exceeding-limit drinkers who consumed opioid analgesics. 
Interestingly, CNS-acting medication users drinking within NIAAA recommended limit did not 
seem to significantly have higher odds of falling, though non-drinking CNS-acting medication 
users demonstrated 27% greater odds of falling. This suggests a complex non-linear effect of 
combined use of alcohol and CNS-acting medications on the risks of falling, driven by labyrinth 
of known and unknown factors.  
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Some of the possible explanations for this finding are summarized below: 
1. Our findings seemed to parallel the theory of protective effect of moderate drinking on 
the risk of falls in older adults.
1,120 
 The risk estimate observed in our study might be 
interpreted as the protective effect of moderate alcohol intake negating the harmful effect 
of CNS-acting medication use. However, it is noteworthy that the relationship between 
moderate alcohol use and risk of fall has been unclear and documented inconsistently in 
the literature
120
  
2. Older adults who take CNS-acting  medication and report consuming higher amount of 
alcohols may tend to have psychiatric conditions, depressive symptoms, pain, or history 
of problem drinking, which may increase their risk of falls.
9
  
3. Another potential premise is the effect of alcohol on bone mineral density (BMD); 
alcoholics are reported to have lower BMD, possibly due to accompanying nutritional 
deficiencies whereas moderate drinking might be associated with greater BMD.
123,124
  
4. Moderate drinkers might be healthier than heavy drinkers. Thus, the healthier profile of 
moderate drinkers could be confounding the association between moderate drinking and 
risk of falling.
125
 Moreover, such healthier older adults may have been following a 
healthier lifestyle, endorsing healthy eating habits, exercising, refraining from harmful 
activities such as smoking or heavy drinking. Although, the effect of health and 
functional status of older adults have been controlled in the logistic regression analysis, 
other variables such as diet, and exercise could not be taken into account due to lack of 
this information in the dataset.  
5. Studies have shown that people with higher educational level or belonging to upper 
socio-economic background tend to drink regularly but moderately. There is a possibility 
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that the link between the benefits of moderate drinking observed in our study could be 
explained by premorbid intellect, and its correlation with cognitive reserve. To elaborate, 
individuals with better premorbid cognition (person's intellectual functioning prior to 
known or suspected onset of brain disease or dysfunction) or with higher education level 
tend to have more cognitive reserve. Hence such individuals may have elevated threshold 
for experiencing functional impairment and less sensitive to the effect of alcohol.
126,127
  
Besides, several studies have advocated the beneficial effect of moderate drinking on 
cognitive function in older adults.
126,127
  
6. Another possible explanation could be development of tolerance (requirement to 
consume higher amount of the drug to achieve the same response) to alcohol due to 
regular, moderate drinking. Continuous, constant and moderate exposure to alcohol may 
result in lesser effect of alcohol due to metabolism driven by induced enzyme secretion or 
several other mechanisms involved at a cellular or molecular level.
128,129
  The CNS-acting 
medications such as benzodiazepines, barbiturates, anticonvulsant agents, and other 
sedative-hypnotics potentiate the inhibitory action of GABA by acting on a separate 
binding site on the receptors and changing the conformation of the receptor Alcohol 
modified the GABA receptor by “altering the membrane environment such that the 
receptor has an increases affinity for GABA and other sedative-hypnotics”. Thus the 
pharmacological action of these benzodiazepines, barbiturates, sedatives-hypnotics, and 
alcohol on the same receptor explains the similar impact of these agents and development 
of cross-tolerance.
 128
   
7. The beneficial effect of moderate drinking observed in our study could also be an artefact 
of residual confounding or the cross-sectional study design.  
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Some of the above explanations such as the healthy drinker effect, high cognitive reserve, 
development of tolerance, and potential benefits of moderate drinking could also explain the 
absence of a significant relationship between alcohol and risk of falling, controlling for CNS-
medication use. The relationship between alcohol consumption and risk of falls has been 
inconsistent and unclear in the literature. Some studies have found that high alcohol consumption 
is associated with risk of falling
1,93,114,130,131
 while other studies have failed to establish the 
association.
132
 A systematic review summarized the relationship between falls or fall injuries and 
alcohol use in older adults. The review summarized four studies that reported increased risk of 
falls or fall injuries associated with alcohol use (ranging from daily use to an average weekly 
consumption of greater than 21 drinks) however, twenty-one studies found no association 
between alcohol consumption and risk of falls or fall injuries.
119
 A study involving older 
participants of the Cardiovascular Health Study (CHS) reported that the cross-sectional analysis 
indicated an apparent inverse association between alcohol intake and risk of frequent falls 
(adjusted OR: 0.41, 95% CI: 0.14-1.17), but the longitudinal analysis found 25% (95% CI: 3-
52%) higher risk in drinkers of 14 or more drinks per week. A possible explanation for this 
observation could be that older adults at risk for falling tend to decrease their alcohol use over 
time or heavy drinkers at risk of fall tend not to enroll in cohort studies.
1
 Stenbacka et al. found 
that high levels of alcohol intake (greater than 500 grams/month) were associated with higher 
risk of injurious falls (relative risk: 2.27, 95% CI: 1.45-3.57).
93
 Few studies have described a 
protective association between moderate drinking and fall risk in older adults. A case-control 
study determined a protective effect (adjusted OR: 0.49, 95% CI: 0.25-0.95) of moderate 
drinking on the risk of hip fracture in mid and older aged adults.
118
 A study by Cawthon et al. 
concluded that light alcohol intake may decrease the risk if falling, but a history of problem 
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drinking increased fall risk.
123
 Mostly the CNS depressant effect of alcohol (causing sedation, 
drowsiness, dizziness, impaired and psychomotor function) has been implicated as an underlying 
rationale for the increase in fall risk.
2
 However, the effect of alcohol on bone mineral density 
may influence the association between alcohol and risk of falling. Several studies have been 
conducted to assess the relationship between bone mineral density and alcohol consumption. The 
evidence generated by this study is unclear and inconsistent; however, several longitudinal 
studies reported moderate alcohol intake was not predictive of the rate of bone loss.
123
  
Consistent with the literature, our findings suggest that CNS-acting medication use is a 
risk factor for fall in older adults. Furthermore, use of opioid analgesics, benzodiazepines, and 
psychotherapeutic agents (including antidepressants, anxiolytics, and antipsychotics) were 
associated with increased risk of falls. However, use of sedative-hypnotic medications or 
anticonvulsants was not significantly associated with fall risk. The higher risk for falling has 
been associated with the use of CNS-acting medications or psychotropic medication as detected 
by various observational studies including studies with prospective cohort and case control 
designs. A nested case-control study established that using psychotropic medications within three 
months of falling was associated with a higher risk of falling accidents among older men (OR: 
2.14, 95% CI: 1.87-2.44) and older women (OR: 2.21, 95% CI: 2.04-2.39).
133
A cross-sectional 
analysis of data from a large population of community-dwelling older adults estimated that the 
risk of falling increases by nearly 47% (OR: 1.47, 95% CI: 1.24-1.74) in users of psychotropic 
drugs.
134
 Previous studies have found the use of sedative-hypnotics or anticonvulsants to be 
significantly associated with fall risk.
115,132
 Contrary to the literature, our study did not detect 
significant association between the use of sedative-hypnotic or anticonvulsant, and fall risk. 
Possible explanations for this could be: i) the drug classification employed by the data source, ii) 
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under-reporting of sedative-hypnotic use, iii) use of newer sedative-hypnotic or anticonvulsants 
with better safety profiles such as zaleplon, in older adults prone to falling, or iv) an artefact of 
study design or residual confounding.  
Effects of alcohol consumption and CNS-acting medication use on the risk for injurious 
falls were studied separately employing a multi-nominal logistic regression model. CNS-acting 
medication use was found to be a risk factor for injurious falls but not a risk factor for non-
injurious falls. CNS-acting medication users had 61% greater likelihood of having an injurious 
fall compared to nonusers. Alcohol use, both within-limit drinking and exceeding-limit drinking, 
was not found to be associated with the odds of falling. The absence of a relationship between 
high alcohol use and risk of injurious falls observed in our study could also be due to the low 
sample size in that subgroup. A Swedish study found that high alcohol consumption (≥ 1,000 g 
of 100% ethanol per month) was associated with increased risk for one injurious fall in older 
women aged 60 years and older.
93
 The effect of concurrent use of alcohol and CNS-acting 
medication could not be investigated in this study due to the small sample size in some 
subgroups.  
The effects of alcohol consumption and CNS-acting medication use on the risks for 
recurrent falls were estimated separately utilizing a multi-nominal logistic regression model. 
CNS-acting medication use was found to be a risk factor for recurrent falls. Users of CNS-acting 
medications were 35% more likely to be recurrent fallers than non-users but association between 
CNS-acting medication use and risk for single fall was not significant. Drinking at an exceeding 
limit was associated with 48% higher odds of recurrent falls. However, it should be noted that 
only 24 older adults were recurrent fallers who are exceeding-limit drinkers. An analysis with a 
larger sample size can help confirm this finding. Other studies have also demonstrated 
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association between alcohol and risk for recurrent falls in older adults.
131,135
 A longitudinal study 
found that igh alcohol consumption (18 or more drinks per week) was a predictor of recurrent 
falls.  
The prevalence of falls and injurious falls reported in our study is similar to that seen in 
other studies as well. An analysis of survey reported data from MCBS 2002 Cost and Use file 
found that 22.1% (2909 out of 12669 respondents) of Medicare beneficiaries aged ≥65 years fell 
in the previous year and 33% of the participants who reported at least one fall required medical 
attention for at least one fall.
136
 The prevalence and pattern of alcohol consumption reported in 
this study is comparable to the prevalence estimated in using other national datasets. Analysis of 
the 2003 MCBS data showed that during a typical month in the past year 65.5% of the sample 
reported drinking no alcohol, 25.4% reported drinking within guidelines, 3.8% exceeded the 
monthly limit only, and 5.4% reported heavy episodic drinking.
137
 In general, the pattern and 
prevalence of alcohol or CNS-acting medication use differs depending upon the setting and 
design of the study or data source, definitions, cut-off limits, types of CNS-acting drug class 
used, data collection method, or country of study. Hence comparison of the magnitude of use of 
alcohol or CNS-acting medications between studies is difficult. Psychotropic medications are 
more prevalent among community-dwelling older adults than other age groups with research 
findings suggesting that between 35% and 53% of assisted living residents receive one or more 
psychotropic medications.
33
  
There are several limitations to this study. It is a cross-sectional study hence the cause-
effect relationship between the exposures and risk of fall cannot be determined. Further research 
using a case-control or cohort study design is necessary to confirm the findings of this study. It is 
beyond the scope of this study to definitively ascertain the concurrent use of CNS-acting 
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medication and alcohol. However the alcohol consumption measured in this study depicts typical 
or regular consumption in the past year. Usually older adults follow a consistent pattern of 
alcohol intake, however, certain events such as bereavement, retirement, loneliness, and disease 
conditions may cause them to increase or decrease their alcohol intake.
22,109,125
 Under-reporting 
of alcohol intake or fall events could bias the risk estimate assessed in this study. The duration, 
dose, and regimen of CNS-acting medications were not considered in this study. Residual 
confounding could also be a possibility. Inaccurate reporting or random error in collection or 
coding of data could have occurred. The findings of this study are only applicable to non-
institutionalized older adults.  
This study has several strengths. The risk estimates obtained in this study are controlled 
for the confounding effect of various risk factors including antihypertensive medication use
138
, 
eye impairment, functional status of the participants (using ADL and IADL, perceived health 
status), comorbidity, polypharmacy, age, gender, education, race,and  social activity.
9,139
  The 
medication use has been captured using survey as well as administrative data. This study uses a 
nationally representative sample of community-dwelling older adults aged 65 years or older. 
6.6 Conclusion 
The major findings of this study i.e. the risk of falls is higher among older adults taking 
CNS medication and either binge drinking or consuming alcohol at a level that exceeds the 
recommended limit, provide evidence of harmful effects of high alcohol intake by CNS-acting 
medication users. Based on the premise that alcohol consumption is a modifiable behavior and 
CNS-acting medication use in this group of older adults is justified, high alcohol consumption 
should be discouraged among CNS-acting medication users. Furthermore, this study confirms 
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that CNS-acting medication use is a risk factor for falls in older adults. To our knowledge, no 
other study has investigated the combined effect of alcohol and CNS-acting medication on risk 
of falls in older adults. Thus, the findings of this study may play an important role in drawing the 
attention of researchers and healthcare professionals to this area of study as well as adding to the 
literature 
Findings of this study highlight the potential value of screening older adults for high 
alcohol use, apart from other risk factors of falls. Dissemination of this information among health 
professionals will create awareness about the potentially deleterious effect of high alcohol 
consumption, especially among those prescribed CNS-acting medication. Greater attention 
should be given to patients on multiple CNS-acting medications or taking psychotherapeutic 
agents and opioid analgesics while screening for fall risk. In the era of evidence-based practice, 
the findings of our study will play a significant role in clinical practice to identify older adults at 
risk of fall. To summarize, these findings underscored the harmful effect of potential concurrent 
use of CNS-acting medications and excessive alcohol consumption 
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Chapter 7 
Section 7.1 Conclusion 
This dissertation aimed to provide a comprehensive perspective on alcohol use 
considering medication use and comorbid conditions. The first goal was to understand the pattern 
and prevalence of alcohol use that is deemed “risky” owing to the excessive amount of alcohol 
consumption, and immoderate alcohol intake in the presence of certain disease conditions and 
medications. In the next step, potential concurrent use of alcohol and CNS-acting medication 
was studied to determine the proportion of older adults at risk of experiencing alcohol-CNS 
medication interactions. Additionally, the effect of potential concurrent use of alcohol and CNS-
acting medication on the risk of falls was investigated by performing a cross-sectional analysis. 
The findings of this study are applicable to community-dwelling American older adults aged 65 
years or older.  
The MCBS 2009 data showed at-risk drinking varied between 5.6%-11% among older 
adults, depending on the definition of at-risk drinking. Potential concurrent use of CNS-acting 
medications and alcohol was observed to be 12.1% among non-institutionalized, Medicare 
beneficiaries aged 65 years or older. On the other hand, analyses of the NHANES data showed 
8.9% of non-institutionalized older adults reported drinking daily and taking at least one CNS-
acting medication in the past month. The prevalence rate obtained from NHANES data was a 
conservative estimate. These findings strongly suggest that a substantial proportion of older 
adults reported potentially harmful alcohol use and could be susceptible to alcohol-related 
adverse effects. Thus, identifying these vulnerable older adults and providing appropriate 
intervention is necessary. Interventions such as screening for at-risk drinking, counselling, and 
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screening for potential alcohol-medication or alcohol-drug interactions could minimize the risk 
among those older adults. However, to maximize the utilization of healthcare resources, older 
adults more likely to be at risk of alcohol-related adverse events need to be managed at the 
outset. The socio-demographic factors identified in this study can provide an insight into those 
risk factors. Age between 65-74 years, male gender, being white, history of smoking, high 
education, and, good health condition were some factors associated with hazardous alcohol use, 
identified using MCBS and NHANES data. 
The effect of potential concurrent use of alcohol and CNS-acting medication on the risk 
of falls was studied employing a cross-sectional study design. Though alcohol consumption was 
not found to be significantly associated with fall risk, high alcohol consumption (more than 30 
drinks/month) accompanied by CNS-acting medication use was associated with an increased 
odds of falling (OR: 1.72, 95% CI: 1.13-2.61). Older adults taking CNS-acting medication and 
reportedly binge-drinking encounter a significant increased risk of falls. CNS-acting medication 
use, in the absence of alcohol intake, was found to increase the odds of falling by 27% (OR: 
1.27, 95% CI: 1.07-1.51). CNS-acting medication use was also associated with risks for recurrent 
falls and injurious falls. High alcohol consumption (more than one 30 drinks/month) was found 
to be associated with risk for recurrent falls. The effect of combined use of alcohol and CNS-
acting medication on the risks for recurrent falls and injurious falls could not be studied due to 
lack of small size.  
The baby-boomer generation is known to use substances of abuse at a higher rate than the 
previous generations, so with the aging of this generation, the number of older adults requiring 
treatment for substance abuse is likely to increase. Additionally, older adults constitute the 
fastest growing segment of U.S. population. Thus, the demand for specialized health care 
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services will expand in future. In this scenario, understanding the adverse effects of risky 
drinking and identifying the factors associated with at-risk drinking is of utmost importance.  
By measuring the prevalence of at-risk drinking or potential concomitant use of alcohol 
and alcohol-interactive drugs, the proportion of older adults who could be at risk was determined 
which provided an insight into the magnitude of the problem. By identifying the factors 
associated with at-risk drinking or daily drinking, preventive measures or screening processes 
can be directed to those “high-risk” older adults. On the other hand, understanding the effects of 
concurrent use of alcohol and alcohol-interactive medications (in the case of our study, CNS-
acting medications) on health outcomes may play a significant role in evidence-based practice. In 
this current age, evidence forms the basis for framing treatment guidelines, planning preventive 
measure, and creating awareness among older adults. Hence this study not only fills a gap in 
literature but also creates evidence that can influence healthcare practices to achieve better 
outcomes.  This study can also play a role in increasing awareness among older adults about the 
potential adverse effects of alcohol use in the presence of comorbid conditions or when 
concomitantly consumed with medications.  
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Section 7.2 Future Directions 
The findings of this study can play a significant role in encouraging further research in 
this area, especially understanding the effect of the concomitant use of alcohol and alcohol-
interactive medications in older adults. Based on the findings of our study, further research to 
understand the effect of alcohol and CNS-acting medications on the risks for falling by 
employing case-control or cohort study designs is very important to confirm the findings this 
study.  
In the current age of “big data”, databases obtained from different sources, such as 
survey-collected data, administrative claims data, and electronic medical record, can be a useful 
and efficient base for conducting an epidemiological study. By using multiple years of MCBS 
data, a retrospective cohort study can be designed to evaluate the aforementioned research 
questions. In addition, Health Retirement Study (HRS) data linked to CMS data, or NHANES 
linked with CMS data can also be potential data sources for such studies.
97,140
 Several 
longitudinal studies such as The Health, Aging, and Body Composition (Health ABC) study and 
Cardiovascular Health study (CHS) are also potential sources of data for conducting this 
research.
141,142
 Moreover, assessing emergency department visits resulting from co-
administration of alcohol and psychotherapeutic agents can also help us understand the 
implications of concurrent use of alcohol and CNS-acting medications. DAWN is one of the data 
sources to conduct such a study.
26
   
Understanding the relationship between at-risk drinking and healthcare utilization and cost of 
this utilization in older adults is an important and interesting question that needs further research. 
Such a study will help assess the impact of at-risk drinking on healthcare resource utilization. 
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The MCBS data combines administrative claims records and information on out-of-pocket costs, 
access to care and other such variables collected from survey. Linking Part D data with other 
MCBS study data can also help obtain information of medication utilization. In addition, 
conducting a prospective study in congregate living facilities can be an alternative which can 
provide rich qualitative information about the drinking habits of older adults which a secondary 
database may not be able to provide.  
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Appendix A 
SAS Codes  
Logistic Regression  
proc surveylogistic data=newCNS_fall_medddrnk    varmethod=brr (fay=0.3); 
repweight CS1YR001-CS1YR100; 
   class   meddrnk (ref="nomed_nodrnk") 
      educate  (ref="more highschool")  
      marital  (ref= "married") 
      race     (ref= "white") 
      social   (ref="no") 
      age      (ref=">85") 
      H_SEX    (ref="2") 
     polypharm (ref=">=11")  
      IADL_cat (ref= "no") 
       ADL_cat (ref= "no")  
     old_health(ref="worse") 
          bp   (ref= "0")  
        eye   (ref= "no_impair") 
        comorbid (ref="zero") / param=ref;  
   model fall (event='yes')  = meddrnk  age H_SEX educate marital race social 
polypharm IADL_cat ADL_cat old_health  bp eye comorbid ;     
 weight CS1YRWGT;  
run; 
Multi-nominal Logistic Regression  
proc surveylogistic data=Newlib.atrisk_wt varmethod=brr (fay=0.3); 
class educate  (ref="more highschool")  
      marital  (ref= "married") 
      race     (ref= "white") 
      earn     (ref=">25000") 
      social   (ref="no") 
      age      (ref=">85") 
      smoke    (ref="neversmoker") 
      H_SEX    (ref="2") 
     polypharm (ref=">=11")  
     old_health(ref="worse") 
       comorbid (ref=">=5")  
      jobstat   (ref="No")  
       IADL_cat (ref= "no") 
       ADL_cat (ref= "no")  / param=ref; 
   model allrisk (ref="non-drinker") = age H_SEX race marital educate social 
earn jobstat smoke polypharm comorbid IADL_cat ADL_cat old_health / 
link=glogit; 
weight CS1YRWGT; 
repweight CS1YR001-CS1YR100; 
run; 
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